0001493152-23-009895.txt : 20230331 0001493152-23-009895.hdr.sgml : 20230331 20230331063833 ACCESSION NUMBER: 0001493152-23-009895 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 98 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230331 DATE AS OF CHANGE: 20230331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DSwiss Inc CENTRAL INDEX KEY: 0001652561 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 474215595 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-208083 FILM NUMBER: 23783111 BUSINESS ADDRESS: STREET 1: UNIT 18-11, 18-12 & 18-01, TOWER A, STREET 2: VERTICAL BUSINESS SUITE, BANGSAR SOUTH, CITY: KUALA LUMPUR STATE: N8 ZIP: 59200 BUSINESS PHONE: (603)2770-4032 MAIL ADDRESS: STREET 1: UNIT 18-11, 18-12 & 18-01, TOWER A, STREET 2: VERTICAL BUSINESS SUITE, BANGSAR SOUTH, CITY: KUALA LUMPUR STATE: N8 ZIP: 59200 10-K 1 form10-k.htm
0001652561 false FY No 0001652561 2022-01-01 2022-12-31 0001652561 2022-06-30 0001652561 2022-12-31 0001652561 2021-12-31 0001652561 2021-01-01 2021-12-31 0001652561 us-gaap:CommonStockMember 2020-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001652561 us-gaap:RetainedEarningsMember 2020-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2020-12-31 0001652561 2020-12-31 0001652561 us-gaap:CommonStockMember 2021-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001652561 us-gaap:RetainedEarningsMember 2021-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2021-12-31 0001652561 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001652561 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001652561 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001652561 us-gaap:CommonStockMember 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-12-31 0001652561 DQWS:DSwissHoldingLimitedMember country:HK 2022-12-31 0001652561 DQWS:DSwissSdnBhdMember country:MY 2022-12-31 0001652561 country:MY DQWS:DSwissBiotechMember 2022-12-31 0001652561 DQWS:DSwissHoldingLimitedMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissHKLimitedMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissSdnBhdMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissBiotechSdnBhdMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissHKLimitedMember us-gaap:SubsequentEventMember 2023-01-17 2023-01-18 0001652561 DQWS:DSwissHKLimitedMember us-gaap:SubsequentEventMember 2023-01-18 0001652561 DQWS:ComputerAndSoftwareMember 2022-01-01 2022-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001652561 us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001652561 DQWS:MotorVehiclesMember 2022-01-01 2022-12-31 0001652561 DQWS:MalaysianRinggitExchangeMember 2022-12-31 0001652561 DQWS:MalaysianRinggitExchangeMember 2021-12-31 0001652561 DQWS:PeriodAverageMalaysianRinggitMember 2022-12-31 0001652561 DQWS:PeriodAverageMalaysianRinggitMember 2021-12-31 0001652561 DQWS:HongKongExchangeMember 2022-12-31 0001652561 DQWS:HongKongExchangeMember 2021-12-31 0001652561 DQWS:PeriodAverageHongKongMember 2022-12-31 0001652561 DQWS:PeriodAverageHongKongMember 2021-12-31 0001652561 DQWS:ChineseRenminbiExchangeMember 2022-12-31 0001652561 DQWS:ChineseRenminbiExchangeMember 2021-12-31 0001652561 DQWS:PeriodAverageChineseRenminbiMember 2022-12-31 0001652561 DQWS:PeriodAverageChineseRenminbiMember 2021-12-31 0001652561 DQWS:ManagementServicesAgreementIMember DQWS:DSwissHKLimitedMember 2016-06-26 2016-06-27 0001652561 DQWS:ComputerAndSoftwareMember 2022-12-31 0001652561 DQWS:ComputerAndSoftwareMember 2021-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001652561 us-gaap:OfficeEquipmentMember 2022-12-31 0001652561 us-gaap:OfficeEquipmentMember 2021-12-31 0001652561 DQWS:MotorVehiclesMember 2022-12-31 0001652561 DQWS:MotorVehiclesMember 2021-12-31 0001652561 DQWS:FirstFinanceLeaseAgreementMember 2022-01-01 2022-12-31 0001652561 DQWS:SecondFinanceLeaseAgreementMember 2022-01-01 2022-12-31 0001652561 country:US 2022-01-01 2022-12-31 0001652561 country:US 2021-01-01 2021-12-31 0001652561 country:SC 2022-01-01 2022-12-31 0001652561 country:SC 2021-01-01 2021-12-31 0001652561 country:HK 2022-01-01 2022-12-31 0001652561 country:HK 2021-01-01 2021-12-31 0001652561 country:MY 2022-01-01 2022-12-31 0001652561 country:MY 2021-01-01 2021-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2022-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2021-12-31 0001652561 DQWS:SeychellesMember 2022-12-31 0001652561 DQWS:SeychellesMember 2021-12-31 0001652561 DQWS:HongKongMember 2022-12-31 0001652561 DQWS:HongKongMember 2021-12-31 0001652561 DQWS:MalaysiaMember 2022-12-31 0001652561 DQWS:MalaysiaMember 2021-12-31 0001652561 DQWS:PeoplesRepublicOfChinaPRCMember 2022-12-31 0001652561 DQWS:PeoplesRepublicOfChinaPRCMember 2021-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissHKLimitedMember DQWS:HongKongMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissHKLimitedMember DQWS:HongKongMember 2022-12-31 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember srt:MinimumMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember srt:MaximumMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember 2022-12-31 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember 2022-01-01 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2022-01-01 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2021-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2022-01-01 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2021-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2022-01-01 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2021-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2022-01-01 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2021-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2022-01-01 2022-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2022-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2021-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2022-01-01 2022-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2022-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2021-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2022-01-01 2022-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2022-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2021-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2022-01-01 2022-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2022-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2021-12-31 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 2022-12-31 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyAMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyAMember 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyBMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyBMember 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyCMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyCMember 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyDMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyDMember 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyAMember 2022-12-31 0001652561 DQWS:NVMember 2022-01-01 2022-12-31 0001652561 DQWS:NVMember 2022-12-31 0001652561 country:SC 2022-12-31 0001652561 country:HK 2022-12-31 0001652561 country:MY 2022-12-31 0001652561 DQWS:NVMember 2021-01-01 2021-12-31 0001652561 DQWS:NVMember 2021-12-31 0001652561 country:SC 2021-12-31 0001652561 country:HK 2021-12-31 0001652561 country:MY 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:MYR xbrli:shares iso4217:MYR

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Fiscal Year Ended December 31, 2022

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________

 

Commission File Number 333-208083

 

DSwiss, Inc.

(Exact name of registrant issuer as specified in its charter)

 

Nevada   47-4215595

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite,

Avenue 3, Bangsar South, No.8 Jalan Kerinchi, 59200, Kuala Lumpur, Malaysia.

(Address of principal executive offices, including zip code)

 

Registrant’s phone number, including area code (603) 2770-4032

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act: None

 

Securities registered pursuant to Section 12(g) of the Securities Exchange Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

 

Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

YES ☐ NO ☒

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-accelerated Filer ☐ Smaller reporting company ☒ Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes ☐ No ☒

 

The aggregate market value of the Company’s common stock held by non-affiliates computed by reference to the closing bid price of the Company’s common stock, as of the last business day of the registrant’s most recently completed second fiscal quarter:

 

Not Applicable

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

 

Not Applicable

 

APPLICABLE ONLY TO CORPORATE REGISTRANTS

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at December 31, 2022
Common Stock, $.0001 par value   206,904,585

 

 

 

 

 

 

DSwiss, Inc.

FORM 10-K

For the Fiscal Year Ended December 31, 2022

Index

 

    Page #
PART I    
     
Item 1. Business 2
Item 1A. Risk Factors 10
Item 1B. Unresolved Staff Comments 10
Item 2. Properties 11
Item 3. Legal Proceedings 11
Item 4. Mine Safety Disclosure 11
     
PART II    
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 11
Item 6. Selected Financial Data 13
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 13
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 19
Item 8. Financial Statements and Supplementary Data 19
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 20
Item 9A. Controls and Procedures 20
Item 9B. Other Information 21
     
PART III    
     
Item 10. Directors, Executive Officers and Corporate Governance 22
Item 11. Executive Compensation 25
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 26
Item 13. Certain Relationships and Related Transactions, and Director Independence 27
Item 14. Principal Accounting Fees and Services 28
     
PART IV    
     
Item 15. Exhibits, Financial Statement Schedules 28
     
SIGNATURES 29

 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “foresee,” “estimate” and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted. These risks and uncertainties include the following:

 

  ● The availability and adequacy of our cash flow to meet our requirements;
     
  ● Economic, competitive, demographic, business and other conditions in our local and regional markets;
     
  ● Changes or developments in laws, regulations or taxes in our industry;
     
  ● Actions taken or omitted to be taken by third parties including our suppliers and competitors, as well as legislative, regulatory, judicial and other governmental authorities;
     
  ● Competition in our industry;
     
  ● The loss of or failure to obtain any license or permit necessary or desirable in the operation of our business;
     
  ● Changes in our business strategy, capital improvements or development plans;
     
  ● The availability of additional capital to support capital improvements and development; and
     
  ● Other risks identified in this report and in our other filings with the Securities and Exchange Commission or the SEC.

 

This report should be read completely and with the understanding that actual future results may be materially different from what we expect. The forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Use of Defined Terms

 

Except as otherwise indicated by the context, references in this Report to:

 

  ● The “Company,” “we,” “us,” or “our,” “DSwiss” are references to DSwiss, Inc., a Nevada corporation.
     
  ● “Common Stock” refers to the common stock, par value $.0001, of the Company;
     
  ● “U.S. dollar,” “$” and “US$” refer to the legal currency of the United States;
     
  ● “Securities Act” refers to the Securities Act of 1933, as amended; and
     
  ● “Exchange Act” refers to the Securities Exchange Act of 1934, as amended.

 

1

 

 

PART I

 

ITEM 1. BUSINESS

 

Corporate History

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015.

 

DSwiss, Inc. operates through its wholly-owned subsidiary, DSwiss Holding Limited, a Company organized under the laws of Seychelles.

 

The principal activity of the Company and its subsidiaries is to supply high-quality health and beauty products, including beverages to assist in weight management, anti-aging products, and immune system products designed to improve the overall health system in our body.

 

We have currently conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles is an investment holding company with 100% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold 100% equity interest in DSwiss Sdn. Bhd. We have invested in DSwiss Biotech Sdn. Bhd., a Company incorporated in Malaysia and owned a 40% equity interest.

 

The Company, through its subsidiaries and its variable interest entities (“VIEs”), mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

 

  Company name  Place and date of incorporation  Particulars of issued capital  Principal activities  Proportional of ownership interest and voting power held
1. DSwiss Holding Limited  Seychelles,
May 28, 2015		  1 share of ordinary share of US$1 each  Investment holding  100%
               
2. DSwiss (HK) Limited  Hong Kong,
May 28, 2015		  1 share of ordinary share of HK$1 each  Supply of beauty products  100%
               
3. DSwiss Sdn Bhd  Malaysia,
March 10, 2011		  2 shares of ordinary share of RM 1 each  Supply of beauty products  100%
               
4. DSwiss Biotech Sdn Bhd (1) (2)  Malaysia,
March 17, 2016		  250,000 shares of ordinary share of RM 1 each  Supply of biotech products  40%

 

  (1)

Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of this entity unilaterally, and hence the Company has control over this entity.

     
  (2) On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

Business Overview

 

One of the leading one-stop Turnkey Private Label ODM/OEM service provider, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms. DSwiss addresses a distinct demand in the market for a manufacturer who could ensure the quality of the ingredient sources and offer efficient one-stop service from raw material, product development, manufacturing and packaging.

 

Since our founding, we have experienced tremendous growth in Malaysia. We offer exceptional lifestyle solutions to consumers all over the world thanks to our over 10 years of continuous innovation and work in the health and beauty business. Our company’s Chief Executive Officer, Vincent Leong has led it with a strong hand, and as a result, our products are now consumed around the world, such as Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. With the help of our distributors, we have so far extended throughout Asia, and we are adamant about extending our geographic reach into untapped markets.

 

With a team of professionals at the helm, DSwiss is assured of providing the best products and attending client’s needs from consultations to products. To fulfil customer needs, we carry out research and development based on our philosophy of “creating beauty, health, and the ecosystem”. Our cutting-edge research and development team has always been exploring new product lines and integrating the most recent science and technology, which will enable us to produce more evidence-based, high-value added formulations and products and maintain our competitive position in the market.

 

2

 

 

With our extensive years of expertise in the OEM and ODM services industry, we offer comprehensive solutions to our customers. In addition to business consultancy, DSwiss offers useful guidance on current market trends as we all as marketing solutions and support to assist our clients’ business endeavours. Versatility and reliability are evidently the driving principles behind DSwiss, who manufactures products using high-grade ingredients and materials at every stage of research, development, and production.

 

As advocates of natural and high-quality active ingredients, we actively seek for and select the best ingredients, as we are dedicated to adhering to policies under rigorous quality control and assurance criteria, thereby maximizing the safety and efficacy of our products. We dedicate ourselves to maintaining the highest standard in our products in order to provide assurance and a continual commitment to producing high-quality products in accordance with the strict specifications and guidelines specified out by Ministry of Health (“MOH”) Malaysia. Each step of production process has quality control built in and implemented. We guarantee the highest quality product using precise production techniques and specialised equipment, promising ongoing improvements and enhancements based on customer feedback. DSwiss takes pride in offering the best results in customisable solutions for health supplements and beauty product manufacturing.

 

Talent Development in Diverse Expertise

 

DSwiss has assembled a strong team and strategic partners of manufacturing and R&D facilities across the world to meet the need for the most cost-effective and high-quality product and service. DSwiss embraces every new opportunity as an incentive to forge a partnership with its customers by working with them to develop and produce their customised unique formulation.

 

In the previous year, we expanded our professional team of nutritionists, scientists, laboratory technicians, customer relationship executives, operation teams, and graphic designer. This team collaborates to manufacture innovative natural health and beauty products with the best ingredients and formulas while adhering to legal standards. To strengthen the product’s unique selling point, our committed team works together both internally and with our clients to create concept, packaging and product graphics that are exceptionally inventive and creative.

 

Currently, we are carrying out our future plan from the previous year in Talent and Product Development, which involves studying and developing new formulas to the market. Market analysis literature research and product testing for overall efficacy and compliance with JAKIM Halal and Malaysian Ministry of Health criteria are all necessary for such development. Our professionals manage the entire process, including the sourcing of raw materials, production, quality control, stability and safety test, lab testing by third-party labs, packaging and shipping.

 

With our experience and knowledge, we have further increased our ODM/OEM clientele in 2022 and have also improve our brand’s recognition within the sector. Today, manufacturers must possess more specialised knowledge, R&D experience, and cutting-edge technologies due to the rapidly increasing demand for high-quality products. Our goal at DSwiss is to be a solid and trustworthy service provider and partner for individuals who are dedicated to the success of their brands of health and beauty products.

 

Moving forward, the development of DSwiss will continue to be fuelled by our future goal of becoming the global pioneer in healthcare and skincare/personal care brand manufacturer. Whilst DSwiss has always prioritized in expanding business within Asia, we definitely intend to eventually take our brand worldwide. With the mission of being the world’s leading biotechnology firm for health and beauty, we strive to lead the industry with innovative technologies, one-stop solution of manufacturing, creative packaging and exceptional customer service.

 

3

 

 

Our ODM/OEM Services

 

Overview

 

We are Turnkey Private Label Manufacturing Services provider for nutraceutical and skincare/ personal care ODM/OEM products.
Provides a one-stop services ranges from research and development of custom formulation, manufacturing and production, packaging and shipping including import and export and all licenses needed. We also provide premium services, strict lab testing and quality control, with efficient production
Our professionals provide custom formulation that are scientifically-proven and naturally-effective, high-value added formulations and products
Our production facilities are in compliance with national and international standards including GMP (Good Manufacturing Practices), HACCP (Hazard Analysis and Critical Control Point), JAKIM Halal, ISO and MESTI.

 

Consultation

 

 

With the experiences working with different clients, we have experienced tremendous growth. We provide helpful assistance on how to manage a successful and efficient business in all areas, as well as advice on the most recent market trends and best practices. We offer excellent marketing solutions and support in addition to business consultancy to help with your business endeavors.

 

Unique Customised Formulations and Ingredient Sourcing

 

 

Our innovative in-house R&D team will perform comprehensive study to provide specialized formula and individualized services. Only the best ingredients and resources sourced and chosen from reliable vendors. In order to maximize the security and efficiency of our products, we are dedicated to adhering to stringent quality control and assurance criteria.

 

4

 

 

Design and Packaging

 

 

Our committed teams work together both internally and externally with clients to create inventive packaging and product visuals that will strengthen the unique selling points.

 

In accordance with the standards established by the Ministry of Health, our services include consultation on packaging (text, label and graphics), the sustainability of the packaging materials, product stability, and shelf life

 

Regulatory Service

 

 

In order for your product to efficiently launch on the market, our knowledgeable and committed team of regulatory specialists will assist with various documentations and applications from Ministry of Health (Malaysia), HALAL (Malaysia) and other regulatory bodies.

 

5

 

 

Production and Quality Assurance

 

 

Our products are subjected to stringent quality and safety control that adheres to our GMP requirements. We make every effort to guarantee that finished products and raw materials are tested promptly and according to our internal laboratory’s standards. Based on the needs of our customers, our well-equipped factory has a variety of machines that can produce a variety of dosage forms and containers.

Each procedure has quality control built in and used. We guarantee that our clients receive the highest quality goods and services while constantly making improvements and additions thanks to our exact production methods and specialized equipment.

 

Logistics & Delivery

 

 

We take pride in offering comprehensive service. Our team makes sure that every product is delivered on time and in the finest condition possible.

 

6

 

 

Products and Formulations

 

Functional Food

 

 

Functional food, also known as nutraceuticals are foods that provide positive health effects beyond basic nutrition. For instance, with additional benefits such as promoting body function, reduce the risk of disease, and overall health improvement.

 

Fortified with nutrients, minerals, vitamins and bioactive compounds that promote good health including avoid nutritional deficiencies, maintain intake of adequate nutrients, and maintain good physiological functions.
Our experienced and professional food technologies and scientist team would formulate the food supplement in which they come in different forms (powder, liquid, chewable tablets, jellies, tea-bags, capsules and gummies).
Aims to formulate with natural, effective, proprietary standardized extracts and scientifically proven ingredients.

 

Skincare Products

 

 

 

Skincare products are essential to fulfil people’s pursuit of beauty with a range of practices that enhances and care for skin integrity, conditions and appearance.

 

7

 

 

Experienced R&D team aims to formulate with effective ingredients that are naturally effective and scientifically-proven to possess beautifying functions; and at the same time safe with the use of appropriate type and amount. For example, free from banned substances, heavy metals and allergens.
Able to provides skincare product in various forms like serum, toner, cleanser, essence, cream, facial mask, gel, lotion to meet specialized needs.

 

Personal Care Products

 

 

Personal care products describe a range of consumable products intended to maintain personal hygiene, personal grooming or for beautification purposes. Such products include cosmetics, shower gel, shampoo, soap, scrub, exfoliant, toothpaste, gel, sunscreen, conditioner and lotion.
The application of personal care products can be used any intended body parts such as skin, nails, hair, lips, oral or external genital organs.
Can be introduced: rubbed, poured, sprinkled, sprayed, or directly applied in order to cleanse, beautifying, altering appearance or maintain personal hygiene like protect from germs, prevent bad odor, and keep in good condition.

 

Pet-Care Products

 

 

8

 

 

Adhering to the philosophy of equality of life, we ventured into the sector of pet-care products with the aim to provides comprehensive care to beloved pets with the intention to improve pet’s quality of life.
Provides pet supplements as defined substance for oral consumption by pet, whether in or on feed or offered separately with nutrients provision, relieve health conditions. . For instance, boosting overall health and energy, enhances immunity, reduce risk of illness and age-related conditions, and to improve performance and mental activities. Also provides pet-care products including pet shampoo intended to hygiene, grooming and beautification.
Customized formulation that are suitable for specific needs of pets requirement such as mild and gentle to sensitive animal’s skin that are different from a human, but at the same time effective to address health issues or to improve conditions.

 

Trademark

 

The Company owned several trademark registers under its subsidiaries in respective jurisdiction of which the subsidiary is operates.

 

●Cambodia
●Malaysia
●Singapore
●China
●Hong Kong
●India
●Myanmar
●Vietnam
●EUIPO

 

Future Plan

 

Marketing Campaign and Publicity Enhancement

 

The Company is actively seeking opportunity to increase the market share of beauty and health industry locally and overseas, which requires continuous spending on marketing campaign primarily via social media and other online e-commerce platform which already in place currently to ensure the company product exposure and brand awareness.

 

Future marketing campaign and publicity enhancement will be conduct thru but not limited to following:

 

  1. Work closely with Professional biotech and life sciences partner to straighten our advantages.
  2. Work closely with new retail tech partner to increase our sales and exposure.
  3. Providing the complete provider solution in biotechnology, nutraceutical, skincare for turnkey private label manufacturing services

 

Human Resources and Talent Development

 

Taking into consideration of the aforementioned development, the company is well aware that with existing manpower is far from sufficient to the materialization of future plan, thus spending on human resources and talent development is inevitable, including but not limited to internal admin and operation, sales and marketing, accounting and finance as well as top management.

 

Merger and Acquisition

 

The Company is actively seeking opportunity to merge and acquire potential target company to derive extraordinary synergies in multiple segments but limited to healthcare, bio-technology, beauty slimming and wellness, food science and related industries. The management believe that organic growth itself is incapable of coping with the expectation of shareholders in the current dynamic business environment, thus via merger and acquisition the Company can create greater value to every stakeholder not limited to shareholders.

 

9

 

 

Marketing

 

We recognise the growing trend of social media and because of that, the management had decided to place a higher priority on social media for our marketing strategy. Coupled with the extensive networks we had built since our inception, the nature of our job has become easier and efficient to reach out to our clients. But, perhaps the most imperative to our success is the ability to connect with our customers and receive their feedback directly. From the feedback we received, we can understand our customer’s demands better and make further improvements. As a result, our customers’ base has been growing exponentially and resulted in a robust brand image of our company.

 

Competition

 

The beauty and healthcare industry are highly competitive, we might be in disadvantage competing with competitor who greater reserve or access to capital than we do to carry out operations and marketing efforts. We hope to maintain our competitive advantage by utilizing the experience, knowledge, and expertise of our current staff as well as offering exemplary our customer service. Besides, we would like to explore the functional medicine and homeopathic supplements for complementary health and integrative health market needs.

 

Customers

 

For the year ended December 31, 2022, the Company has generated $1,849,047 revenue from clients under the ordinary course of business of the Company. The revenue mainly represented OEM/ODM sales of Nutraceutical / Skincare and Medical Consumable Supplies to clients.

 

Employees

 

As of December 31, 2022, the Company has twelve (12) full time employees including Mr. Leong Ming Chia who is our Chief Executive Officer, director, secretary and treasurer that works full time.

 

Currently, our CEO all have the flexibility to work on our business up to 70 hours per week, but are prepared to devote more time if necessary.

 

We do not presently have pension, health, annuity, insurance, stock options, profit sharing, or similar benefit plans; however, we may adopt plans in the future. There are presently no personal benefits available to our Officers, Directors or employees.

 

Government Regulation

 

We are subject to the laws and regulations of the jurisdictions in which we operate, which may include business licensing requirements, income taxes and payroll taxes. In general, the development and operation of our business is not subject to special regulatory and supervisory requirements.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

10

 

 

ITEM 2. PROPERTIES

 

Our principal executive office is located at Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite, Avenue 3, Bangsar South, No. 8, Jalan Kerinchi, 59200, Kuala Lumpur, Malaysia. This location has been rented by DSwiss Sdn Bhd for a 24-month period from January 1, 2022 to December 31, 2023, for an initial deposit of MYR 67,200 and additional monthly payments in the amount of MYR 16,800 over the course of the lease. The office lease is ending on December 31, 2023.

 

In July 2018, the Company obtained a loan in the principal amount of MYR250,000 (approximately $60,479) from Public Bank Berhad, a financial institution in Malaysia, to finance the acquisition of a motor vehicle. The loan bears interest at the base lending rate less 2.38% per annum, is payable in 83 monthly instalments of MYR3,473 (approximately $840) each and a final monthly instalment of MYR3,391 (approximately $820) and matures in June 2025.

 

As of December 31, 2022, the Company has an outstanding loan to be settle for aforementioned acquisition of motor vehicle of MYR104,108 (approximately $23,577), of which MYR 41,676 (approximately $9,438) to be settled in 12 instalments in year 2023 and MYR62,432 (approximately $14,139) to be settled in 18 instalments after year 2023.

 

In December 2021, the Company had obtained another loan financing in the principal amount of MYR180,000 (approximately $43,134) from Public Bank Berhad, a financial institution in Malaysia, to finance the acquisition of a motor vehicle. The loan bears interest at the base lending rate less 2.04% per annum, is payable in 60 monthly instalments of MYR3,306 (approximately $792) each and matures in December 2026.

 

As of December 31, 2022, the Company has an outstanding loan to be settle for aforementioned acquisition of motor vehicle of MYR155,382 (approximately $35,189), of which MYR39,672 (approximately $8,985) to be settled in 12 instalments in year 2023 and MYR115,710 (approximately $26,205) to be settled in 35 instalments after year 2023.

 

Loan acquired for the acquisition of motor vehicle mentioned above are denominated in MYR, of which subjected to the fluctuation in reporting currency.

 

ITEM 3. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. There are currently no pending legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Our common stock is currently quoted on the OTC Pink under the trading symbol “DQWS.”

 

Trading in stocks quoted on the OTC Pink is often thin and is characterized by wide fluctuations in trading prices due to many factors that may have little to do with a company’s operations or business prospects. We cannot assure you that there will be a market for our common stock in the future.

 

For the periods indicated, the following table sets forth the high and low bid prices per share of common stock based on inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

 

11

 

 

Fiscal Year 2022  Highest Bid   Lowest Bid 
First Quarter  $0.25   $0.10 
Second Quarter  $0.29   $0.13 
Third Quarter  $0.29   $0.10 
Fourth Quarter  $0.29   $0.08 

 

Holders

 

As of December 31, 2022, we had 206,904,585 shares of our Common Stock par value, $.0001 issued and outstanding. There were 428 beneficial owners of our Common Stock.

 

Transfer Agent and Registrar

 

The transfer agent for our capital stock is VStock Transfer, LLC, with an address at 18, Lafayette Place, Woodmere, New York 11598 and telephone number is +1 (212)828-8436.

 

Penny Stock Regulations

 

The Securities and Exchange Commission has adopted regulations which generally define “penny stock” to be an equity security that has a market price of less than $5.00 per share. Our Common Stock, when and if a trading market develops, may fall within the definition of penny stock and be subject to rules that impose additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors (generally those with assets in excess of $1,000,000, or annual incomes exceeding $200,000 individually, or $300,000, together with their spouse).

 

For transactions covered by these rules, the broker-dealer must make a special suitability determination for the purchase of such securities and have received the purchaser’s prior written consent to the transaction. Additionally, for any transaction, other than exempt transactions, involving a penny stock, the rules require the delivery, prior to the transaction, of a risk disclosure document mandated by the Securities and Exchange Commission relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market. Finally, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. Consequently, the “penny stock” rules may restrict the ability of broker-dealers to sell our Common Stock and may affect the ability of investors to sell their Common Stock in the secondary market.

 

In addition to the “penny stock” rules promulgated by the Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit the investors’ ability to buy and sell our stock.

 

Dividend Policy

 

Any future determination as to the declaration and payment of dividends on shares of our Common Stock will be made at the discretion of our board of directors out of funds legally available for such purpose. We are under no contractual obligations or restrictions to declare or pay dividends on our shares of Common Stock. In addition, we currently have no plans to pay such dividends. Our board of directors currently intends to retain all earnings for use in the business for the foreseeable future.

 

Equity Compensation Plan Information

 

Currently, there is no equity compensation plan in place.

 

12

 

 

Unregistered Sales of Equity Securities

 

Currently, there is no unregistered sales of equity securities.

 

Purchases of Equity Securities by the Registrant and Affiliated Purchasers

 

We have not repurchased any shares of our common stock during the fiscal year ended December 31, 2022.

 

ITEM 6. SELECTED FINANCIAL DATA

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the notes to those financial statements appearing elsewhere in this Report.

 

Certain statements in this Report constitute forward-looking statements. These forward-looking statements include statements, which involve risks and uncertainties, regarding, among other things, (a) our projected sales, profitability, and cash flows, (b) our growth strategy, (c) anticipated trends in our industry, (d) our future financing plans, and (e) our anticipated needs for, and use of, working capital. They are generally identifiable by use of the words “may,” “will,” “should,” “anticipate,” “estimate,” “plan,” “potential,” “project,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend,” or the negative of these words or other variations on these words or comparable terminology. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. You should not place undue reliance on these forward-looking statements.

 

The forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date on which the statements are made or to reflect the occurrence of unanticipated events.

 

Overview

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015. DSwiss Holding Limited owns 100% of DSwiss (HK) Limited, a Hong Kong Company, which owns 100% of DSwiss Sdn Bhd, the operating Malaysia Company of which is described below. In 2016, DSwiss (HK) Limited invested in DSwiss Biotech Sdn Bhd, incorporated in Malaysia, and owned 40% equity interest. We have incorporated a new company namely DSwiss International Trading (Shenzhen) Limited in China, with 100% equity interest owned by DSwiss (HK) Limited. On November 9, 2020, DSwiss International Trading (Shenzhen) Limited was officially deregistered.

 

Our Company is a beauty supply company formed with the goal of supplying high quality beauty products directly to our clients. Our beauty supplies include, but are not limited to, beverages to assist in burning and reducing fat, anti-aging creams, and products designed to improve the overall health and physical appearance of our clients. Currently we supply our products in Malaysia, Singapore, Indonesia, Hong Kong and China. However, we have intentions to expand to Myanmar, Macau, Vietnam and Cambodia, and subsequent to that we will make efforts to expand throughout the world a premier biotech-nutraceutical company, supplying high-quality health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to improve the overall health system in our body.

 

At this time, we operate exclusively online through our website: http://www.dswissbeauty.com/

 

Our Company continuously strives to improve the already high standard of our goods and services through ongoing research and market development. We are going to penetrate into South East Asia markets through the recruitment of distributors and via the social media like Facebook and Instagram. We foresee to spend a substantial amount in marketing and advertising in the coming year. At DSwiss we are determined to bring new products to markets that we have not yet explored.

 

13

 

 

Products which meet the definition of a functional food and cosmetics related products need to be registered or notified with the Drug Control Authority (DCA), Ministry of Health Malaysia. Manufacturing, marketing, importation and the sale of unregistered products is a violation of the Drug Control Regulations and Cosmetics Act 1984 of Malaysia and enforcement action can be taken.

 

At DSwiss, research and development is an ongoing effort whose purpose is to ensure our products on the forefront of quality and effectiveness. Equipped with state-of-the-art machinery, our innovative research and development team are constantly exploring on new development and product lines that will enable us to provide the highest quality standard and remain competitive in the industry.

 

DSwiss’s products are certified and approved by the Ministry of Health (“MOH”) Malaysia. Due to the stringent requirements from MOH Malaysia, we strive to upkeep the highest possible standard in our products to provide assurance and as a prove of our continuing commitment to providing quality products.

 

We always strive to offer products as high quality as possible, and hope that this assurance from an esteemed regulatory body will also serve to prove our continuing commitment to providing quality goods.

 

DSwiss have own brand Quantum Resonant Magnetic Analyzer which is DSwiss Quantum Resonant Magnetic Analyzer. DSwiss Quantum Resonant Magnetic Analyzer is a Hi-tech innovation project, which is related to medical, bio-informatics, electronic engineering, etc. It is based on quantum medical, and scientifically analyzes the human cell’s weak magnetic field collected by advanced electronic device. The analyzer can work out the customer’s health situation and main problem. According to the checking result, the analyzer can figure out the reasonable treatment recommendation. The quantum resonant magnetic analyzer is the individualized guide of comprehensive healthy consulting and updated healthy sciences, and its characteristics and advantages are comprehensive, non-invasive, practical, simple, quick, economical and easy to popularize. We can see DSwiss Quantum Resonant Magnetic Analyzer can help our customers to more concern about their health and skin condition.

 

Our expected growth is planned to occur primarily through the implementation of our social media marketing strategy. DSwiss already has a strong relationship with social media (eg. Facebook, Instagram and Wechat). The global presence social media has helped provide to us has been an invaluable resource, and as we continue to expand our business operations and spread our brand awareness, we intend to primarily utilize social media to reach our customers. The benefits of social media are countless, but perhaps the most imperative to our future success is our ability to connect with customers directly, to receive their feedback almost instantaneously. On that note, the feedback we have received from our clients has been overwhelmingly positive, which has helped us to create a robust brand image.

 

While DSwiss has been focused almost exclusively upon pursuing operations within Asia, we do have plans to expand outward and become a household name across the world. Our strategy to do so going forward is by forming partnerships with local companies in various countries that may be willing to stock our products or promote them to their own customers. We believe that by forging strategic relationships and partnerships we can expand our operations across the globe at a greater pace and with greater certainty than we would if we tried to expand on our own.

 

Results of Operations

 

Revenues for the year ended December 31, 2022 and 2021

 

The Company generated revenue of $1,849,047 and $1,958,655 for the year ended December 31, 2022, and 2021 respectively. Revenue has decreased by $109,608 which is a 5.6% decrease comparatively, which is due to the losses in foreign currency translation. The revenue mainly represented OEM/ODM sales of Nutraceutical and Skincare Supplies to the customers.

 

Cost of Revenue and Gross Margin

 

Cost of revenue for the Company year ended December 31, 2022, amounted to $1,404,054 as compared to $1,459,531 for the year ended December 31, 2021. The decrease of $55,477 in cost of revenue was in line with the decrease in revenue. As a result, the gross profit has decreased from $499,124 for the year ended December 31, 2021 to $444,993 for the year ended December 31, 2022.

 

14

 

 

Gross margin of the Company has decreased from 25.48% in year ended December 31, 2021 to 24.06% in year ended December 31, 2022, which is a net decrease of 1.42%.

 

Cost of revenue comprise of freight-in, cost of goods purchased and packing material cost.

 

Operating Expenses

 

Selling, general and administrative expenses for the year ended December 31, 2022 and 2021 amounted to $402,412 and $308,686 respectively, the increase of $93,726 which is 30.36% higher comparatively which was contributed by the increase of group operations.

 

Operating expenses for the year ended December 31, 2022 and 2021 amounted to $1,303 and $1,464 respectively, the decrease of $161 which is 10.99% lower comparatively.

 

Other Income

 

The Company recorded an amount of $4,823 and $8,390 as other income for the year ended December 31, 2022 and 2021 respectively. This income is derived from the interest income earned and exchange gain.

 

Net Profit and Net Profit Margin

 

Net loss for the year ended December 31, 2022 was $2,937 as compared to $150,102 for the year ended December 31, 2021. The decrease in net profit of $153,039 was resulted from the decrease in revenue and higher selling, general and administrative expenses. Taking into the profit for the year ended December 31, 2022, the accumulated loss for the Company has increased from $1,309,711 to $1,324,002.

 

Liquidity and Capital Resources

 

As of December 31, 2022, we had working capital surplus of $16,426 consisting of cash and cash equivalent of $214,269 as compared to working capital deficit of $10,674 and our cash and cash equivalent of $234,546 as of December 31, 2021.

 

Net cash generated from operating activities for the year ended December 31, 2022 was $22,428 as compared to net cash generated from operating activities of $251,691 for the year ended December 31, 2021. The decrease in cash generated from operating activities are mainly resulted from the decrease in operating profit.

 

Net cash used in investing activity for the year ended December 31, 2022 was $14,376 as compared to net cash used in investing activity for the year ended, 2021 were $62,075. The cash used in investing activities are mainly for purchase of plant and equipment.

 

Net cash used in financing activities for the year ended December 31, 2022 was $53,955 as compared to net cash used in financing activities $78,951 for the year ended December 31, 2021. The net cash used in financing activities are mainly for the repayment to a director of Company.

 

The revenues generated from our current business operations alone was sufficient to fund our operations or planned growth. However, we will consider acquiring additional funding to continue to operate our business, and to further expand our business. Sources of additional capital through various financing transactions or arrangements with third parties may include equity or debt financing, bank loans or revolving credit facilities. We may not be successful in locating suitable financing transactions in the time period required or at all, and we may not obtain the capital we require by other means. Our inability to raise additional funds when required may have a negative impact on our operations, business development and financial results.

 

Critical Accounting Policies and Estimates

 

Leases

 

The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.

 

15

 

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.

 

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Revenue recognition

 

In accordance with the Accounting Standard Codification Topic 605 “Revenue Recognition” (“ASC 605”), the Company recognizes revenue when the following four criteria are met: (1) delivery has occurred or services rendered; (2) persuasive evidence of an arrangement exists; (3) there are no continuing obligations to the customer; and (4) the collection of related accounts receivable is probable.

 

Revenue is measured at the fair value of the consideration received or receivable, net of discounts and taxes applicable to the revenue.

 

Revenue from supplies of beauty products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

 

Cost of revenues

 

Cost of revenues includes the purchase cost of retail goods for re-sale to customers and the packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

16

 

 

Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

Shipping and handling fees are expensed as incurred for the year ended December 31, 2022 were $ 63 while for the year ended December 31, 2021 were $2,876.

 

Selling, general and administrative expenses

 

Selling, general and administrative expenses are primarily comprised of travelling and accommodation fees such as petrol, toll and parking and shipping and handling fees.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification   Estimated useful lives 
Computer and software   5 years 
Furniture and Fittings   5 years 
Office equipment   10 years 
Motor vehicle   5 years 

 

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the year ended December 31, 2022.

 

Income taxes

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

17

 

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts major businesses in Malaysia. The Company is subject to tax in these jurisdictions. As a result of its business activities, the Company will file tax returns that are subject to examination by the foreign tax authority.

 

The Company did not have any unrecognized tax positions or benefits and there was no effect on the financial conditions or results of operations for the year ended December 31, 2022 and year ended December 31, 2021. The Company and its subsidiary are subject to local and various foreign tax jurisdictions. The Company’s tax returns remain open subject to examination by major tax jurisdictions.

 

Net profit per share

 

The Company calculates net profit per share in accordance with ASC Topic 260 “Earnings per share”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the year ended December 31, 
   2022   2021 
         
Year-end MYR : US$1 exchange rate   4.42    4.17 
Year-average MYR : US$1 exchange rate   4.41    4.13 
Year-end HK$ : US$1 exchange rate   7.81    7.80 
Year-average HK$ : US$1 exchange rate   7.83    7.78 
Year-end RMB : US$1 exchange rate   6.92    6.46 
Year-average RMB : US$1 exchange rate   6.75    6.45 

 

18

 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, accounts payable and accrued liabilities, and amount due to a director approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
 

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

   
 

Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

FASB issues various Accounting Standards Updates relating to the treatment and recording of certain accounting transactions. On June 10, 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-10, Development Stage Entities (Topic 915) Elimination of Certain Financial Reporting Requirements, including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation, which eliminates the concept of a development stage entity (DSE) entirely from current accounting guidance. The Company has elected adoption of this standard, which eliminates the designation of DSEs and the requirement to disclose results of operations and cash flows since inception.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.

 

Off-Balance Sheet Arrangements

 

As of December 31, 2022, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The financial statements required by this item are located in PART IV of this Annual Report.

 

19

 

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Disclosures Control and Procedures

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

 

  ● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;
     
  ● Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
     
  ● Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

As of December 31, 2022, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on such evaluation, the Company’s management concluded that, during the period covered by this Report, internal controls and procedures over were not effective. This was due to deficiencies that existed in the design or operation of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

 

Identified Material Weakness

 

A material weakness in internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.

 

Management identified the following material weakness during its assessment of internal controls over financial reporting as of December 31, 2022.

 

1. We do not have Written Policies & Procedures – Due to lack of written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines, the Company did not establish a formal process to close our books monthly and account for all transactions and thus failed to properly record the Private Placement or disclose such transactions in its SEC filings in a timely manner.

 

20

 

 

2. We do not have adequate segregation of duties and effective risk assessment – Lack of segregation of duties and effective risk assessment may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors.

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2022 based on criteria established in Internal Control—Integrated Framework issued by COSO.

 

Management’s Remediation Initiatives

 

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we have initiated, or plan to initiate, the following series of measures:

 

1. We plan to create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to us. The accounting personnel is responsible for reviewing the financing activities, facilitate the approval of the financing, record the information regarding the financing, and submit SEC filing related documents to our legal counsel in order to comply with the filing requirements of SEC.
   
2. We plan to prepare written policies and procedures for accounting and financial reporting to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity and debt transactions.
   
3. We intend to add staff members to our management team for making sure that information required to be disclosed in our reports filed and submitted under the Exchange Act is recorded, processed, summarized and reported as and when required and will the staff members will have segregated responsibilities with regard to these responsibilities.

 

We anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2022.

 

Changes in internal controls over financial reporting

 

There was no change in our internal controls over financial reporting that occurred during the period covered by this Report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting:

 

This annual report does not include an attestation report of the Company’s registered independent public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered independent public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Annual Report on Form 10-K.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

21

 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Our executive officer’s and director’s and their respective ages as of the date hereof are as follows:

 

NAME   AGE   POSITION
Leong Ming Chia   40   Chief Executive Officer, President, Secretary, Treasurer, Director
Wong Sui Ting   50   Director

 

Set forth below is a brief description of the background and business experience of our executive officer and director for the past five years.

 

Leong Ming Chia - President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, Director

 

Mr. Leong achieved an Advanced Diploma of Microelectronics & Physics from TAR College in 2003 as well as a Bachelor’s Degree of Microelectronics & Physics from Campbell University in 2005. In 2007 Mr. Leong joined Tradenex, which is a subsidiary of the Federation of Malaysian Manufacturers, as part of their sales and marketing department. Mr Leong was responsible for developing a marketing plan, overseeing the execution and evaluating the results across B2B, B2C and retail sales channels in order to enable inter-enterprise connectivity, communication and collaboration along the business value chain. From March 2009 onward Mr. Leong was appointed as a committee member of Cross Border Business Association in Hong Kong, promoting cross border trade and opportunities. Since January 2012 Mr. Leong joined DSwiss Sdn Bhd as a Business Development Advisor where Mr Leong developed a set of marketing tool and is bringing the company from traditional sales model to e-commerce model. In September 2015, Mr. Leong was also appointed as the chief executive officer and director of the Company.

 

On May 31, 2017, upon the resignation of Mr. Chua Lee Yee resignation as a Chief Financial Officer, Secretary, Treasurer and Director, Mr. Leong has taken over the position as a Chief Financial Officer, Secretary and treasurer along with existing position as the Chief Executive Officer, President and Director.

 

Mr. Leong’s experience in the marketing and business development have led the Board of Director to reach the conclusion that he should serve as a Director of the Company.

 

Wong Sui Ting - Director

 

Mr. Wong serves as a Director in the Company. Mr. Wong holds a Bachelor of Business (Accounting) from Monash University since year 1995. Also, he is an Associate Member of Malaysia Institute of Accountancy (MIA, Chartered Accountant) since 1999 and CPA Australia since 1998. Mr. Wong co-founded Qinetics Solutions Sdn Bhd in 2000 and acts as Chief Financial Officer since the establishment. He was tasked with overseeing and managing the overall financial affairs and operations of Qinetics, playing an active role in corporate decisions and strategies. In 2011, Mr. Wong co-founded and acts as Chief Executive Officer of Forum Digital Sdn Bhd. His responsibility in the company is to oversee the operation and in charge of business development of the company.

 

Mr. Wong’s experience in accounting and the financial industry, as well as his knowledge of business development, has led the Board of director to reach the conclusion that he should serve as the director of the Company. On May 31, 2017, Mr. Wong was appointed as the director of the Company.

 

Corporate Governance

 

The Company promotes accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with the Securities and Exchange Commission (the “SEC”) and in other public communications made by the Company; and strives to be compliant with applicable governmental laws, rules and regulations. The Company has not formally adopted a written code of business conduct and ethics that governs the Company’s employees, officers and Directors as the Company is not required to do so.

 

In lieu of an Audit Committee, the Company’s Board of Directors, is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Company’s financial statements and other services provided by the Company’s independent public accountants. The Board of Directors, the Chief Executive Officer and the Chief Financial Officer of the Company review the Company’s internal accounting controls, practices and policies.

 

22

 

 

Committees of the Board

 

Our Company currently does not have nominating, compensation, or audit committees or committees performing similar functions nor does our Company have a written nominating, compensation or audit committee charter. Our Directors believes that it is not necessary to have such committees, at this time, because the Director(s) can adequately perform the functions of such committees.

 

Audit Committee Financial Expert

 

Our Board of Directors has determined that we do not have a board member that qualifies as an “audit committee financial expert” as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as “independent” as the term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule 4200(a)(14) of the FINRA Rules.

 

We believe that our Director(s) are capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. The Director(s) of our Company does not believe that it is necessary to have an audit committee because management believes that the Board of Directors can adequately perform the functions of an audit committee. In addition, we believe that retaining an independent Director who would qualify as an “audit committee financial expert” would be overly costly and burdensome and is not warranted in our circumstances given the stage of our development and the fact that we have not generated any positive cash flows from operations to date.

 

Involvement in Certain Legal Proceedings

 

Our Directors and our Executive officers have not been involved in any of the following events during the past ten years:

 

1. bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
2. any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
3. being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his/her involvement in any type of business, securities or banking activities; or
4. being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
5. Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;
6. Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;
7. Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:(i) Any Federal or State securities or commodities law or regulation; or(ii) Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or(iii) Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
8. Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

Code of Ethics

 

We have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees and determined that since the business is operated by a small number of persons, general rules of fiduciary duty and federal and state criminal, business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or Directors expand in the future, we may take actions to adopt a formal Code of Ethics.

 

23

 

 

Shareholder Proposals

 

Our Company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations for Directors. The Board of Directors believes that, given the stage of our development, a specific nominating policy would be premature and of little assistance until our business operations develop to a more advanced level. Our Company does not currently have any specific or minimum criteria for the election of nominees to the Board of Directors and we do not have any specific process or procedure for evaluating such nominees. The Board of Directors will assess all candidates, whether submitted by management or shareholders, and make recommendations for election or appointment.

 

A shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our President, at the address appearing on the first page of this Information Statement.

 

ITEM 11. EXECUTIVE COMPENSATION

 

The following table sets forth information concerning the compensation of our Chief Executive Officer, and the executive officers who served at the end of the year ended December 31, 2022, for services rendered in all capacities to us.

 

Summary Compensation Table:

 

Name and Principal Position  Period  Salary ($)   Bonus ($)   Stock Awards ($)   Option Awards ($)   Non-Equity Incentive Plan Compensation ($)   Nonqualified Deferred Compensation Earnings
($)		   All Other Compensation ($)   Total ($) 
Leong Ming Chia, Chief Executive Officer,  For the year ended December 31, 2022   27,240    5,675        -        -          -                   -    4,279    37,194 
President, Secretary, Treasurer, Director (1)  For the year ended December 31, 2021   29,024    12,093    -    -    -    -    15,836    56,953 
                                            
Wong Sui Ting,  For the year ended December 31, 2021   -    -    -    -    -    -    -    - 
Director (2)  For the year ended December 31, 2020   -    -    -    -    -    -    -    - 

 

(1) On September 8, 2015 Leong Ming Chia was appointed Chief Executive Officer, President and a member of our Board of Directors. On May 31, 2017, upon the resignation of Chua Lee Yee from the position of Chief Financial Officer, Treasurer, Secretary and Director, Leong Ming Chia replaced Chua Lee Yee as the Chief Financial Officer, Treasurer and Secretary of the company.
(2) On May 31, 2015 Wong Sui Ting was appointed as a member of our Board of Director.

 

24

 

 

Narrative Disclosure to Summary Compensation Table

 

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers. Our directors and executive officers may receive stock options at the discretion of our board of directors in the future. We do not have any material bonus or profit-sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may be granted at the discretion of our board of directors from time to time. We have no plans or arrangements in respect of remuneration received or that may be received by our executive officers to compensate such officers in the event of termination of employment (as a result of resignation, retirement, change of control) or a change of responsibilities following a change of control.

 

Stock Option Grants

 

We have not granted any stock options to our executive officers since our incorporation.

 

Compensation of Directors

 

The table below summarizes all compensation of our directors as of December 31, 2022.

 

Name and Principal Position  Period  Salary ($)   Bonus ($)   Stock Awards ($)   Option Awards ($)   Non-Equity Incentive Plan Compensation ($)   Nonqualified Deferred Compensation Earnings ($)   All Other Compensation ($)   Total ($) 
Leong Ming Chia, Chief Executive Officer,  For the year ended December 31, 2022   27,240    5,675        -        -          -                   -    4,279    37,194 
President, Secretary, Treasurer, Director (1)  For the year ended December 31, 2021   29,024    12,093    -    -    -    -    15,836    56,953 
                                            
Wong Sui Ting,  For the year ended December 31, 2021   -    -    -    -    -    -    -    - 
Director (2)  For the year ended December 31, 2020   -    -    -    -    -    -    -    - 

 

(1) On September 8, 2015 Leong Ming Chia was appointed Chief Executive Officer, President and a member of our Board of Directors. On May 31, 2017, upon the resignation of Chua Lee Yee from the position of Chief Financial Officer, Treasurer, Secretary and Director, Leong Ming Chia replaced Chua Lee Yee as the Chief Financial Officer, Treasurer and Secretary of the company.
(2) On May 31, 2015 Wong Sui Ting was appointed as a member of our Board of Director.

 

Employment Agreements

 

We do not have an employment or consulting agreement with any officers or Directors.

 

25

 

 

Compensation Discussion and Analysis

 

Director Compensation

 

Presently only Leong Ming Chia receives fee for his service as a member of the Board of Directors. The Board of Directors reserves the right in the future to award the members of the Board of Directors cash or stock-based consideration for their services to the Company, which awards, if granted shall be in the sole determination of the Board of Directors.

 

Executive Compensation Philosophy

 

Our Board of Directors determines the compensation given to our executive officers in their sole determination. Our Board of Directors reserves the right to pay our executive or any future executives a salary, and/or issue them shares of common stock in consideration for services rendered and/or to award incentive bonuses which are linked to our performance, as well as to the individual executive officer’s performance. This package may also include long-term stock based compensation to certain executives, which is intended to align the performance of our executives with our long-term business strategies. Additionally, while our Board of Directors has not granted any performance base stock options to date, the Board of Directors reserves the right to grant such options in the future, if the Board in its sole determination believes such grants would be in the best interests of the Company.

 

Incentive Bonus

 

The Board of Directors may grant incentive bonuses to our executive officer and/or future executive officers in its sole discretion, if the Board of Directors believes such bonuses are in the Company’s best interest, after analyzing our current business objectives and growth, if any, and the amount of revenue we are able to generate each month, which revenue is a direct result of the actions and ability of such executives.

 

Long-term, Stock Based Compensation

 

In order to attract, retain and motivate executive talent necessary to support the Company’s long-term business strategy we may award our executive and any future executives with long-term, stock-based compensation in the future, at the sole discretion of our Board of Directors, which we do not currently have any immediate plans to award.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

As of December 31, 2022, the Company has 206,904,585 shares of common stock issued and outstanding, which number of issued and outstanding shares of common stock have been used throughout this report.

 

The following table sets forth, as of December 31, 2022 certain information with regard to the record and beneficial ownership of the Company’s common stock by (i) each person known to the Company to be the record or beneficial owner of more than 5% of the Company’s common stock, (ii) each director of the Company, (iii) each of the named executive officers, and (iv) all executive officers and directors of the Company as a group:

 

Title of Class  Name of beneficial owner(i)  Shares of Common Stock Beneficially Owned   Percent of Class 
            
Common Stock  Leong Ming Chia (i), (ii), (iii)   62,906,493    30.40%
              
Common Stock  Wong Sui Ting (ii)   50,000    0.02%
              
   All of the officers and directors as a group (iv)   62,956,493    30.42%
              
5% Shareholders             
Common Stock  Greenpro Venture Capital Limited (i)   15,159,157    7.33%
Common Stock  Hew Yuen Foong (i)   33,000,000    15.95%
Common Stock  Teo Jen Jiang (i)   44,000,000    21.27%
Common Stock  Siow Kock Yong (i)   32,874,393    15.89%

 

26

 

 

Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon exercise of an option or warrant) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily reflect the person’s actual voting power at any particular date.

 

(1) Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Beneficial ownership also includes shares of stock subject to options and warrants currently exercisable or exercisable within 60 days of the date of this table. In determining the percent of common stock owned by a person or entity as of the date of this Report, (a) the numerator is the number of shares of the class beneficially owned by such person or entity, including shares which may be acquired within 60 days on exercise of warrants or options and conversion of convertible securities, and (b) the denominator is the sum of (i) the total shares of common stock outstanding on as of the date of this Annual Report (206,904,585 shares), and (ii) the total number of shares that the beneficial owner may acquire upon exercise of the derivative securities. Unless otherwise stated, each beneficial owner has sole power to vote and dispose of its shares.
(2) Based on the total issued and outstanding shares of 206,904,585 as of the date of this Annual Report.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE

 

Related Party Transactions

 

For the years ended December 31, 2022 and December 31, 2021, the Company has the following transactions with related party:

 

   For the year ended
December 31, 2022 (Audited)		   For the year ended
December 31, 2021 (Audited)		 
Professional Fees:          
- Related party A  $12,226   $13,279 
           
Sales          
- Related party B  $-   $374,555 
- Related party C   -    13,124 
- Related party D   24,261    11,607 
           
Total  $36,487   $412,565 

 

The related party A is a wholly owned subsidiary of a 7.33% shareholder of the Company.

 

Founder of the Company resigned as director and shareholder of company B on October 02, 2022.

 

The related party C’s director and shareholder is the founder of the Company.

 

The related party D’s director is the founder of the Company. The shareholder of related party D is related party C.

 

The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.

 

27

 

 

Review, Approval and Ratification of Related Party Transactions

 

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officer(s), Director(s) and significant stockholders. We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. On a moving forward basis, our Directors will continue to approve any related party transaction.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Below is the aggregate amount of fees billed for professional services rendered by our principal accountants with respect to our last two fiscal years.

 

   For the Year Ended
December 31, 2022		   For the Year Ended
December 31, 2021		 
Audit fees  $24,200   $16,000 
Audit related fees   -    7,500 
Total  $24,200   $23,500 

 

The category of “Audit fees” includes fees for our annual audit, quarterly reviews and services rendered in connection with regulatory filings with the SEC, such as the issuance of comfort letters and consents.

 

The category of “Audit-related fees” includes employee benefit plan audits, internal control reviews and accounting consultation.

 

All of the professional services rendered by principal accountants for the audit of our annual financial statements that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for last two fiscal years were approved by our board of directors.

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a) Financial Statements

 

The following are filed as part of this report:

 

Financial Statements

 

The following financial statements of DSwiss, Inc. and Report of Independent Registered Public Accounting Firm are presented in the “F” pages of this Report:

 

  Page
   
Index F-1
   
Report of Independent Registered Public Accounting Firm F-2
   
Financial Statements  
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations F-4
   
Consolidated Statements of Stockholders’ Equity F-5
   
Consolidated Statements of Cash Flows F-6
   
Notes to Consolidated Financial Statements F-7 – F-20

 

(b) Exhibits

 

The following exhibits are filed or “furnished” herewith:

 

3.1 Articles of Incorporation**
   
3.2 Bylaws**
   
31.1 Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer*
   
32.1 Section 1350 Certification of principal executive officer*
   
101.INS Inline XBRL Instance Document
   
101.SCH Inline XBRL Taxonomy Extension Schema Document
   
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

 

** As filed in the Registrant’s Registration Statement on Form S-1 Amendment No.8 (File No. 333-208083) on July 20, 2016.

 

28

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  DSWISS, INC.
  (Name of Registrant)
     
Date: March 31, 2023    
     
  By: /s/ Leong Ming Chia
  Title: President, Chief Executive Officer, Chief Finance Officer, Secretary, Treasurer, Director
   

Principal Executive Officer

Principal Financial Officer

 

29

 

 

INDEX TO FINANCIAL STATEMENTS

 

  Page
Financial Statements  
   
Report of Independent Registered Public Accounting Firm F-2
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations and Comprehensive Profit/(Loss) F-4
   
Consolidated Statements of Changes in Stockholders’ Equity F-5
   
Consolidated Statements of Cash Flows F-6
   
Notes to Consolidated Financial Statements F-7 - F-20

 

F-1

 

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

The Board of Directors and Stockholders of DSwiss, Inc.

Unit 18-11, 18-12 & 18-01, Tower A,

Vertical Business Suite, Avenue 3, Bangsar South,

No. 8, Jalan Kerinchi, 59200, Kuala Lumpur,

Malaysia

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheets of DSwiss, Inc. (“the Company”) as of December 31, 2021 and December 31, 2022 and the related statements of operations and comprehensive income, stockholders’ equity, and cash flows for the year ended of December 31, 2021 and December 31, 2022 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and December 31, 2022, and the results of its operations and its cash flows for the year ended of December 31, 2021 and December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Going Concern

 

The financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, as at December 31, 2022 the Company has suffered an accumulated deficit of $1,324,002. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters also are described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to those charged with governance that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical matters.

 

/s/ JP CENTURION & PARTNERS PLT  

JP CENTURION & PARTNERS PLT (PCAOB: 6723)

  
We have served as the Company’s auditor since 2020.  
   
Kuala Lumpur, Malaysia  
Date: March 31, 2023  

 

F-2

 

 

DSWISS, INC.

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31, 2022 and 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

   2022   2021 
   As of December 31, 
   2022   2021 
ASSETS          
CURRENT ASSETS          
Cash and cash equivalents  $214,269   $234,546 
Accounts receivable   17,492    2,053 
Other receivables, prepaid expenses, and deposit   21,749    53,693 
Tax recoverable   745    814 
Inventories   7,483    17,131 
           
Total current assets   261,738    308,237 
           
NON-CURRENT ASSETS          
Property and equipment, net   72,179    92,970 
Intangible assets, net   3,459    4,498 
Operating lease right-of-use assets, net   44,548    92,606 
           
Total non-current assets   120,186    190,074 
           
TOTAL ASSETS  $381,924   $498,311 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts payable  $29,539   $10,901 
Other payables and accrued liabilities   154,710    205,359 
Finance lease liability   16,515    16,697 
Amount due to a director   -    40,509 
Operating lease liability   44,548    45,270 
Current tax liabilities   -    175 
           
Total current liabilities   245,312    318,911 
           
NON-CURRENT LIABILITIES          
Finance lease liability   38,461    58,055 
Operating lease liability   -    47,336 
           
Total non-current liabilities   38,461    105,391 
           
TOTAL LIABILITIES   283,773    424,302 
           
STOCKHOLDERS’ EQUITY          
Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding   -    - 
Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares and 206,904,585 shares issued and outstanding as of December 31, 2022 and 2021 respectively   20,690    20,690 
Additional paid-in capital   1,395,426    1,395,426 
Accumulated other comprehensive losses   (5,846)   (32,985)
Accumulated deficit   (1,324,002)   (1,309,711)
           
TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY   86,268    73,420 
NON-CONTROLLING INTEREST   11,883    589 
TOTAL STOCKHOLDERS’ EQUITY   98,151    74,009 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $381,924   $498,311 

 

See accompanying notes to consolidated financial statements.

 

F-3

 

 

DSWISS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
REVENUE  $1,849,047   $1,958,655 
           
COST OF REVENUE   (1,404,054)   (1,459,531)
           
GROSS PROFIT   444,993    499,124 
           
OTHER INCOME   4,823    8,390 
           
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES   (402,412)   (308,686)
           
OPERATING EXPENSES   (1,303)   (1,464)
           
FINANCE COST   (6,212)   (2,600)
           
LEASE EXPENSES   (42,310)   (44,486)
           
(LOSS)/PROFIT BEFORE INCOME TAX  $(2,421)  $150,278 
           
INCOME TAXES PROVISION   (516)   (176)
           
NET (LOSS)/PROFIT   (2,937)   150,102 
           
Non-Controlling Interests   (11,354)   23,357 
Other comprehensive income/(loss):          
- Foreign currency translation adjustment   27,139    (4,808)
COMPREHENSIVE INCOME  $12,848   $168,651 
           
Net (loss)/profit per share- Basic and diluted   (0.0001)   0.0008 
           
Weighted average number of common shares outstanding - Basic and diluted  $206,904,585   $206,904,585 

 

See accompanying notes to consolidated financial statements.

 

F-4

 

 

DSWISS, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

   Number of shares   Amount   PAID-IN
CAPITAL		   COMPREHENSIVE
GAIN/(LOSS)		  

ACCUMULATED

GAINS/(LOSSES)

   CONTROLLING INTEREST   TOTAL
EQUITY		 
   COMMON STOCK   ADDITIONAL  

ACCUMULATED

OTHER

   ACCUMULATED   NON-     
  

Number of

shares

   Amount  

PAID-IN

CAPITAL

  

COMPREHENSIVE

LOSSES

  

GAINS/

(LOSSES)

  

CONTROLLING

INTEREST

  

TOTAL

EQUITY

 
Balance as of December 31, 2020   206,904,600    20,690    1,395,426    (28,177)   (1,483,170)   25,727    (69,504)
Shares spinoff adjustment resulted from a stock distribution by a corporate shareholder   (15)   -    -    -    -    -    - 
Foreign currency translation adjustment   -    -    -    (4,808)   -    (1,781)   (6,589)
Net gain   -    -    -    -    173,459    (23,357)   150,102 
Balance as of December 31, 2021   206,904,585    20,690    1,395,426    (32,985)   (1,309,711)   589    74,009 
Foreign currency translation adjustment   -    -    -    27,139    -    (60)   27,079 
Net loss   -    -    -    -    (14,291)   11,354    (2,937)
Balance as of December 31, 2022   206,904,585    20,690    1,395,426    (5,846)   (1,324,002)   11,883    98,151 

 

See accompanying notes to consolidated financial statements

 

F-5

 

 

DSWISS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”))

(Audited)

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
CASH FLOWS FROM OPERATING ACTIVITIES:          
(Loss)/Profit before tax   $(2,421)  $150,278 
Adjustments to reconcile net (loss)/profit to net cash generated from operating activities:          
Depreciation and amortization   72,441    65,382 
Amortization for intangible assets   1,029    1,034 
Changes in operating assets and liabilities:          
Accounts receivable   (15,551)   6,848 
Accounts payable   14,702    9,819 
Inventories   8,707    19,764 
Other payables and accrued liabilities   (42,440)   49,249 
Prepaid expenses and deposits   28,995    (460)
Reduction in lease liability   (42,212)   (46,923)
Cash generated from operating activities  $23,250   $254,991 
Taxation paid   (822)   (3,300)
Net cash generated from operating activities  $22,428   $251,691 
           
CASH FLOWS FROM INVESTING ACTIVITY:          
Purchase of property and equipment   (14,376)   (62,075)
Net cash used in investing activity  $(14,376)  $(62,075)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayment to directors   (38,284)   (112,851)
Advance to related companies   -    (398)
Additional of finance lease   -    43,535 
Repayment of finance lease   (15,671)   (9,237)
Net cash used in financing activities  $(53,955)  $(78,951)
           
Effect of exchange rate changes on cash and cash equivalents   25,626    (34,123)
           
Net change in cash and cash equivalents   (20,277)   76,542 
Cash and cash equivalents, beginning of year   234,546    158,004 
           
CASH AND CASH EQUIVALENTS, END OF YEAR  $214,269   $234,546 
SUPPLEMENTAL CASH FLOWS INFORMATION          
Income taxes paid  $141   $3,300 
Interest paid  $421   $2,600 

 

See accompanying notes to consolidated financial statements.

 

F-6

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

1. ORGANIZATION AND BUSINESS BACKGROUND

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015.

 

DSwiss, Inc. operates through its wholly owned subsidiary, DSwiss Holding Limited, a Company organized under the laws of Seychelles.

 

The principal activity of the Company and its subsidiaries is to supply high-quality health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to improve the overall health system in our body.

 

We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with 100% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold 100% equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.

 

We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned 40% equity interest.

 

The Company, through its subsidiaries and its variable interest entities (“VIEs”), mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

  

  Company name 

Place and date of

incorporation

  Particulars of issued capital  Principal activities 

Proportional of ownership

interest and

voting power

held
1. DSwiss Holding Limited  Seychelles,
May 28, 2015		  1 share of ordinary share of US$1 each  Investment holding  100%
               
2. DSwiss (HK) Limited  Hong Kong,
May 28, 2015		  1 share of ordinary share of HK$1 each  Supply of beauty products  100%
               
3. DSwiss Sdn Bhd  Malaysia,
March 10, 2011		  2 shares of ordinary share of RM 1 each  Supply of beauty products  100%
               
4. DSwiss Biotech Sdn Bhd (1) (2)  Malaysia,
March 17, 2016		  250,000 shares of ordinary share of RM 1 each  Supply of biotech products  40%

 

  (1)

Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of this entity unilaterally, and hence the Company has control over this entity.

     
  (2) On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

F-7

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Business Overview

 

One of the leading one-stop ODM/OEM manufacturing companies, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms. DSwiss addresses a distinct demand in the market for a manufacturer who could ensure the quality of the ingredient sources and offer efficient one-stop service from raw material, product development, manufacturing and packaging.

 

Since our founding, we have experienced tremendous growth in Malaysia. We offer exceptional lifestyle solutions to consumers all over the world thanks to our over 10 years of continuous innovation and work in the health and beauty business. Our company’s Chief Executive Officer, Vincent Leong has led it with a strong hand, and as a result, our products are now consumed around the world, such as Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. With the help of our distributors, we have so far extended throughout Asia, and we are adamant about extending our geographic reach into untapped markets.

 

With a team of professionals at the helm, DSwiss is assured of providing the best products and attending client’s needs from consultations to products. To fulfil customer needs, we carry out research and development based on our philosophy of “creating beauty, health, and the ecosystem”. Our cutting-edge research and development team has always been exploring new product lines and integrating the most recent science and technology, which will enable us to produce more evidence-based, high-value added formulations and products and maintain our competitive position in the market.

 

With our extensive years of expertise in the OEM and ODM services industry, we offer comprehensive solutions to our customers. In addition to business consultancy, DSwiss offers useful guidance on current market trends as we all as marketing solutions and support to assist our clients’ business endeavours. Versatility and reliability are evidently the driving principles behind DSwiss, who manufactures products using high-grade ingredients and materials at every stage of research, development, and production.

 

As advocates of natural and high-quality active ingredients, we actively seek for and select the best ingredients, as we are dedicated to adhering to policies under rigorous quality control and assurance criteria, thereby maximizing the safety and efficacy of our products. We dedicate ourselves to maintaining the highest standard in our products in order to provide assurance and a continual commitment to producing high-quality products in accordance with the strict specifications and guidelines specified out by Ministry of Health (“MOH”) Malaysia. Each step of production process has quality control built in and implemented. We guarantee the highest quality product using precise production techniques and specialised equipment, promising ongoing improvements and enhancements based on customer feedback. DSwiss takes pride in offering the best results in customisable solutions for health supplements and beauty product manufacturing.

 

2. GOING CONCERN UNCERTAINTIES

 

The accompanying financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

As of December 31, 2022, the Company suffered an accumulated deficit of $1,324,002. The continuation of the Company as a going concern through December 31, 2022 is dependent upon improving the profitability and the continuing financial support from its major stockholders. Management believes the existing major shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.

 

There is no assurance that the Company will able to maintain profitable in the future, which raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result in the Company not being able to continue as a going concern.

 

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

 

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

F-8

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification   Estimated useful lives 
Computer and software   5 years 
Furniture and Fittings   5 years 
Office equipment   10 years 
Motor vehicle   5 years 

 

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the year ended December 31, 2022.

 

F-9

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Leases

 

The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.

 

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.

 

F-10

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Net profit per share

 

The Company calculates net profit per share in accordance with ASC Topic 260 “Earnings per share”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

F-11

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1, HK$ into US$1, RMB into US$1 and THB into US$1 has been made at the following exchange rates for the respective periods:

   As of and for the year ended
December 31,		 
   2022   2021 
         
Year-end MYR : US$1 exchange rate   4.42    4.17 
Year-average MYR : US$1 exchange rate   4.41    4.13 
Year-end HK$ : US$1 exchange rate   7.81    7.80 
Year-average HK$ : US$1 exchange rate   7.83    7.78 
Year-end RMB : US$1 exchange rate   6.92    6.46 
Year-average RMB : US$1 exchange rate   6.75    6.45 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

F-12

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

FASB issues various Accounting Standards Updates relating to the treatment and recording of certain accounting transactions. On June 10, 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-10, Development Stage Entities (Topic 915) Elimination of Certain Financial Reporting Requirements, including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation, which eliminates the concept of a development stage entity (DSE) entirely from current accounting guidance. The Company has elected adoption of this standard, which eliminates the designation of DSEs and the requirement to disclose results of operations and cash flows since inception.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.

 

F-13

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

4. VIE STRUCTURE AND ARRANGEMENTS

 

On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to 100% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.

 

The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:

 

(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;

 

(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;

 

(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;

 

(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and

 

(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.

 

In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including

 

(i) a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;
   
(ii) a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and
   
(ii) an Equity Pledge Agreement that pledges the shares in DSBT.

 

This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.

 

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

F-14

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

5. STOCKHOLDERS’ EQUITY

 

As of December 31, 2022 and 2021, the Company had a total of 206,904,585 and 206,904,585 of its common stock issued and outstanding. There are no shares of preferred stock issued and outstanding.

 

6. PROPERTY AND EQUIPMENT

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Computer and software  $105,535   $102,050 
Furniture and fittings   6,144    6,144 
Office equipment   21,152    13,126 
Motor vehicle   135,868    133,003 
Total property and equipment   268,699   $254,323 
Accumulated depreciation   (187,236)   (157,105)
Effect of translation exchange   (9,284)   (4,249)
Property and equipment, net  $72,179   $92,970 

 

Depreciation expense for the year ended December 31, 2022 and December 31, 2021 were $30,131 and $18,734, respectively.

 

7. INTANGIBLE ASSETS

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Trademarks  $12,077   $12,077 
Amortization   (8,164)   (7,135)
Effect of translation exchange   (454)   (444)
Intangible assets, net  $3,459   $4,498 

 

Amortization for the year ended December 31, 2022 and December 31, 2021 were $1,029 and $1,034, respectively.

 

8. OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

 

   

As of

December 31, 2022

    

As of

December 31, 2021

  
Prepaid expenses   $ 2,080     $ 977  
Deposits     19,669       52,716  
Total other receivables, prepaid expenses and deposits   $ 21,749     $ 53,693  

 

9. INVENTORIES

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Finished goods, at cost  $7,483   $17,131 
Total inventories  $7,483   $17,131 

 

F-15

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

10. OTHER PAYABLES AND ACCRUED LIABILITIES

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Other payables  $100,385   $164,529 
Accrued audit fees   20,266    21,342 
Accrued other expenses   16,683    14,136 
Accrued professional fees   17,376    5,352 
Total payables and accrued liabilities  $154,710   $205,359 

 

11. FINANCE LEASE LIABILITIES

 

The Company purchased motor vehicles with finance lease. The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly. The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly. The obligation under the finance lease is as follows:

 

  

As

of December 31, 2022

  

As of

December 31, 2021

 
Finance leases  $58,768   $81,676 
Less: interest expense   (3,792)   (6,924)
Net present value of finance leases   54,976    74,752 
           
Current portion   16,515    16,697 
Non-current portion   38,461    58,055 
Total  $54,976   $74,752 

 

As of December 31, 2022, the maturities of the finance leases for each of the years are as follows:

 

      
2023   16,515 
2024   17,222 
2025   13,153 
2026   8,086 
Total  $54,976 

 

12. AMOUNT DUE TO A DIRECTOR

 

As of December 31, 2022 and December 31, 2021, the amount due to director of the Company are $0 and $40,509, respectively. The advance from a director of Company is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

 

F-16

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

13. INCOME TAXES

 

For the year ended December 31, 2022 and year ended December 31, 2021, the local (United States) and foreign components of (loss) / profit before income taxes were comprised of the following:

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
         
Tax jurisdictions from:          
- Local  $(43,174)  $(43,429)
- Foreign, representing          
Seychelles   (11,643)   (1,427)
Hong Kong   (3,951)   (4,937)
Malaysia   56,347    200,071 
(Loss)/Profit before income tax  $(2,421)  $150,278 

 

The provision for income taxes consisted of the following:

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
         
Current:          
- Local  $-   $- 
- Foreign   (516)   (176)
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(516)  $(176)

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2022 and 2021.

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
Deferred tax assets:          
Net operating loss carry forwards          
-United States of America  $(99,152)  $(90,085)
-Seychelles   -    - 
-Hong Kong   (104,132)   (103,480)
-Malaysia   (36,884)   (46,376)
-PRC  $-   $- 
    (240,168)   (239,941)
Less: valuation allowance  $240,168   $239,941 
Deferred tax assets  $-   $- 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Seychelles, Hong Kong, Malaysia, PRC that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of 31 December, 2022, the operations in the United States of America incurred $472,151 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 21%. The net operating loss carry forwards begin to expire in 2038, if unutilized. The Company has provided for a full valuation allowance of $99,152 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Seychelles

 

Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.

 

Hong Kong

 

DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income. As of December 31, 2022, the operations in the Hong Kong incurred $631,103 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 16.5%. The Company has provided for a full valuation allowance of $104,132 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

F-17

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Malaysia

 

DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from 17% to 24% on its assessable income. As of December 31, 2022, the operations in the Malaysia incurred $216,968 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 17%. The Company has provided for a full valuation allowance of $36,884 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

14. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the year ended December 31, 2022 and 2021, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2022   2021   2022   2021   2022   2021 
   Revenues   Percentage of Revenues   Accounts Receivable, Trade 
Customer A  $501,470   $1,176,280    26%   60%  $-   $87 
Customer B  $386,232   $374,555    20%   19%  $-   $122 
Customer C  $221,638   $-    12%   -%  $-   $- 
   $1,109,340   $1,550,835    58%   79%  $-   $209 

 

(b) Major vendors

 

For the year ended December 31, 2022 and 2021, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2022   2021   2022   2021   2022   2021 
   Purchases   Percentage of Purchases   Account Payable, Trade 
Vendor A  $477,099   $746,964    23%   51%  $1,626   $- 
Vendor B  $331,538   $-    15%   -%  $-   $- 
Vendor C  $221,743   $-    33%   -%  $16,759   $- 
   $1,030,380   $746,964    71%   51%  $18,385   $- 

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of MYR, HK$ and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

F-18

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

15. LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

 

The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.

 

As of January 1, 2022, the Company recognized approximately US$386,451, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of 5.40% adopted from Malayan Banking Berhad’s base lending rate as a reference for discount rate.

 

A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.

 

The initial recognition of operating lease right and lease liability as follow:

 

As of December 31, 2022, operating lease right of use asset as follow:

 

   Year ended December 31, 
   2022   2021 
As of January 1,  $92,606   $47,653 
Add: New Lease commenced on 1 January 2022   -    92,606 
Accumulated amortization   (42,310)   (46,571)
Effect of translation exchange   (5,748)   (1,082)
Balance as of December 31  $44,548   $92,606 

 

As of December 31, 2022, operating lease liability as follow:

 

As of January 1,  $92,606 
Less: gross repayment   (45,763)
Add: imputed interest   3,453 
Effect of translation exchange   (5,748)
Balance as of December 31, 2022  $44,548 
Less: lease liability current portion   44,548 
Lease liability non-current portion  $- 

 

For the year ended December 31, 2022 and 2021, the amortization of the operating lease right of use asset are $42,310 and $44,486 respectively.

 

   Year ended December 31, 
   2022   2021 
         
Cash paid for amounts included in the measurement of lease liabilities:        - 
Operating cash flow from operating lease  $42,212   $44,486 
Right-of-use assets obtained in exchange for operating lease liabilities   44,548    45,270 
Remaining lease term for operating lease (years)   1    - 
Weighted average discount rate for operating lease   5.40%   4.47%

 

For the year ended December 31, 2022 and 2021, lease expenses were $42,310 and $44,486 respectively.

 

F-19

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

16. RELATED PARTY TRANSACTIONS

 

For the years ended December 31, 2022 and December 31, 2021, the Company has the following transactions with related party:

 

   For the year ended
December 31, 2022 (Audited)		   For the year ended
December 31, 2021 (Audited)		 
Professional Fees:          
- Related party A  $12,226   $13,279 
           
Sales          
- Related party B  $386,232   $374,555 
- Related party C   -    13,124 
- Related party D   24,261    11,607 
           
Total  $36,487   $412,565 

 

The related party A is a wholly owned subsidiary of a 7.33% shareholder of the Company.

 

The related party B’s director and shareholder is the founder of the Company. Founder of the Company resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.

 

The related party C’s director and shareholder is the founder of the Company.

 

The related party D’s director is the founder of the Company. The shareholder of related party D is related party C.

 

The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.

 

17. SEGMENTED INFORMATION

 

ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.

 

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada *   Seychelles *   Hong Kong *   Malaysia *   Total * 
   For the year ended December 31, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,849,047   $1,849,047 
Cost of revenue   -    -    -    (1,404,054)   (1,404,054)
Depreciation and amortization   -    -    -    (72,441)   (72,441)
Net (loss) / profit before taxation   (43,174)   (11,643)   (3,951)   56,347    (2,421)
                          
Total assets  $27,294   $7,056   $14,264   $333,310   $381,924 

 

   Nevada *   Seychelles *   Hong Kong *   Malaysia *   Total * 
   For the year ended December 31, 2021 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,958,655   $1,958,655 
Cost of revenue   -    -    -    (1,459,531)   (1,459,531)
Depreciation and amortization   -    -    -    (65,382)   (65,382)
Net (loss) / profit before taxation   (43,429)   (1,427)   (4,937)   200,071    150,278 
                          
Total assets  $7,366   $6,475   $16,287   $468,183   $498,311 

 

*Revenues and costs are attributed to countries based on the location of customers.

 

18. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2022 up through the date the Company issued the audited consolidated financial statements.

 

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

F-20

 EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, LEONG MING CHIA, certify that:

 

1. I have reviewed this annual report on Form 10-K of DSwiss, Inc. (the “Company”) for the year ended December 31, 2022;

 

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 31, 2023 By: /s/ Leong Ming Chia
    LEONG MING CHIA
   

Chief Executive Officer,

President, Director, Secretary, Treasurer

    (Principal Executive Officer)

 

 

 

 EX-32.1 3 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of DSwiss, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: March 31, 2023 By: /s/ Leong Ming Chia
    LEONG MING CHIA
    Chief Executive Officer, President, Director
    (Principal Executive Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 
 GRAPHIC 4 form10-k_034.jpg begin 644 form10-k_034.jpg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end GRAPHIC 5 form10-k_024.jpg begin 644 form10-k_024.jpg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end GRAPHIC 6 form10-k_025.jpg begin 644 form10-k_025.jpg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end GRAPHIC 7 form10-k_026.jpg begin 644 form10-k_026.jpg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end GRAPHIC 8 form10-k_027.jpg begin 644 form10-k_027.jpg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end GRAPHIC 9 form10-k_028.jpg begin 644 form10-k_028.jpg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

RO)+60O&^5/4>M?44*B MUB]CYO$4F[26YMIJ&V,P3J#(.5"UZ=X/F$EI$?4=*\SLI]'O7_TV1K=B,;@* M]+\(1:?;VJ1V,[31CHQKEQT4H:,Z\#.4I>\M3MV&8ZR9AMEK7)_=UCWAP^:^ M>/;+"O\ NZ='(%RQ/6L_[0!'R:JO?D.0.E &T9^:42YK"%\=W/3ZU=@GW8YH M3&:BMFI1TJK$V:MKTI@0R56JW*O%5MM2,@O&Q"CUF%\<^]7[E@UFR]QTK*:1 M3 M+3^9B/:N1M+TL!S74:#)YL\OLF?UJ01 MNHG-2.X(VYP?0TZ(?>+< "LV]N2&.TD 4T,+AR#5)[C) ]*J7&I>7G)K-;6( MO,P2 :9-S;\\BD60Y-9:ZE"_1JE2[1CP: -RV.$QVZU<\[.%!P*Q89O1JNQ2 M@=\T%&G'/L&.:MQ7//\ ]>LCS,]*!*RFD!T*S G-.$HSBL.*[(/.15P7.WYB M>*8%YES(&S]:B*C!4]#4)O R_+C/UIR7"MCD9H ?&,$H:YMK_,SHMM,2K$9. M,=:ZE65RK#[PKR7Q*GB&U>[DTZ]9G$K%4 [9Z4@=^AWMO!+=?>B$:^K4Z;2O M*C,D;AF'4=*\MM-0\0-;(;JZN4<]1G%;.F2:@]Y$9+R9AGD%J?+W5:(211\I%X4XRJMG%:DYW1P(#C2:ACU >8%W"JVLBX>U6WMY#&\AY?;D@>PK.BT&,QJIGO/,/6 M3?S_ (8K*SZ&MTCK8I@ZYR..:H>()9#8H(N=S8)!Z5%%%+IQC!D,D+?+N8<@ MU%J1)E\E00& <<\>AIIV$]4>0>,O!-[=7T!7$:Q$8Y[5ZW=:;J;S,Z3X7L*IK9ZD),-.,#TKK6+J)**.5T(7;9Q<_P * M;^'8RWJ,#U&VNU\,:)-I$"1,1\M:*RW@558AL59BEE9AN %.>)J37*V$:,(N MZ1J%_P!WUK*O&R35W?A:R+^<(36!L5Y9,+UK,DE&X\TRXO24;%ZFZN1FB MPCHC>HC?>%;&GW D (Z&O,9-2,;7JLLR[U1$QM_&M@60 QYK5#'\:"%/.O&'W1T7ZU#5QG4V[[M-<>@--$/50M(GB22>,QS1J).Q'0U21+0^^G$:QM2@#*63C'45L \% >= MO%85_*ZA@.&IH#BM7E>'=N./3FN*N-2;[21NKJ?$LN2X/;O7FUR[&\/-4*QU M,&I/Q\U;-EJ#O( 6KBK9FXYKA64A=1DUK0@_05@:,LPVJ/[W&:EE(M1\CY>03TJEI^L)BP^;$H.XD8SS6,;NU=WRZ$[CFNJ$&81] M.]8BV$9)Q#&,DT@N5ECM94Y"-FJ7]FV_VD21_(?4&N9\>W,^CQQRPN4RV,(: MY+2/$U]<7L<^M=3X9\7'46ED:+844,3GL37CVN836KH+T#8%=W\/52 M6:='&5:#D?C4;FFQZ!XFUJZL6MS;7(CWH26XYY]ZYF[\9:O#:[TU$%\IK'K%I%&'E3,H3GC .WK[U,U=W0XNRL>CD KS6-?SP6C%VE QVK9/^ MK/TKQSQ]J%W;:TD44I6,C)%)(1ULWB: 2;4Y-7-/U(W4N :\;349Q.NY\\UZ M+X2F,\I8G/2JL(]!CCW1YK%U>(!2:Z"'_5?A6+K RIJD(Y%\".3BN&U2X*W# M5W;CY)!7 :RN+EJ8T9JWC"X3ZTEQNO\-W]GO"2:;:RL MQY:1-Q_6J=DKANG:>B%<_+;+U_*M M^-72+,8CCQV2-1_2L77BNA:@RAX&+-X1L-RD$*1@CWKI,5EM974R9-ZX^E5S MI5QG_D(2_G3W$1ZEXAL].+PNS&XVY50M>3W6G-M"8F<;/ISI&S!3M'4XXK+>$A^G2NPO(6$9'.WKBN> MN(\;CC@52 I,V5P3TIL8^?.:A:7FG12?.*8'4Z,L<;+/+R5^X/?UKO/!DDDM M[>7#\@JJ@UYW8N"!FO1= N([>T2*/ZL?4U#07.Q\T"12#TK/U6+S8V9.O6F" M?Y2Q-0373%-PZ=QZ4T!YUXD)#29X->=S'-T:](\5.I+-QS7FLG_'TWUJ@-.T M&<"NDTV(!E)&?:N>L.2*ZO3 1*N*0CJ]+MIGPR*0?I73VUC<%](9'':RQK(EB5?]<@^E7$MQM)QGCO4;V$!. M[RQN-(9"CQ$\2,WT%6DD4!L*PXZL:6*UCC^ZH&*CGE\S]W'C [^] '&>-_&O M]A6Z1K$7>0E1Z"N(T;Q].FJHSQ'$A"D"G_%.SN;>ZAN9&W0EL!?0UP=K=LUQ M&5&UE<$&GU$?4%E=?:;0.Q/S+ZTJQ$#J*YO0A?G28BS MMJ5VUTDA4BQV)-0 MVT.USC/BO@6L R#^\KSW0(VDU%0APW8^E=9\0K/5@$N+PJ8E. %[&N1T60Q7 MRLIP1TJT[H6Q[-ZL;&W6:P1E8?+)GK6K9^)[W6Y3:VR)&3P6]*CF?0=D>&^)[;[)K]U 2"RM MR1W-=C\.#F]E'_3 _P ZXWQ.7/B*^\Q][B0AF]2*ZWX;R ZFXSSY!K2)+#QD M^-8 _P"F8'ZUPFM.?M^S)QL!Q7=>,1G6_N'UE&-_D\+M%-B0VQ+/87F M.-NT=?>O2/AQ*%O9T+98 #%>:V<\$5I-$\F&<@CCTKN?AG=I/K%V(R7Z9(!P M/J:3V8SV-Y@(S]*\5\?W"RZXH[J*]K* Q?A7BOQ$C5-:C*CDCFLX[C..DD"2 MJ:]-\"N&[UY?XM/+9R#7GOB!-LY^M-,:.:E^]72^';8/MD7(<&N:E MZUTGANZ$9 ]*TZ SU#2)1M3?P5&.E=(C!HN#UKE-,D5D#9YKH(6!48[5SR@B ME)FI$WRTA;FH(R=N-U,.<_?:F!6+8KGM657F9U7ZX]:V;B41J2:YZYO8Q*?- M.%I#,J>W,L#-NPHXYKD]2(17"G('>MW5=07[2(8P2I/'O7+ZF[+O'(&:<6)H MRSR30IVL#40DYI"_O5B.AL;@$J >:[K19#L7FO,-,E8W:+ZUZ=HC+M4,F/?M M28'51GS(PI; J#4/DB(7(XZ^M R.$-/5HI%*7"'/8]J$!YMXBE8[P3FN%)_T M@_6O6/$>E0R0LZJ",'E37EEU&(KPJ.15-"N:-BV&%=AI)!F2N-L^U=/IP(S4C-&6]:0X3"@]:M6\8B4NX^@K M+2TO'&?*V8_O5+%#=-*J'.#WSTI@>>_%F=;C3H?D*LLHR#7E$*@.I QR*]D^ M(VC7>HVT4,(& X)- 9FVF:0_058CUW03NT"V(Z%!6@#5+18!:V4$)/R1 MJ!S6@2JDXJ6Q,XGXA:51FN M4U;Q/%:*RV\7F%>"?2BX%JW\-1S:5;07,Q!A4#*\56T#34TK6+\QN7BBA+!C MZUD/XAFO/#MQ>(VUD8K@=JD\"->W_@_4+J67=)-*8T9VP,"ION,\A\0C;K=U MR?FQR/SKM_A-;&75I9N-D<."3 MZFG>VH;B>-O"]_?Z@MVB-M1<*"Y7'Z5P;:7>/(B<8]ZZ[X?QW6G:U]FE$D*S M N86C*!O0\]:]DN+.%H7WHI&.F*YZ>>R74O+8()2 8N.1CKS^--["O8Z!WQ# MGVKSKQ3X3EUR\%PDI0J.F*]#W PCD=*SD:83D<&,]JS3L,\7;P?J#7QMY$)4 M?Q"N\\*:/+H[^6V3[UVD5I$9=Q YJ>2SCSE0!57N!;@D!B'TK/U&<(A-7H(M MJXK+U=/W34TA7.9NKP2.RK7G_B#/G-GUKLF_X^'%M7M+ M:19/D4DU1GXJ[IMY-;X\IB*T!GI>ES7+0QLL)**,$Y%=9;R7$JJ5MVP.O(KR MZTO]1$2,E].A9AT>NNT6>^GN=D][.Z[T=6D8Y'\4A-<*UFRL5## ./O4K#/0[W!RMM&E\ X)'9:[ M295+$X%8M]I7VAA(H^93D&LRCE;V:)IFQ;*)5&T,3S7(ZIM 9?,!8]0.U=7> M1'[:ZGJ#7,:TJJVT=:I/6PF!. M<''3TKQ^V^^*]7\+LQL() W)49SZU+&=4M@P4XR!3)=/D*=&-U8'##FO(-23R]19>V>*]<\027%PCJ#\OH*\TO]*N M);L-@U>Z$069Z5T%BV'6J-KHTPQP:V;72YPPI)"9UVC7DT&TH?PKM;*_AE4" M>,'C'3I7&Z78O&JEJZ6UC88P./4U+*1M)I\#L'@N2GL>:G\EHL%9 V.F#6?' MP>O3TI[$JY%2,TP7(W/(!["HWX^=6.[O5 .?4BI// '/)H K7\23]>3GO4*0 M1H.E,U'48[=2S$#%;:C\.AKFK37+-Y*L> HZ5V/ACPO;^'++[/"2SG[SGJ:W0 O % M2Q+ELU+?0T!8"!2^3E@?2K!X%1C.:M$C)8?W3<]JX37-!N+BX\^W MODJ:H/'\_2F)GG#:O?60^SW=ULE7U'45-!K@'+W0/X5H>.O#3:E;":V 69.0 M?6O/8/#>JS2^6GWO=J1,5?J>J:;K=NT0/F*V?>MN*X68 J_%>41>&]:TB/SI M2I0<\/FM_0M>W,(W;# X-!6QZ,A&WK6?J #(14EK<"6,$&H+PDJ:8'(W=N$G M+"N&\1<2GZUZ1=Q98FN,UVP\UB0*I,+'GMPU3VKX3V]:TKG22?X:@&FS)&1' MQ[U?0#1LIC>+A 0L8K;LFEC!".X)]#7.6%K=B1E#LW'11TKJM*L9!@N#^-92 M&7(899\*[N=W'+&K/]E3#@ 8'3@5>MX<%>.XK4*X)J4!=+JSD9S5H(1#\J\D M=31#9;)-WE\5-=S&&!FV]!1ZC//;R%8KF[GD_O''TKS_ %.4S2R2GH>!7?Z^ MDCP^6/O2'GZ5REQI)9<;3Q4TDV[CEHK'(C))P*E2&1CPIKI;?0LG[E:UOH(X MRM=-C.YREG8S-(.*]0\*6[KID2MG*D@_G5*ST9$8?+75Z+;B&,IMZ-FI8T;% MK!YB&-B0#SD'O1+IK@NM/X(9!^(K#N=)C,F0@_* MNSFMR<_/FLZ> U=R6FD[>".:15CFO&UW)!IDCJ#D#.17D,]_-E>Z:UI8U+3&C/.X=*\2U M?29M(U%[:52!U4^HJD2RCUJQ&-H!QT-0]!6SH^D3:BZC:0F?SJB)245=G7Z# MKES+;QV\<)8+_%7^Z',9+=2 M?2M"XZ&LGPX[LQ(3D5KM\TA%-EB]JD9RTVF _ MPTD6C+)&5X'U%=%Y /44Y;<(.&QGMBK3 YZWT0VDQDR#D8P!6E! 5/2M Q,Q M&6&/2GK#BE)W"Q!$I#K]:U#'S558\,/K6C@8J4 CZI=OG8J(/S-5Y!+*E3+&!57(*L=L >E:%H@1C2*H':IH^&%*XRXJ\9 M/:G!21GO4:MQ4JO4E#23C%5WA#YXS5EB,YI@(!S3$9\UOM7=54P!^16[/!OM MF*D$%?UKGDG(88]:9+)HD>)@>GI6ZD"7,*LA"N1UK,6Z@DBPX.1Z58M[L9&# ML4=!Z4#)YK>9%*K'^.>OTJ"'*[]S 9Z5L0WL$A"-(N_^=-N+*W:3S,A6]1T- M(9SUQA)@V[/&>>F:IR2EW !Y)K6EC60%-G"G%5+NW2VC60* 2PSGL*&@N/A0 MM*$)R*Y/XA^&OMMK]H@3,RA\_:/HF*W[:V$:CBJ9PM2G*\AT$(BCZ4K M=:E?I4/>D=<8V1(G2I%%,6I5%9/4U% I:7%!JT(.HH'%*!3U6J$"BE8?+3P. M*&'RT 5C52Z4%:N,*@E7<*9G(Y+6XFDM)$098C@5XI(DD&O.CJMB MDC$L,UC3^#+&>X:9H1O)SFC8(M]2/PO)NL8_H*W;H_NZKVFF)9*%C& *ENSB M,U6X]C*0;IJMR0!EZ54AYFK2[BDT-% P;1FD"5>,:MQ36MAM^4X/O4%%,1C/ M2G[,5*+>3/&*;D@D&@"/;\U6ATJ#O3_,%" CDO;F1MI?:/1:F@!V$EOS-5B, ML&%68>!RO/:J)'N-R>XJ"GL^'(-1,W-)#8\4\&H ]+Y@IB+ :G;\52:X5>]5 MY=051UH V1.,4&Y &0:YTZFI&-U6+.Y\U_F8;?YT6"YOYE= RH2I[TZ,/(X4 M*0>^:=;W$90$D=*N1SKG* 'WH&"VQ1/G/7^$5SK6@%]*A' 8X';%=,'#-RZ*KJT@;@$ TXBD5OL#*^S&">:GCTR95&T[QW]JT&B,EKF-L@QUJA?CSD9#V'!%9EO>/N/S%3T^M:$VV M4GJ:L.VTA1U/6G8BCA7#;N.,5$@W.6-3U);'+$I[5,% %(M./2@<8D3CBH<< MU.U1J.:ALU'H*E IJBGBDAABBG8HQ5HD%J04P#FI5%4 HH(XIP%!Z4 56%1- M4TG6H6ID,1&VU(;A0.E5VR.E5I&?G%!%RR\RL>*J7?\ JS]*;'N+4^Y_U?X4 MT6G7YC1>XF3[P#2^8E4VFJ/S?>@1J*$ M09V!JO(H\EO7'6J#2LHX-;1BFB&[,T)&&[.:K/.%ZFLZ>[E]A67HO>J4VK(O\ $*Y6YO[CGYZQKF^GR?GH'8Z^YUQ1GYZQ[G73SAJY M6:\F)^]5*2XD/\5(=CI6UU@V=_ZU)%XD(.3(?IFN*DE]AW-.PTCT-/$ M:]DY_NX%3ZANMID=BSQOP&/4'TK*L)Y%A7!K7GE:73Y ^#@9'L11%V8Y*Z M)M.NE2(IDX/O3);6=9&,2,ZMS]*SK%R5.:TXKV>)O+5_E]#6AB0+-);3;)$( M!ZJ?2G72$ /&"Z$=15JYPL <@,S\DM4=E(3)MP I[ 4A,S%M#C<>N60GKFFV6B;^S=QR%J.332HZ"M9#Q39#E:YS8YZ:U\O)Q6)<2[)W C&>AKIKS@&N.U-RL[D= GRAPHIC 10 form10-k_029.jpg begin 644 form10-k_029.jpg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end GRAPHIC 11 form10-k_030.jpg begin 644 form10-k_030.jpg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form10-k_031.jpg begin 644 form10-k_031.jpg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end GRAPHIC 13 form10-k_032.jpg begin 644 form10-k_032.jpg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form10-k_033.jpg begin 644 form10-k_033.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P"/=2%JTQIH M Z&E_L\=QFLKFYCR,I_@Y%*X&5N;./:FEB36O\ MV?DYV\T?VU;(TTC'%*= M/('2@#DM>!_L6?(QQ7&Q,GV*-0?G,O3VKT3Q3:E-!N#C@"O-K4%GB [N!6L= MC.6YUGB='.@R<''EBO-M,4_VE;_[XKVCQ1IS#PM,^.D0_E7DFBVY?6;10.LH M%$=@EN=[>HXC'RGI6>BN7'!KNKW2"8AA>U9B:,V\<5E7TI/LTO3!KK1IGM^E+_ &6?3]* NCD/LTOI2&TE/:NQ_LKV_2C^RO:@+HXM MK.8H1@T_[#*RKQR!78?V7P3BI1I60#B@+HXHV$OH:7^SI3U!KMQI/M3AI'M0 M*Z.9T/1Y'OO.+%5B&2 <%O;Z5=N[*% TATY68'@!PQ/YUT*:8B6[+LW[^H+; M5^A]:R-2@E1/DTZT9.O#X./:F"9P^MB2@7\,#LP59;24_P +GY<^QZ5QVI:>R3L&_=N>W0&KBR9(PMS>QJ:W MN##*K8Z$'%,EC:)\,H/N*(T20]ZL@[FVG6X$SJ4%>PQZ4N%^0=!VK*1I%F?X8CE@FE0+DNH;)'/%=$ME)(R[_J"I_3^E M0-"-/MWFP%R,;NP^M9EQXYM+5C':QS7,A!^2%2V?Q%"V#T-\696+:NW PH' MMUI[VD3*2%&[(QSP>E<5<>*?$URPDLO#\Z*.1YS!3^55AXI\6@CS=&55/]UN M])H9VTMD& 0 [H_F*^A/ M'-L!X0U(XZ1$UX!I@'VZT_Z[K_,52V!NY[9XGL@?"5R,=(/Z5XCX;M@WB*P& M.LXKZ*\2V^[PQ= #_EW/\J\"\)+N\5Z:IZ?:!26P7/=;JQ'E#CM6>+(;NE== ME;/E =J7RQ18+LQOL(]*:;(>E;7ECTIC1CTI6"YC_ &(8/%/6 MT&T<5IM&-IHV#8*+!F0:Y2\U-PQ;=G MUR.*EM(TC%LV)[E)&P9!QT&>E8]W-P5;G;G [5GR7L4WR>:(WQ^9[9J@][)* MQ5L[@2,KU%0V:I6%OA!-$T4J JW 8#BN.U&T,:F//F1 D8)Y'T/]*Z>61BK# M)/J,_K6/?JR@*>@]133!HXB[B,9_O1GI[4RR@WWB@=#W]15^\C^<@#*MVK=\ M/:'&/#NLW]PI,T$0\H'MD]:VOH8%*PESJD6.AG3^=?1$,((7CL*^;-.?_B96 M^#UG3^8KZ=@3Y4^@I2W$GH5-9T^"XTAUN-XC#*Q"'&<'H?8UCQW-C;Q[+2U5 M5"D@1Q\#%=9/) MJ\52=JE?N_4^]46TJ *[B/.>.."*P;FWUO1G\V"5[B $<'KZU/9^*"2JW$ M94' )/7-24>O1'BI>*A2I :W.4"!2A.$SX/U3_ *X-_*OG+3N+VVP?^6Z_S%?2/C7!\(ZI_P!<&_E7 MS9IQQ>P'/29?YB@#Z3U]<^&KD?\ 3N?Y5\]>$^/%NG#TN5KZ'UO_ )%NX/\ MTP/\J^>?#! \6:>?^GI: /IJX7_1_P *Q2/FK>F&;;\*PWX8U$AHU[3F,?2K M.*K61S&/I5NJ$1.RQKN;@4UG0*&R,'I5?4Y!':OY@/ED$,P_A]Z\?O/'UW8D M:4&:26!F19?[W]TU$YJ.XCVE2#WYI<5S_AB=Y=*@DGF\QRHYZG/O709R,U2= MU<8A%+BDS0Q.TXZXI@9]WK-K:OY?S229QM7_ !K(N?$-P6*Q[(OH,FLO7(KJ M2+=90M)/D;%7J3FM#0/!\A?[;K\WF3. %MHV^5!Z$]S7(Y5)NR/45.A2BI3U M8MMK5W(,K<(X#%6W(.#^%3-KES",R)!(/8[35;Q++;Z7=A?LBPQ/%\K*,*Q! MZ'WK@[[7K.+$KL$4G&":SE.<7:YI&E2J1Y[61Z%_PE=ONVO:RKZD$&HY/$%O M?,T$:SA%'(&%+?B:YJQO[>_$17;LV]3WJ24V_P!L1$/S=0!VJ?;5 ^JTDR/6 M;-C;/?6$\LDZGD?H:UA)R5V<]2')*PZX7.,=/>JPKT#1/A]%I4GV[59$N;HG*Q*/WOKZ6H/ZUI8SN<9IQ'V^W/_ $W3^8KZGMQ^[3_=%?*-@V+N M _\ 3=/YBOJ-[U;6UB.,L5&!^%.6XD9&IV4L^IRAIR(R>@./UJH_AZQ#;UC? M<>^\D_D?I6@+XGE8OG.23C/-/>;*A\E@V..A!J6RTC+72S8R,UJ[[.ZL:L>: MTF U0R]2VH+G9+D@CIM[>M9.H:! M#<#[V'SU4=#5J/4PB[F.%(Q@B*<6B>@GBBD;I3$<_XQ M&?">IC_I@W\J^:++ N8CGGSE_G7TQXN&?"NIC_IW?^5?,=JVV>/_ *ZK_.F@ M/IS6.?#,_P#U[G^5?.OAHX\4V'_7TO\ .OHO4R#X8E][?^E?./A\[?%%ES_R M\K_.@#ZFD_X]O^ U@N<.:W6.;8?[M8,A&\_6HD-&M8',8J[6=I[?NZO$TT(; M,J/$R/C:PP/\ $-;.)"8I90PD'W0ON:]@\7W+PZ8FQBNYP#@X MK@-0O9I+9PK$2 9#=_SK.HDQJ',>G:58PV%G' A5BH&<5H9KRCX<:C=RZ_-# M/,[J8LX9B<'->J;JN+T!JS'9ILA)C8*<':<'WIN:1F^4_2J$<%K.KW>E6A,4 M,DDL0+(8U).X=CBNP\+:U%XBT>'48 ?G'[P-_P LF'53[BLF]7^S[KS75GM[ MC.X@9VFF^&]DI);'6WMI:WT6R M>".=0$?['OHM:L8?]!E(26+G;&_8CT!_G7O<;X^AJCK.E6VJ MZ?/9748>"92K BMVCBC)IGS-8^+3:P>4(S&.GR'K^-=!IM[?WZ&Z"&"'&/,D M.,_2M*XTFPT+5GLH]*:XO$. %B+D^A%='IOA"345-UKP=(BN([-7Q@>K$=/I M7+;F>B/2=105W*YP&I>(K>"WDB$JL=IIVIZE]KU!KM2=[V\1./[Q09JWJGP[ ML6GE:TF90S'"2_,%^AK(GT,V/[O[67" #"K_ %K51C%:'+.>?LT)Y'L6[?A72>!M-M+'P];SQ0C[1,, MO*W+'\?2NL5JT2,)29!I>D:?HMMY&GVL<"=RHY;ZGJ:2_/[NK1?BJ-^&Y=WA;Q O\ TYC^=;WQ5_Y!5H?^FE)[2U9"\2R"20#^ MZO-?0D<4F\$< $]?3THEN.(OG*%<[5 '&2:IS7 92""H] ,C_/%69&.6#(H7 MIT[54GVHI^<'?C!ST^E9-FB12N$6= 2P(8Y+KV]L50>R6,DESE?7VJO$4KN+8R>M9&O:S;:/ILDS%3+@K&F>6:GZSJMM MIMG)=2NH X^I[ 5Y'J^ISZO>&XF;C^!0>%%:4X;VW'69?SI@U&!+C_6K@KZUX>\_B7Q((_P" M"H98]> RWB"0Y]%J(U.5WNOQ*=&ZM9_@>]?VI9_\]UIK:Q8 3S)M0 MN&. Q.3BDET..,#.I71&/[YK*57727X&D:&FL?Q/?V\36 BVY.<8ZBL>;7; M0.3N4 ^KBO$QH\9/-]Q/)NKLX_VJ3J/^;\!JBOY?Q/;K;Q=I]O\ MK.OU#BISXZT[M@_\#%>$'1K#!_?7.?=J0Z+9AQ7\OXG MKGB'Q39:K;I A5-K9)9Q7./<63$%KV+I@C=7GYT>V.0/-S[M2?V-;A?XS_P* MDW?[7X%*%OL_B>A:%J&GZ#K)OQ>12*5(*!L=:Z=_B;IP. JG_@8KQ/\ LF#J M$?\ [ZJ,Z9#DCRV'U-5%V^U^ G!/[/XGM,GQ1L4_Y9(?^V@J$_%BP&5,*<_] M-!7C TZ#<04/YTATZ ?\LZKF_O$U41;VN1^Z7\JUM M12?%F/&!Y/3WKS]K:T/W8%J%K>W'_+%:SOYLUM0O)"X^I)..U4Y$(.5D8[C]TG MCFIGN;+@-. <>O:JDUW!'&RI+N93^/UJ&:(C9S#+&-Q923DM5/6-2BL[:2:= MP$5U.N;B)E5UQM!W5Y+XO\2MK%\]O"W^B1MV_C/K3A'F9,IL8B/MFI5QCI02*[4DE8Y6[L]V9"6^Z,4UX0@Y4"K4D1.W8 M,4LT V*2V<5\Y<^@,R4L$^5!BFQL_79BIYE&S SBJZ@H3N!Q]::V![DAD J( ME023R:89HG.Q<%AV!I.-W(HL(9+*00,9I2VY1E:P[7&. $ M)"C\JFMIU5,,@'X5'*^U!4#2X;/\/I1>X^4FF\O:P49R*RU"2P0-P>H_6K+W M/WB%[5F0GRX4 )Y)/7I6L3.1I" $#G]:BGB;'"CCU-1Q7!)XJP3O3 '-3=IC MY;E18PRD' ]Q57:8V*;MW/%7$#&1A(A"BJTBD704&Y]3O4=LI;(07/6GA M36[T!H[)U4]&D(7_ .O6DOPWUJ3&^>UC_P"!%OZ5ZS#;)&F3A5ICSH#@#BGM MJS.]W9'EJ_#;44.'OK<#V5C44WPWU4C]Q=6\GL2%O]M<9KZ#8*XP363J%C:W436]S M$D\#]8W&<>XJ^<<9J.0<^'UNYFU6Z0&*)ML"L.&8=3^%>A2GSQ(A!! QN/I6] M.-M3FJSN[%"3S[!2X;SK8D;E;G'T/]#3K>_M+V/=!(&?J4/7VJCJ$E_IP,MI M\PXRC X:N3SI^LW;S:?,VC:W"6QG-46M; M:&/#[1L_.JVG:Q-_%(CA.F6,@+,,2.I^Z/0&O.@.*5V:1B[DEB$QJ2.AK)^];H0?XB,UTEZBK"Q!R17.Q0-]AC<' M"F1N#73#8PGN6%A5<'-7%V;!ZBJ>Y1P,DU% )7GOSL:)O]6?XA72Z/:O;6:Q,H&,'-0:K<-&?D8EB",UFY M\J&H\SL7;69))-L2JD:] .*V(F[(!GO7.:,'-OECRW:M,SB"1.3R>:(3>[%. M"V1>U6]BLK4F5]H Y/I5"RG6Y.]75USP5-0ZL_VFT;*@@CGO7,^'VNM.UL0, MK?9Y5R"3GG%:3DFR(0?*ST$+];OM/TG_B5VKW-Q(=JA1PGJQKP'Q - M2O\ 5&$T-T5!RN^/!W=\_C6L::F][$N?*K[GT/I5U]HL-XE5Y0/F4?K7!?$1 M+:&YM)8H%1Y5.\J, XK*^'\FJVYEG=Y/)08"OU.*[?44M-:L_LMY$"K#J.JM MZ@UG.:IRY6:1@Y+F1Y"T@,GH*1I!C(K7UCPM>Z;(WEQ-/#_#)&,\>X[5SI+( MQ4@_0UT1Y9:HS;:W)9)#5=Y3ZTYR=QW U!)C/ K1(AMB-(3U-9URDTK_ -X= MC5T]>E &.U:)V,I*^YF@/'\I)XJW;7#A@"34YC##E M]:V@Z9)K.IQVJLP3[TK@9VH.IK&0>M?1WPY\+V&D>&DGBDANY;Q0TTZ*?$[:SH%A%S'*S%ID^G3 M\*)IA>7!FN 'E 'M._GY:0[G?I6*-:FZBV'YT[^WIAR+4?G7A^REV/;]K'N;6P= MTJ.88&0HK,_X2&;'-J/SICZ[(W_+O^M+V4^P_:Q[ET%ASMJY;OP&(_2L/^VY M0?\ CV&/K3AK]P!C[.*'2EV#VL.YOYC=L@5*(EX8@?A7-?V]-GFV!_&I%\2R MK_RYY_&I="?8KVT.YNSY8$#I5=V*@VAW+TDA;;<036T M*,GT,95H+J=Q8V4EY$TD<19%(#'TKT72].B2QME:(>9$.&]JS_!]FD/AR&RD=/:NBMALC'H!6#6MC2]U<9(&5LXPIX^E<_K<1.UD)^]@[1FMR]N$4' MYP3Z50+J]Q;Q,, X8FLI)/0T@VM30L;=;+34X.[;QNZUGZI*P= #T8 FM6:4 M2[2H^7E%]^.36-=!I[C:IQ\H)'N*TFDM$1!MN[&V]X7E,3'Y@Q ![BJ]U 7* MS6QVR*3M_P!X'D52NE:*X,B,01\V1V-3VNH&.[*RKMBN1N5AT63N/QK*R9J_ M=U1H6R/=H)6!7/+ ]C6C#;^;(H3& ,%O\*S8KA'*F-N3D%0>N.M;MJ5V?+@ M]!5TUJ8U&[##$$4A?QS69<6<)-'6*$XMDGD]'3.?Q'-=_&@"_)UQ7->)EDCL9Y#(RG')QNQ1 M&FU:P.IW/([R*TEG*2EK"<<%9LE#]#U%9=U:R0 .2CQGI)&X93^(I-1N$N]1 M"3+MCY^;=WJVEYI]L(+5$61I!@X7@?6O247%''S*3[&9S2A<]JO'3X]Q()_. ME%A&/7\ZNQGS%0(,<4I7CISZUU>F?#_5=3B\Y8!!"1P\[;<_0=:Z#3OAA;QS M!]2OO,1>?+B&,_4FLY2C'=FT(3ELCE/#/A:?7)Q))F.S1L.XZM[+_C7K^FRO MX;MQ]APD2@#R#]TCZ>OO3UAM+&R6*WC6-(QA$7L*P[V^QDDLSCG&:X:E:5[H M]"G0CRV9V]MXAT_5U: D),1A[>0\GZ>HKB/$OA]+!VO-&21^?WEJJEL>X_PK MC=3U$LLCNQ 3Y@RG#*?8UCV7Q,U^UD:T$Z740R%:9KWVKWQNKF;]YSC: M, 5N6-LLEI$S9)*\DU6,=*L[.>E&SF@"H8QZ4GE"NK\-^'#J\SO+\MNH(W?[7:NK7P7I,5L82C.Y MZR$\_A6*.&TA?.ZX7(D(Z@#O]:];@ M\(Z3IRFX*/,PR0LC9 _"N:U_Q(L!2+9B,2"(A5Z#." *EUG\,$4J*^*3.[M^ M;&/9$(PR@A<<"AW9 ,C%2VA\ZUC<84%00/:I)-IB)R"1ZURRC?4Z5*VA22%) M#ELD_2LK5HVBN4G4$[&!Q6]$^[D)BL[4T\P$C-19)%J3N5=5U>6S@5UC! &= MOH"*BL[N*[M#>1YR[=/3'6K&K60N+O%8NCYLK4V08 MSN7)RM5VU-!A%;)[U'<1%AR:JHBH_&U6Z=*ZKNYR65C;\PM'\P'3I5=9! MYFW@9JL&=3A6/--:-Y)$5FSW!JG=B5D:L1BB4ES@]<5RVOWM681RZJ%'(XSSS_\ JJOH6E37%Q)<%0(H!O8D]>P%7M;NY;HF(R.Q0<@G M&,=]>@:G?"- D3B*->K>@K"I4 M21U4*3D[DDUX&W&*IS2'+9.,"J-A?6]PTGDDN%/+=OSJOJ>H*%*IU/ KS MYR;/5C!1T$U#4HDB^1BS#@BN.U35I8T)2/YGX&[MZU-KE]#I\.2_SGD#O7++ M]IU*8W%SE8^B(.XK2C2<]7L95ZRIJRW,[5;V62Q9D8F,'&[IN-<_8G-TOKS7 M4>((PFDX4 $ 5R]C_Q^)^->K"*BM#Q:LW.5V!8[FKMM*7=IMN?]FN';[S? M6N\T89TJV_W:)[$PW-%$^4_2O.IB3*^X\EC7H\LJVUI+.W1$+5YP[>8S'N3F MKH=2:W0;M]Z4],4<_A00,3_05$BXH]E^PMZ4?8&-=5]@'I2?8!_=KCL=7,E=8+ >E M)]@']VBP[G)?86]*#8MCH:ZW^SQ_=H.GCTHL%SCVL'STK8T+P\+^1Y)3\J# M'N:VDTOS&"@5NZ7IZV4;$],]O6LYNR+AJR6SL8K.UB@@0*B8/U]ZN&,%1D=* MEQM&W/%,*Y^E<_*; MO=+V%6B>$J&#J0^'[*XD8L_EA6]R./Z5N2K%@DG [BN;\&3Q)H\<,;2.5X(9-N#]*VY[L*Q4 MKM^M92:2-8IMBM+&?E0''K5.=E)8$=N]/!+MG)(].*HZC#<$CRX\@]B:PYFS M91299@G@>%8=ZF1,Y&:R]9T]I9=ZOB0 '([54O;9[5_M"RE"B_-'C'Z]ZQK? M6[V747#.?+$+,0>V/ZU?*IJW4%)P=^AT,D+20!3G@8-9ES \4>&!([&N/U;Q M7JD$Z)%*5^3Y@1R#Z?AQ52#QQJMN5$Q6XCSRKK_6I>%DU=,I8A)ZG?::Q)(; MJ#UK5FE,93.,#J:YW2O$FE7L8FC0PRG[T;'H?\*NF[34!.BS!/EVJ5.2,]36 M*A*+LRY34E=&]_:4#Q8WKNQ65<:G#%.1G'IDYJ.#1(3$%>]W''4G!KD_$EM> M6$4TE@QDECY"LV>.Y'O79&TG8XVN4[ :I HS)($Q_%GBIAXATY'VM<(QR%^5 MLD>Y]*\!ENM7OW;YKJ1F/. 0!6EHND7]Q.(]TBH1\TH/"^WN:Z51MNSG=6_0 M]DU3QOI5E%M6Y$K'Y?D/W?QKC;6]U+QO=7$0$<=O"N)",D\\ #/M5,>&[10I M97JVK+0(-+,9BPA;F)Q@>Q/K M76^'O"B2%K[55S&#^[C/1O0GVK2/V/7;1I[=_*N@N!G@@^XJ&^UF_EM4LX;& M<3*GED"/Y?SZ5ASRV;/0=&FVG%%K4?$<=IN@4! @X Z 5C165WKNVZO97%J" M2MOT+>[?X5#;Z!B5+K69E+KR(]W ^OK6I)KVF09 N(U '4MTK%MMG0DDM"*] MO8]/MQ%''L &U$6N8OM5^QHTD[ S$<)_='O1J7B6*:21[5#(!UEQP![5CPV$ MUY(+J]&%SN2,]3[M_A50I.3U,JM=06FY2$5*3D[LP_$:_\ $H?V(KD;#_C\C_&NS\1K_P 2>7ZBN-L!_IL= M:QV,9;C&^^WUKOM#&='MC_LUP+_ZQ_J:] T!=VBVW^[2J;#I[EK5+=[C1[F- M 2VS( [XYKSELYP!]*])U6\_L[29I@P$A&V//Q-7< [ _,I MIY.0.]0^:?2C>3STK6YE8LP+OF4'IG)^@J*Y8EP#Z;C]3S3H6^1^N6&T'TJ& M1M\C-ZFI>Y2V/K0VV.U)]G'I6L\(-0-'CM6%B[E#[./2D^SCTJ]M]J3;2L.Y M2^SCTI&@ '2KVVH+AMJU,FHJY44Y.Q6C(0M@<],U:M)#M4-U!SCWJK@(BECR MWI4JNB,#D5YO.V[L]+D25D:B8E0,>#2,<# & .]5HIO0?2K(<>8-RY4BMTU8 MP::93GB,BEL]!P17#Z_HD*V]\ML MY>_O6D;GRV XQGI7?W+@J=O'>N8UBQE MO+>8*^UR/E-92ERO0TBN9:G'>#_$#Q7T>GN_[VXSL?@[V'4$C]*[R$-+)F<$ M'T)ZUX;J4[:?K3S67I/[J*U8''J2./YUNRWI=V55("C ^M4;BU M=[1H@X5Y"&?/3 Z"G!\H2N]#S&\M?/B:68$%I'8''0''%8C6^).&)'H*]+U# M3EVJBK@^@.:RO[",SD[ .PQ6BKI;DNC?8YJV7;%LB!+GJ>]=AX?LFBA,[9W M9R35BR\/QVJ@E06/]XUJQQ"2:.TB^[N!DXQP*5W-V0.T44;>QU#5)VGN)'MK M//[M%X>3W/H*M/HEH 1L8YZDL3FMUQS4+K7>H)*QP.;;N<^VA6@_Y9\>E/\ ML21J%10 .@%:[)3&CR*=A7,A[;Y>E5WMJVGBRO2JY@R:8KF.UH^2TM=:+?#'BD$&4/'>I<4]T:QJRBK)GG3V_BO4W(N M"Z*>NY@!3X?!MUO#SE)2.<-*<']*[_R.>E A]J+);![23W,*'3&,<:W$<2K' MRL40^7/J?6K,EM[5KK#D\BAK;.3BA)+84IN3NS :UYZ4V2VV1DXK=-KSTJ&] MM]MJQQVID'#>(D_XDTQ^E<5IJYU"(>]=YXA3.AW!]!7#Z2,ZI;CU;^E:QV,Y M;E:3B5_J:].\+6WF>'K5L=C_ #KS&;_7R?[Q_G7L/@F'?X4LVQZ_SI5-APW. M%\;32#6A;$_)'&NT?7J:YH, *Z'Q[(/^$MN%7_EFB*?RS_6N>5E<8/6MH?"C M*6[%)4TTA>U.$0H*#/%4(FV 6X8#^$D_B<#^M5.]79\BWQD8&P>_3-4C4HIG MVEB@QY[4HZU,!60%1H*9Y-7B!@U3GNHX1DD8]:EM+<:3>B&F'BLB[;$I"\_6 MKD^J*\3*BLK>O:LH2&23 YK@Q-5-<54$[M(O)4] M1D=*U)('DC*[JK?9%4\X+'J:XFF=RDK&E9A1$I!)SQDFII9=O4]*I6X>-,$U M?6,2(",$GK75!W5CEGH[D1<.N0:K7+I&A9NGTJVT&U>.E5ID)SE01CH:EIC3 M1Y/XI\*#[1(L89K:X8MD=8S@M^IK@K2_OM)U47%N?)OK?AD'21?0^O%>\ZS; M*UJR9^\"I ]#7C6NZ'/!=&UF#K.N9+:X8 "5?0^F*WH5+WA(SK0^W$],\.>( M8-7TQ+J2=!O.U@&^XWI[5OPRPQDD'<#_ !$Y_6O K)KNRG%RT$L?&9%485AZ MBO2-.UK3]0TZWDBSE>#'O)Y]36=2ER:K8N%3GT>YV^Z(!I%VGOPU?#WGP9:?[S?SI3V'##_.O/!$YY#5K# MX49RW &5>XI/.8=0#0$?N:=M_'WJM1:#Y+A'AVX(/R_H,5!5FY4*NT*.N#^ MJMD+T!J44S[2'6IU-0?Q5.M9B''H3;,V<&JD(VP M;N[M9L\D MD;A6X!Z'L:F3[E)=BEJ.)9$C)[Y)%S@!\PH<$ XKMKC)!; M:%Q[U165F4JRJRGLW(KFY^2?,=/+S1L>%2W=PL04!OLP)"/&^XK^'^-06MZZ M7/F@MA2&;8.#]1VKMO%'A9/,DN=)00.V=R*V-V>M<:]LH98T7[)=H"&C;.V3 M'O7J4JL*BT//J4I0>IWV@>-;NZUFUBO7C_>_(S+T/IBN_N0JQEP,AEQD5\]M M(8AN,;P2 @@*/ESZBO4/!OC 7MA]DU(X=2%20]Q[^EIP8J70L%-IX[T8J0BFUWGGC-O-!6G@48 MH 9MXJ-EJ8CBHS2&5)$R*@B4$GCO5MN]01#&[ZTAD4R U#MJS+5?O0,LQ5-5 M>,G-3T""J]X/]':IZ@N_]0U '&^)USX;U#_KD:\5T'_D/67_ %U%>V^(AGP[ MJ'_7(UXEH7_(>LO^NHJEL-[E:\'^G7(_Z:-_.O:/AUSX+MO]]_YUXS?C&HW7 M_71OYU[+\-^?!=O_ -='_G2GL..YSOQ;@A#Z7<;P)B'0IW*]<_G7F87)^5CF MNV^)UPTWBL0D_+! JJ/0G)-<: -W%:07NHB3U&!B#AB1[TH0EA\W![TYEW#) M%,Y1A@G%4T)"/OR 3GO^=3V-S';7]O-/;K/%'(K-$_1P#R#23A205]2*C5=[ M!<@9/4TD-GV@WWJF7I4+_>ISRK%"TC' S63T!:F?J6ZXNHH%'R*=S&IVP(Q M5(3$OG@%SFK+-E/I7GN7,VSO4>5)%2X&7P._%36D2JG X-1!3)/5L8B4+40C MKI2HP33(CA/>G%\MCTKKMHHJ!C;[3(D M95.^1TK8F"2(2>_>LTPN"P'"MWQD5Q35F=D'='+ZE$"[>4RLA.D9Y3(/4=:Q=1L/*E5@H*_PMTK)1E'5&[E&2Y6<; MJ_PW\J)9; NR@?-&3N)'J*Y_[,+")(HE968L,D 0)#<>G!-5$RLL (!Z@Y/%=YID,=X/+O64;L,%)_2JC'F=DB93Y% M=F=X4M&:6'S(3^[4#/H2,UVR1M&V4'RGJM06\"07,I5/E=MX9>G0#'Z5>S7= M3@HJQP5)N;N(1Q3=IIV>:#6ID)BDQ2FB@!&'%1-TJ1CQ49Z4 0-UJ&/JWUJ= MNM0I_%]:11'+59JLRU5/>D,GB]ZLU5B/2K.:8@-5KO\ X]V^E6":@N_]0WTH M Y/7QGP_?#_IBU>&Z*<:Y9?]=E_G7NFN'.AWH_Z9-7A.DG&M69_Z;+_.FAC= M1&-3N_\ KJW\Z]D^&G/@N'_KL_\ .O'=4Q_:UYCIYK?SKU_X9MCP8A["9Z4] MAQW/-_&]W]M\8ZBX/RI)Y0_X",?XUS^SN*GOYSLZUG*SN MI],@U;C?,FTG&:Z8:G--69>4=.?J:0_+WXIF\< &ACCDFNKH;N/7DUFV6D3G+C)J)XR!D=14D? ZYJ6IW*V,J;>I.WO6=+-=I M_JWV#Z9K7N%P3[?J*HR*A&[)P*YIJYT0=AT>Y@-SECW-,N401%9%&#W(ID3@ M3!=XVJ/UJ='%Q"6ZJ#@416EAMV=S!EMMMY& <)MZ=CQ5*1B;A[=CG@@?2M:\ M0H&8\8;Y:R 5;4V?/S!>*PE'WC:,O=*-OIEGAU:)YV(=V6Q@< 8I2V1BJAO M+?\ Y[Q_]]"D-[;_ //>/_OH5U'*6PP'>EW516[MSDFXC_[Z%.^V6PZW$?\ MWT* +6ZDW55-[;?\_$7_ 'T*8;^T_P"?F+_OL4 7&/%1LW!JLVI67_/U#_WV M*A;4K+_G[A_[[% %EF^;%0JP(8^]5O[4L-Y/VR'_ +[%0C5=/"-_ID/7^\*1 M1-N15D'BL./6],!'^FP_] M]58&O:7C_C_@_P"^J8K&F6YJ"Z.86JD==TO_ )_H?^^JBN-=TKR2/MT/3^]0 M&IE:Q_R!;W_KDW\J\'TTXUBU]IE_G7M>J:QIKZ3=HMW&6,3 'VKQ"R8#5(# MGI*O\ZI 2ZI_R%KS_KJW\Z]5^'\WE?#ZZD_N-*?_ !VO*=3.=5NSZR-7H?A* M[2'X::J"^'7S./JM*6Q2\CS3.XEO4YIPX/-,7H!3@.,YK/E36I5>3] MYT&?7%.$V"1&<<]2>I-%%%+X@ MJ+W3(UB\+!548W &LBY8Q7$94]!@GUHHJEN+H9FH7KS,8URGJ0:SCE1]]OS- M%%=D%9'-+5B&8@=6_.HSI_.BB@0A51VJ/<RT44 -;/HM,(/M110%A-F1G M IIC/;%%%,5B-D<="M-#R \[:**8A<>8""!7.7MH+740JD8)R,=J**J.Y,EH M5+@DW,A)R<\FNLT:9HO .KX[G'YXHHIU%=+U0J>[]& GRAPHIC 15 form10-k_035.jpg begin 644 form10-k_035.jpg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end EX-101.SCH 16 dqws-20221231.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - GOING CONCERN UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - FINANCE LEASE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - AMOUNT DUE TO A DIRECTOR link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - CONCENTRATIONS OF RISKS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SEGMENTED INFORMATION link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - FINANCE LEASE LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - CONCENTRATIONS OF RISKS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SEGMENTED INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - GOING CONCERN UNCERTAINTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - FINANCE LEASE LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - AMOUNT DUE TO A DIRECTOR (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISKS (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SCHEDULE OF REPORTABLE SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 17 dqws-20221231_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 18 dqws-20221231_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 19 dqws-20221231_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Noncontrolling Interest [Member] Investment, Name [Axis] DSwiss Holding Limited [Member] Geographical [Axis] HONG KONG DSwiss Sdn Bhd [Member] MALAYSIA DSwiss Biotech Sdn Bhd [Member] Legal Entity [Axis] DSwiss HK Limited [Member] DSwiss Biotech Sdn Bhd [Member] Ownership [Axis] Subsequent Event Type [Axis] Subsequent Event [Member] Long-Lived Tangible Asset [Axis] Computer and Software [Member] Furniture and Fixtures [Member] Office Equipment [Member] Motor Vehicles [Member] Award Type [Axis] Year-end MYR [Member] Year-Average MYR [Member] Year-end HK [Member] Year-Average HK [Member] Year-end RMB [Member] Year-Avereage RMB [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Management Services Agreement I [Member] First Finance Lease Agreement [Member] Second Finance Lease Agreement [Member] UNITED STATES SEYCHELLES Income Tax Authority, Name [Axis] United States of America [Member] Seychelles [Member] Hong Kong [Member] Malaysia [Member] People's Republic of China (PRC) [Member] DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer A [Member] Accounts Receivable [Member] Customer B [Member] Customer C [Member] Customers [Member] Cost of Goods and Service Benchmark [Member] Supplier Concentration Risk [Member] Vendor A [Member] Accounts Payable [Member] Vendor B [Member] Vendor C [Member] Vendors [Member] Accounting Standards Update [Axis] Accounting Standards Update 2016-02 [Member] Related Party Transaction [Axis] Related Party A [Member] Related Party B [Member] Related Party C [Member] Related Party D [Member] NV [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Name Auditor Firm ID Auditor Location Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable Other receivables, prepaid expenses, and deposit Tax recoverable Inventories Total current assets NON-CURRENT ASSETS Property and equipment, net Intangible assets, net Operating lease right-of-use assets, net Total non-current assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable Other payables and accrued liabilities Finance lease liability Amount due to a director Operating lease liability Current tax liabilities Total current liabilities NON-CURRENT LIABILITIES Finance lease liability Operating lease liability Total non-current liabilities TOTAL LIABILITIES STOCKHOLDERS’ EQUITY Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares and 206,904,585 shares issued and outstanding as of December 31, 2022 and 2021 respectively Additional paid-in capital Accumulated other comprehensive losses Accumulated deficit TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY NON-CONTROLLING INTEREST TOTAL STOCKHOLDERS’ EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE COST OF REVENUE GROSS PROFIT OTHER INCOME SELLING, GENERAL AND ADMINISTRATIVE EXPENSES OPERATING EXPENSES FINANCE COST LEASE EXPENSES (LOSS)/PROFIT BEFORE INCOME TAX INCOME TAXES PROVISION NET (LOSS)/PROFIT Non-Controlling Interests Other comprehensive income/(loss): - Foreign currency translation adjustment COMPREHENSIVE INCOME Net (loss)/profit per share- Basic and diluted Weighted average number of common shares outstanding - Basic and diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Shares spinoff adjustment resulted from a stock distribution by a corporate shareholder Beginning balance, shares Foreign currency translation adjustment Net gain (loss) Ending balance, value Beginning balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: (Loss)/Profit before tax Adjustments to reconcile net (loss)/profit to net cash generated from operating activities: Depreciation and amortization Amortization for intangible assets Changes in operating assets and liabilities: Accounts receivable Accounts payable Inventories Other payables and accrued liabilities Prepaid expenses and deposits Reduction in lease liability Cash generated from operating activities Taxation paid Net cash generated from operating activities CASH FLOWS FROM INVESTING ACTIVITY: Purchase of property and equipment Net cash used in investing activity CASH FLOWS FROM FINANCING ACTIVITIES: Repayment to directors Advance to related companies Additional of finance lease Repayment of finance lease Net cash used in financing activities Effect of exchange rate changes on cash and cash equivalents Net change in cash and cash equivalents Cash and cash equivalents, beginning of year CASH AND CASH EQUIVALENTS, END OF YEAR SUPPLEMENTAL CASH FLOWS INFORMATION Income taxes paid Interest paid Accounting Policies [Abstract] ORGANIZATION AND BUSINESS BACKGROUND Going Concern Uncertainties GOING CONCERN UNCERTAINTIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] VIE STRUCTURE AND ARRANGEMENTS Equity [Abstract] STOCKHOLDERS’ EQUITY Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Inventory Disclosure [Abstract] INVENTORIES Payables and Accruals [Abstract] OTHER PAYABLES AND ACCRUED LIABILITIES Finance Lease Liabilities FINANCE LEASE LIABILITIES Amount Due To Director AMOUNT DUE TO A DIRECTOR Income Tax Disclosure [Abstract] INCOME TAXES Risks and Uncertainties [Abstract] CONCENTRATIONS OF RISKS Leases [Abstract] LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Segment Reporting [Abstract] SEGMENTED INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation Basis of consolidation Use of estimates Cash and cash equivalents Property and equipment Intangible assets Leases Inventories Revenue recognition Cost of revenue Shipping and handling fees Selling and distribution expenses Income taxes Net profit per share Foreign currencies translation Related parties Fair value of financial instruments Recent accounting pronouncements SCHEDULE OF VARIABLE INTEREST ENTITY SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE SCHEDULE OF FOREIGN CURRENCIES TRANSLATION SCHEDULE OF PLANT AND EQUIPMENT SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS SCHEDULE OF INVENTORIES SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES SCHEDULE OF OBLIGATION UNDER FINANCE LEASE SCHEDULE OF MATURITIES OF FINANCE LEASE SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES SCHEDULE OF PROVISION FOR INCOME TAXES SCHEDULE OF DEFERRED INCOME TAX ASSETS SCHEDULE OF CONCENTRATIONS OF RISKS SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET SCHEDULE OF OPERATING LEASE LIABILITY SCHEDULE OF OPERATING LEASE OTHER INFORMATION SCHEDULE OF RELATED PARTY TRANSACTION SCHEDULE OF REPORTABLE SEGMENTS Company name Place of incorporation Date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held Number of shares, acquired Equity ownership interest rate percentage Consideration price per share Equity ownership interest rate percentage Accumulated deficit Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, estimated useful lives Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Foreign currency exchange rate, translation Intangible asset, useful life Impairment loss Finance lease, description Largest amount of tax benefit, description Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Percentage of annual net profit to be received as fee Common stock shares issued Common stock shares outstanding Preferred stock shares issued Preferred stock shares outstanding Total property and equipment Accumulated depreciation Effect of translation exchange Property and equipment, net Depreciation expense Trademarks Amortization Effect of translation exchange Intangible assets, net Amortization of Intangible Assets Prepaid expenses Deposits Total other receivables, prepaid expenses and deposits Finished goods, at cost Total inventories Other payables Accrued audit fees Accrued other expenses Accrued professional fees Total payables and accrued liabilities Schedule Of Obligation Under Finance Lease Finance leases Less: interest expense Total Current portion Non-current portion Schedule Of Maturities Of Finance Lease 2023 2024 2025 2026 Total (Loss)/Profit before income tax Current: - Local - Foreign Deferred: - Local - Foreign Income tax expense Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Net operating loss carry forwards Less: valuation allowance Deferred tax assets Cumulative net operating losses Income tax rate Net operating loss carryforwards expiration Valuation allowance Statutory income tax, rate Concentration Risk [Table] Concentration Risk [Line Items] Revenues Concentration risk, percentage Accounts receivable, trade Purchases Account Payable, Trade Operating lease right of use asset New Lease commenced on 1 January 2022 Accumulated amortization Effect of translation exchange Operating lease right of use asset, ending Operating lease liability, beginning Less: gross repayment Add: imputed interest Effect of translation exchange Operating lease liability, ending Less: lease liability current portion Lease liability non-current portion Operating cash flow from operating lease Right-of-use assets obtained in exchange for operating lease liabilities Remaining lease term for operating lease (years) Weighted average discount rate for operating lease Lease liability Lease asset- right of use Discount rate of lease payment Amortization of operating lease right of use asset Lease expenses Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Professional Fees Sales Total Ownership percentage Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Revenue Cost of revenue Depreciation and amortization Net (loss) / profit before taxation Assets Subsequent Event [Table] Subsequent Event [Line Items] Computer and Software [Member] Effect of translation exchange. Intangible assets, Effect of translation exchange. Accrued audit fees current. First Finance Lease Agreement [Member] Second Finance Lease Agreement [Member] Schedule of Obligation under Finance Lease [Table Text Block] Due to Officers or Stockholders [Text Block] Finance expenses. United States of America [Member] Seychelles [Member] Hong Kong [Member] Malaysia [Member] People's Republic of China (PRC) [Member] Stockholders equity note spinoff transaction shares. DSwiss HK Limited [Member] DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] Customer A [Member] Customer B [Member] Increase decrease in reduction in lease liability. Customer C [Member] Taxation paid. Vendor A [Member] Vendor B [Member] Payments for advance to related companies. Additional proceeds from finance lease. Vendor C [Member] Addtion in operating lease right of use asset. Effect of translation exchange of operating lease right of use asset. DSwiss Holding Limited [Member] DSwiss Sdn Bhd [Member] DSwiss Biotech Sdn, Bhd [Member] Schedule Of Operating Lease Liability Disclosure [Text Block] DSwiss Biotech Sdn Bhd [Member] Place of incorporation. Effect of translation exchange of operating lease liability. Schedule of Operating Lease Other Information [Table Text Block] Particulars of Issued Capital. Related Party A [Member] Related Party B [Member] Related Party C [Member] Related Party D [Member] NV [Member] Going Concern Uncertainties [Text Block] Summary of Property and Equipment Useful Life [Table Text Block] Shipping and Handling [Policy Text Block] Year-end MYR [Member] Year-Average MYR [Member] Year-end HK [Member] Year-Average HK [Member] Year-end RMB [Member] Year-Avereage RMB [Member] Related Parties [Policy Text Block] Percentage of annual net profit to be received as fee. Management Services Agreement I [Member] Motor Vehicles [Member] Customers [Member] Vendors [Member] Net income (loss) attributable to minority interest. Operating lease right of use assets. DSwiss Biotech Sdn Bhd [Member] [Default Label] Assets, Current Assets, Noncurrent Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Cost of Revenue Gross Profit Selling, General and Administrative Expense FinanceExpenses Operating Lease, Expense Income Tax Expense (Benefit) NetIncomeLossAttributableToMinorityInterest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Payable Increase (Decrease) in Inventories Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (Decrease) in Prepaid Expense and Other Assets Net Cash Provided by (Used in) Operating Activities, Continuing Operations TaxationPaid Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities PaymentsForAdvanceToRelatedCompanies Finance Lease, Principal Payments Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Income Taxes Paid, Net Stockholders' Equity Note Disclosure [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Equity Method Investment, Ownership Percentage Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment EffectOfTranslationExchange Finite-Lived Intangible Assets, Accumulated Amortization IntangibleAssetsEffectOfTranslationExchange Finance Lease, Liability, Undiscounted Excess Amount Current Foreign Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Deferred Tax Assets, Operating Loss Carryforwards Operating Lease, Payments EffectOfTranslationExchangeOfOperatingLeaseLiability Related Party Transaction, Amounts of Transaction Depreciation, Depletion and Amortization EX-101.PRE 20 dqws-20221231_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 21 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Jun. 30, 2022
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2022  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 333-208083  
Entity Registrant Name DSwiss, Inc.  
Entity Central Index Key 0001652561  
Entity Tax Identification Number 47-4215595  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite  
Entity Address, Address Line Two Avenue 3, Bangsar South  
Entity Address, Address Line Three No.8 Jalan Kerinchi  
Entity Address, City or Town Kuala Lumpur  
Entity Address, Country MY  
Entity Address, Postal Zip Code 59200  
City Area Code 603  
Local Phone Number 2770-4032  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Public Float   $ 0
Entity Common Stock, Shares Outstanding 206,904,585  
Auditor Name JP CENTURION & PARTNERS PLT  
Auditor Firm ID 6723  
Auditor Location Kuala Lumpur, Malaysia  

XML 22 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash and cash equivalents $ 214,269 $ 234,546
Accounts receivable 17,492 2,053
Other receivables, prepaid expenses, and deposit 21,749 53,693
Tax recoverable 745 814
Inventories 7,483 17,131
Total current assets 261,738 308,237
NON-CURRENT ASSETS    
Property and equipment, net 72,179 92,970
Intangible assets, net 3,459 4,498
Operating lease right-of-use assets, net 44,548 92,606
Total non-current assets 120,186 190,074
TOTAL ASSETS [1] 381,924 498,311
CURRENT LIABILITIES    
Accounts payable 29,539 10,901
Other payables and accrued liabilities 154,710 205,359
Finance lease liability 16,515 16,697
Amount due to a director 40,509
Operating lease liability 44,548 45,270
Current tax liabilities 175
Total current liabilities 245,312 318,911
NON-CURRENT LIABILITIES    
Finance lease liability 38,461 58,055
Operating lease liability 47,336
Total non-current liabilities 38,461 105,391
TOTAL LIABILITIES 283,773 424,302
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding
Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares and 206,904,585 shares issued and outstanding as of December 31, 2022 and 2021 respectively 20,690 20,690
Additional paid-in capital 1,395,426 1,395,426
Accumulated other comprehensive losses (5,846) (32,985)
Accumulated deficit (1,324,002) (1,309,711)
TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY 86,268 73,420
NON-CONTROLLING INTEREST 11,883 589
TOTAL STOCKHOLDERS’ EQUITY 98,151 74,009
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 381,924 $ 498,311
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 23 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 600,000,000 600,000,000
Common stock, shares issued 206,904,585 206,904,585
Common stock, shares outstanding 206,904,585 206,904,585
XML 24 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive Income - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
REVENUE [1] $ 1,849,047 $ 1,958,655
COST OF REVENUE [1] (1,404,054) (1,459,531)
GROSS PROFIT 444,993 499,124
OTHER INCOME 4,823 8,390
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (402,412) (308,686)
OPERATING EXPENSES (1,303) (1,464)
FINANCE COST (6,212) (2,600)
LEASE EXPENSES (42,310) (44,486)
(LOSS)/PROFIT BEFORE INCOME TAX [1] (2,421) 150,278
INCOME TAXES PROVISION (516) (176)
NET (LOSS)/PROFIT (2,937) 150,102
Non-Controlling Interests (11,354) 23,357
Other comprehensive income/(loss):    
- Foreign currency translation adjustment 27,139 (4,808)
COMPREHENSIVE INCOME $ 12,848 $ 168,651
Net (loss)/profit per share- Basic and diluted $ (0.0001) $ 0.0008
Weighted average number of common shares outstanding - Basic and diluted 206,904,585 206,904,585
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 25 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 20,690 $ 1,395,426 $ (28,177) $ (1,483,170) $ 25,727 $ (69,504)
Beginning balance, shares at Dec. 31, 2020 206,904,600          
Shares spinoff adjustment resulted from a stock distribution by a corporate shareholder
Beginning balance, shares (15)          
Foreign currency translation adjustment (4,808) (1,781) (6,589)
Net gain (loss) 173,459 (23,357) 150,102
Ending balance, value at Dec. 31, 2021 $ 20,690 1,395,426 (32,985) (1,309,711) 589 74,009
Beginning balance, shares at Dec. 31, 2021 206,904,585          
Foreign currency translation adjustment 27,139 (60) 27,079
Net gain (loss) (14,291) 11,354 (2,937)
Ending balance, value at Dec. 31, 2022 $ 20,690 $ 1,395,426 $ (5,846) $ (1,324,002) $ 11,883 $ 98,151
Beginning balance, shares at Dec. 31, 2022 206,904,585          
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
(Loss)/Profit before tax [1] $ (2,421) $ 150,278
Adjustments to reconcile net (loss)/profit to net cash generated from operating activities:    
Depreciation and amortization 72,441 65,382
Amortization for intangible assets 1,029 1,034
Changes in operating assets and liabilities:    
Accounts receivable (15,551) 6,848
Accounts payable 14,702 9,819
Inventories 8,707 19,764
Other payables and accrued liabilities (42,440) 49,249
Prepaid expenses and deposits 28,995 (460)
Reduction in lease liability (42,212) (46,923)
Cash generated from operating activities 23,250 254,991
Taxation paid (822) (3,300)
Net cash generated from operating activities 22,428 251,691
CASH FLOWS FROM INVESTING ACTIVITY:    
Purchase of property and equipment (14,376) (62,075)
Net cash used in investing activity (14,376) (62,075)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayment to directors (38,284) (112,851)
Advance to related companies (398)
Additional of finance lease 43,535
Repayment of finance lease (15,671) (9,237)
Net cash used in financing activities (53,955) (78,951)
Effect of exchange rate changes on cash and cash equivalents 25,626 (34,123)
Net change in cash and cash equivalents (20,277) 76,542
Cash and cash equivalents, beginning of year 234,546 158,004
CASH AND CASH EQUIVALENTS, END OF YEAR 214,269 234,546
SUPPLEMENTAL CASH FLOWS INFORMATION    
Income taxes paid 141 3,300
Interest paid $ 421 $ 2,600
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 27 R7.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND BUSINESS BACKGROUND
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
ORGANIZATION AND BUSINESS BACKGROUND

1. ORGANIZATION AND BUSINESS BACKGROUND

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015.

 

DSwiss, Inc. operates through its wholly owned subsidiary, DSwiss Holding Limited, a Company organized under the laws of Seychelles.

 

The principal activity of the Company and its subsidiaries is to supply high-quality health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to improve the overall health system in our body.

 

We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with 100% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold 100% equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.

 

We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned 40% equity interest.

 

The Company, through its subsidiaries and its variable interest entities (“VIEs”), mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

  

  Company name 

Place and date of

incorporation

  Particulars of issued capital  Principal activities 

Proportional of ownership

interest and

voting power

held
1. DSwiss Holding Limited  Seychelles,
May 28, 2015		  1 share of ordinary share of US$1 each  Investment holding  100%
               
2. DSwiss (HK) Limited  Hong Kong,
May 28, 2015		  1 share of ordinary share of HK$1 each  Supply of beauty products  100%
               
3. DSwiss Sdn Bhd  Malaysia,
March 10, 2011		  2 shares of ordinary share of RM 1 each  Supply of beauty products  100%
               
4. DSwiss Biotech Sdn Bhd (1) (2)  Malaysia,
March 17, 2016		  250,000 shares of ordinary share of RM 1 each  Supply of biotech products  40%

 

  (1)

Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of this entity unilaterally, and hence the Company has control over this entity.

     
  (2) On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Business Overview

 

One of the leading one-stop ODM/OEM manufacturing companies, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms. DSwiss addresses a distinct demand in the market for a manufacturer who could ensure the quality of the ingredient sources and offer efficient one-stop service from raw material, product development, manufacturing and packaging.

 

Since our founding, we have experienced tremendous growth in Malaysia. We offer exceptional lifestyle solutions to consumers all over the world thanks to our over 10 years of continuous innovation and work in the health and beauty business. Our company’s Chief Executive Officer, Vincent Leong has led it with a strong hand, and as a result, our products are now consumed around the world, such as Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. With the help of our distributors, we have so far extended throughout Asia, and we are adamant about extending our geographic reach into untapped markets.

 

With a team of professionals at the helm, DSwiss is assured of providing the best products and attending client’s needs from consultations to products. To fulfil customer needs, we carry out research and development based on our philosophy of “creating beauty, health, and the ecosystem”. Our cutting-edge research and development team has always been exploring new product lines and integrating the most recent science and technology, which will enable us to produce more evidence-based, high-value added formulations and products and maintain our competitive position in the market.

 

With our extensive years of expertise in the OEM and ODM services industry, we offer comprehensive solutions to our customers. In addition to business consultancy, DSwiss offers useful guidance on current market trends as we all as marketing solutions and support to assist our clients’ business endeavours. Versatility and reliability are evidently the driving principles behind DSwiss, who manufactures products using high-grade ingredients and materials at every stage of research, development, and production.

 

As advocates of natural and high-quality active ingredients, we actively seek for and select the best ingredients, as we are dedicated to adhering to policies under rigorous quality control and assurance criteria, thereby maximizing the safety and efficacy of our products. We dedicate ourselves to maintaining the highest standard in our products in order to provide assurance and a continual commitment to producing high-quality products in accordance with the strict specifications and guidelines specified out by Ministry of Health (“MOH”) Malaysia. Each step of production process has quality control built in and implemented. We guarantee the highest quality product using precise production techniques and specialised equipment, promising ongoing improvements and enhancements based on customer feedback. DSwiss takes pride in offering the best results in customisable solutions for health supplements and beauty product manufacturing.

 
XML 28 R8.htm IDEA: XBRL DOCUMENT v3.23.1
GOING CONCERN UNCERTAINTIES
 12 Months Ended
Dec. 31, 2022
Going Concern Uncertainties  
GOING CONCERN UNCERTAINTIES

2. GOING CONCERN UNCERTAINTIES

 

The accompanying financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

As of December 31, 2022, the Company suffered an accumulated deficit of $1,324,002. The continuation of the Company as a going concern through December 31, 2022 is dependent upon improving the profitability and the continuing financial support from its major stockholders. Management believes the existing major shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.

 

There is no assurance that the Company will able to maintain profitable in the future, which raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result in the Company not being able to continue as a going concern.

 
XML 29 R9.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

 

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification   Estimated useful lives 
Computer and software   5 years 
Furniture and Fittings   5 years 
Office equipment   10 years 
Motor vehicle   5 years 

 

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the year ended December 31, 2022.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Leases

 

The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.

 

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Net profit per share

 

The Company calculates net profit per share in accordance with ASC Topic 260 “Earnings per share”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1, HK$ into US$1, RMB into US$1 and THB into US$1 has been made at the following exchange rates for the respective periods:

   As of and for the year ended
December 31,		 
   2022   2021 
         
Year-end MYR : US$1 exchange rate   4.42    4.17 
Year-average MYR : US$1 exchange rate   4.41    4.13 
Year-end HK$ : US$1 exchange rate   7.81    7.80 
Year-average HK$ : US$1 exchange rate   7.83    7.78 
Year-end RMB : US$1 exchange rate   6.92    6.46 
Year-average RMB : US$1 exchange rate   6.75    6.45 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

FASB issues various Accounting Standards Updates relating to the treatment and recording of certain accounting transactions. On June 10, 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-10, Development Stage Entities (Topic 915) Elimination of Certain Financial Reporting Requirements, including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation, which eliminates the concept of a development stage entity (DSE) entirely from current accounting guidance. The Company has elected adoption of this standard, which eliminates the designation of DSEs and the requirement to disclose results of operations and cash flows since inception.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 30 R10.htm IDEA: XBRL DOCUMENT v3.23.1
VIE STRUCTURE AND ARRANGEMENTS
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
VIE STRUCTURE AND ARRANGEMENTS

4. VIE STRUCTURE AND ARRANGEMENTS

 

On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to 100% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.

 

The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:

 

(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;

 

(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;

 

(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;

 

(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and

 

(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.

 

In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including

 

(i) a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;
   
(ii) a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and
   
(ii) an Equity Pledge Agreement that pledges the shares in DSBT.

 

This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.

 

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 31 R11.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

5. STOCKHOLDERS’ EQUITY

 

As of December 31, 2022 and 2021, the Company had a total of 206,904,585 and 206,904,585 of its common stock issued and outstanding. There are no shares of preferred stock issued and outstanding.

 
XML 32 R12.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

6. PROPERTY AND EQUIPMENT

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Computer and software  $105,535   $102,050 
Furniture and fittings   6,144    6,144 
Office equipment   21,152    13,126 
Motor vehicle   135,868    133,003 
Total property and equipment   268,699   $254,323 
Accumulated depreciation   (187,236)   (157,105)
Effect of translation exchange   (9,284)   (4,249)
Property and equipment, net  $72,179   $92,970 

 

Depreciation expense for the year ended December 31, 2022 and December 31, 2021 were $30,131 and $18,734, respectively.

 
XML 33 R13.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

7. INTANGIBLE ASSETS

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Trademarks  $12,077   $12,077 
Amortization   (8,164)   (7,135)
Effect of translation exchange   (454)   (444)
Intangible assets, net  $3,459   $4,498 

 

Amortization for the year ended December 31, 2022 and December 31, 2021 were $1,029 and $1,034, respectively.

 
XML 34 R14.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS
 12 Months Ended
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

8. OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

 

   

As of

December 31, 2022

    

As of

December 31, 2021

  
Prepaid expenses   $ 2,080     $ 977  
Deposits     19,669       52,716  
Total other receivables, prepaid expenses and deposits   $ 21,749     $ 53,693  

 
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
INVENTORIES

9. INVENTORIES

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Finished goods, at cost  $7,483   $17,131 
Total inventories  $7,483   $17,131 

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 36 R16.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER PAYABLES AND ACCRUED LIABILITIES
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
OTHER PAYABLES AND ACCRUED LIABILITIES

10. OTHER PAYABLES AND ACCRUED LIABILITIES

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Other payables  $100,385   $164,529 
Accrued audit fees   20,266    21,342 
Accrued other expenses   16,683    14,136 
Accrued professional fees   17,376    5,352 
Total payables and accrued liabilities  $154,710   $205,359 

 
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCE LEASE LIABILITIES
 12 Months Ended
Dec. 31, 2022
Finance Lease Liabilities  
FINANCE LEASE LIABILITIES

11. FINANCE LEASE LIABILITIES

 

The Company purchased motor vehicles with finance lease. The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly. The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly. The obligation under the finance lease is as follows:

 

  

As

of December 31, 2022

  

As of

December 31, 2021

 
Finance leases  $58,768   $81,676 
Less: interest expense   (3,792)   (6,924)
Net present value of finance leases   54,976    74,752 
           
Current portion   16,515    16,697 
Non-current portion   38,461    58,055 
Total  $54,976   $74,752 

 

As of December 31, 2022, the maturities of the finance leases for each of the years are as follows:

 

      
2023   16,515 
2024   17,222 
2025   13,153 
2026   8,086 
Total  $54,976 

 
XML 38 R18.htm IDEA: XBRL DOCUMENT v3.23.1
AMOUNT DUE TO A DIRECTOR
 12 Months Ended
Dec. 31, 2022
Amount Due To Director  
AMOUNT DUE TO A DIRECTOR

12. AMOUNT DUE TO A DIRECTOR

 

As of December 31, 2022 and December 31, 2021, the amount due to director of the Company are $0 and $40,509, respectively. The advance from a director of Company is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 39 R19.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

13. INCOME TAXES

 

For the year ended December 31, 2022 and year ended December 31, 2021, the local (United States) and foreign components of (loss) / profit before income taxes were comprised of the following:

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
         
Tax jurisdictions from:          
- Local  $(43,174)  $(43,429)
- Foreign, representing          
Seychelles   (11,643)   (1,427)
Hong Kong   (3,951)   (4,937)
Malaysia   56,347    200,071 
(Loss)/Profit before income tax  $(2,421)  $150,278 

 

The provision for income taxes consisted of the following:

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
         
Current:          
- Local  $-   $- 
- Foreign   (516)   (176)
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(516)  $(176)

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2022 and 2021.

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
Deferred tax assets:          
Net operating loss carry forwards          
-United States of America  $(99,152)  $(90,085)
-Seychelles   -    - 
-Hong Kong   (104,132)   (103,480)
-Malaysia   (36,884)   (46,376)
-PRC  $-   $- 
    (240,168)   (239,941)
Less: valuation allowance  $240,168   $239,941 
Deferred tax assets  $-   $- 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Seychelles, Hong Kong, Malaysia, PRC that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of 31 December, 2022, the operations in the United States of America incurred $472,151 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 21%. The net operating loss carry forwards begin to expire in 2038, if unutilized. The Company has provided for a full valuation allowance of $99,152 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Seychelles

 

Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.

 

Hong Kong

 

DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income. As of December 31, 2022, the operations in the Hong Kong incurred $631,103 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 16.5%. The Company has provided for a full valuation allowance of $104,132 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Malaysia

 

DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from 17% to 24% on its assessable income. As of December 31, 2022, the operations in the Malaysia incurred $216,968 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 17%. The Company has provided for a full valuation allowance of $36,884 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 
XML 40 R20.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS OF RISKS
 12 Months Ended
Dec. 31, 2022
Risks and Uncertainties [Abstract]  
CONCENTRATIONS OF RISKS

14. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the year ended December 31, 2022 and 2021, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2022   2021   2022   2021   2022   2021 
   Revenues   Percentage of Revenues   Accounts Receivable, Trade 
Customer A  $501,470   $1,176,280    26%   60%  $-   $87 
Customer B  $386,232   $374,555    20%   19%  $-   $122 
Customer C  $221,638   $-    12%   -%  $-   $- 
   $1,109,340   $1,550,835    58%   79%  $-   $209 

 

(b) Major vendors

 

For the year ended December 31, 2022 and 2021, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2022   2021   2022   2021   2022   2021 
   Purchases   Percentage of Purchases   Account Payable, Trade 
Vendor A  $477,099   $746,964    23%   51%  $1,626   $- 
Vendor B  $331,538   $-    15%   -%  $-   $- 
Vendor C  $221,743   $-    33%   -%  $16,759   $- 
   $1,030,380   $746,964    71%   51%  $18,385   $- 

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of MYR, HK$ and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 41 R21.htm IDEA: XBRL DOCUMENT v3.23.1
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES
 12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

15. LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

 

The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.

 

As of January 1, 2022, the Company recognized approximately US$386,451, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of 5.40% adopted from Malayan Banking Berhad’s base lending rate as a reference for discount rate.

 

A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.

 

The initial recognition of operating lease right and lease liability as follow:

 

As of December 31, 2022, operating lease right of use asset as follow:

 

   Year ended December 31, 
   2022   2021 
As of January 1,  $92,606   $47,653 
Add: New Lease commenced on 1 January 2022   -    92,606 
Accumulated amortization   (42,310)   (46,571)
Effect of translation exchange   (5,748)   (1,082)
Balance as of December 31  $44,548   $92,606 

 

As of December 31, 2022, operating lease liability as follow:

 

As of January 1,  $92,606 
Less: gross repayment   (45,763)
Add: imputed interest   3,453 
Effect of translation exchange   (5,748)
Balance as of December 31, 2022  $44,548 
Less: lease liability current portion   44,548 
Lease liability non-current portion  $- 

 

For the year ended December 31, 2022 and 2021, the amortization of the operating lease right of use asset are $42,310 and $44,486 respectively.

 

   Year ended December 31, 
   2022   2021 
         
Cash paid for amounts included in the measurement of lease liabilities:        - 
Operating cash flow from operating lease  $42,212   $44,486 
Right-of-use assets obtained in exchange for operating lease liabilities   44,548    45,270 
Remaining lease term for operating lease (years)   1    - 
Weighted average discount rate for operating lease   5.40%   4.47%

 

For the year ended December 31, 2022 and 2021, lease expenses were $42,310 and $44,486 respectively.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 42 R22.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

16. RELATED PARTY TRANSACTIONS

 

For the years ended December 31, 2022 and December 31, 2021, the Company has the following transactions with related party:

 

   For the year ended
December 31, 2022 (Audited)		   For the year ended
December 31, 2021 (Audited)		 
Professional Fees:          
- Related party A  $12,226   $13,279 
           
Sales          
- Related party B  $386,232   $374,555 
- Related party C   -    13,124 
- Related party D   24,261    11,607 
           
Total  $36,487   $412,565 

 

The related party A is a wholly owned subsidiary of a 7.33% shareholder of the Company.

 

The related party B’s director and shareholder is the founder of the Company. Founder of the Company resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.

 

The related party C’s director and shareholder is the founder of the Company.

 

The related party D’s director is the founder of the Company. The shareholder of related party D is related party C.

 

The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.

 
XML 43 R23.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENTED INFORMATION
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
SEGMENTED INFORMATION

17. SEGMENTED INFORMATION

 

ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.

 

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada *   Seychelles *   Hong Kong *   Malaysia *   Total * 
   For the year ended December 31, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,849,047   $1,849,047 
Cost of revenue   -    -    -    (1,404,054)   (1,404,054)
Depreciation and amortization   -    -    -    (72,441)   (72,441)
Net (loss) / profit before taxation   (43,174)   (11,643)   (3,951)   56,347    (2,421)
                          
Total assets  $27,294   $7,056   $14,264   $333,310   $381,924 

 

   Nevada *   Seychelles *   Hong Kong *   Malaysia *   Total * 
   For the year ended December 31, 2021 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,958,655   $1,958,655 
Cost of revenue   -    -    -    (1,459,531)   (1,459,531)
Depreciation and amortization   -    -    -    (65,382)   (65,382)
Net (loss) / profit before taxation   (43,429)   (1,427)   (4,937)   200,071    150,278 
                          
Total assets  $7,366   $6,475   $16,287   $468,183   $498,311 

 

*Revenues and costs are attributed to countries based on the location of customers.

 
XML 44 R24.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

18. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2022 up through the date the Company issued the audited consolidated financial statements.

 

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.
XML 45 R25.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 
Basis of consolidation

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
Use of estimates

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 
Cash and cash equivalents

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 
Property and equipment

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification   Estimated useful lives 
Computer and software   5 years 
Furniture and Fittings   5 years 
Office equipment   10 years 
Motor vehicle   5 years 

 
Intangible assets

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the year ended December 31, 2022.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
Leases

Leases

 

The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.

 

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.

 
Inventories

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 
Revenue recognition

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
Cost of revenue

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 
Shipping and handling fees

Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 
Selling and distribution expenses

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 
Income taxes

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 
Net profit per share

Net profit per share

 

The Company calculates net profit per share in accordance with ASC Topic 260 “Earnings per share”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
Foreign currencies translation

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1, HK$ into US$1, RMB into US$1 and THB into US$1 has been made at the following exchange rates for the respective periods:

   As of and for the year ended
December 31,		 
   2022   2021 
         
Year-end MYR : US$1 exchange rate   4.42    4.17 
Year-average MYR : US$1 exchange rate   4.41    4.13 
Year-end HK$ : US$1 exchange rate   7.81    7.80 
Year-average HK$ : US$1 exchange rate   7.83    7.78 
Year-end RMB : US$1 exchange rate   6.92    6.46 
Year-average RMB : US$1 exchange rate   6.75    6.45 

 
Related parties

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 
Fair value of financial instruments

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 
Recent accounting pronouncements

Recent accounting pronouncements

 

FASB issues various Accounting Standards Updates relating to the treatment and recording of certain accounting transactions. On June 10, 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-10, Development Stage Entities (Topic 915) Elimination of Certain Financial Reporting Requirements, including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation, which eliminates the concept of a development stage entity (DSE) entirely from current accounting guidance. The Company has elected adoption of this standard, which eliminates the designation of DSEs and the requirement to disclose results of operations and cash flows since inception.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.
XML 46 R26.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND BUSINESS BACKGROUND (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF VARIABLE INTEREST ENTITY

The Company, through its subsidiaries and its variable interest entities (“VIEs”), mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

  

  Company name 

Place and date of

incorporation

  Particulars of issued capital  Principal activities 

Proportional of ownership

interest and

voting power

held
1. DSwiss Holding Limited  Seychelles,
May 28, 2015		  1 share of ordinary share of US$1 each  Investment holding  100%
               
2. DSwiss (HK) Limited  Hong Kong,
May 28, 2015		  1 share of ordinary share of HK$1 each  Supply of beauty products  100%
               
3. DSwiss Sdn Bhd  Malaysia,
March 10, 2011		  2 shares of ordinary share of RM 1 each  Supply of beauty products  100%
               
4. DSwiss Biotech Sdn Bhd (1) (2)  Malaysia,
March 17, 2016		  250,000 shares of ordinary share of RM 1 each  Supply of biotech products  40%

 

  (1)

Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of this entity unilaterally, and hence the Company has control over this entity.

     
  (2) On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.
XML 47 R27.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification   Estimated useful lives 
Computer and software   5 years 
Furniture and Fittings   5 years 
Office equipment   10 years 
Motor vehicle   5 years 
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION

Translation of amounts from MYR into US$1, HK$ into US$1, RMB into US$1 and THB into US$1 has been made at the following exchange rates for the respective periods:

   As of and for the year ended
December 31,		 
   2022   2021 
         
Year-end MYR : US$1 exchange rate   4.42    4.17 
Year-average MYR : US$1 exchange rate   4.41    4.13 
Year-end HK$ : US$1 exchange rate   7.81    7.80 
Year-average HK$ : US$1 exchange rate   7.83    7.78 
Year-end RMB : US$1 exchange rate   6.92    6.46 
Year-average RMB : US$1 exchange rate   6.75    6.45 
XML 48 R28.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PLANT AND EQUIPMENT

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Computer and software  $105,535   $102,050 
Furniture and fittings   6,144    6,144 
Office equipment   21,152    13,126 
Motor vehicle   135,868    133,003 
Total property and equipment   268,699   $254,323 
Accumulated depreciation   (187,236)   (157,105)
Effect of translation exchange   (9,284)   (4,249)
Property and equipment, net  $72,179   $92,970 
XML 49 R29.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Trademarks  $12,077   $12,077 
Amortization   (8,164)   (7,135)
Effect of translation exchange   (454)   (444)
Intangible assets, net  $3,459   $4,498 
XML 50 R30.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)
 12 Months Ended
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

 

   

As of

December 31, 2022

    

As of

December 31, 2021

  
Prepaid expenses   $ 2,080     $ 977  
Deposits     19,669       52,716  
Total other receivables, prepaid expenses and deposits   $ 21,749     $ 53,693  
XML 51 R31.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORIES

 

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Finished goods, at cost  $7,483   $17,131 
Total inventories  $7,483   $17,131 
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES

  

As of

December 31, 2022

  

As of

December 31, 2021

 
Other payables  $100,385   $164,529 
Accrued audit fees   20,266    21,342 
Accrued other expenses   16,683    14,136 
Accrued professional fees   17,376    5,352 
Total payables and accrued liabilities  $154,710   $205,359 
XML 53 R33.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCE LEASE LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Finance Lease Liabilities  
SCHEDULE OF OBLIGATION UNDER FINANCE LEASE

 

  

As

of December 31, 2022

  

As of

December 31, 2021

 
Finance leases  $58,768   $81,676 
Less: interest expense   (3,792)   (6,924)
Net present value of finance leases   54,976    74,752 
           
Current portion   16,515    16,697 
Non-current portion   38,461    58,055 
Total  $54,976   $74,752 
SCHEDULE OF MATURITIES OF FINANCE LEASE

As of December 31, 2022, the maturities of the finance leases for each of the years are as follows:

 

      
2023   16,515 
2024   17,222 
2025   13,153 
2026   8,086 
Total  $54,976 
XML 54 R34.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES

For the year ended December 31, 2022 and year ended December 31, 2021, the local (United States) and foreign components of (loss) / profit before income taxes were comprised of the following:

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
         
Tax jurisdictions from:          
- Local  $(43,174)  $(43,429)
- Foreign, representing          
Seychelles   (11,643)   (1,427)
Hong Kong   (3,951)   (4,937)
Malaysia   56,347    200,071 
(Loss)/Profit before income tax  $(2,421)  $150,278 
SCHEDULE OF PROVISION FOR INCOME TAXES

The provision for income taxes consisted of the following:

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
         
Current:          
- Local  $-   $- 
- Foreign   (516)   (176)
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(516)  $(176)
SCHEDULE OF DEFERRED INCOME TAX ASSETS

The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2022 and 2021.

 

   For the year ended
December 31, 2022		   For the year ended
December 31, 2021		 
Deferred tax assets:          
Net operating loss carry forwards          
-United States of America  $(99,152)  $(90,085)
-Seychelles   -    - 
-Hong Kong   (104,132)   (103,480)
-Malaysia   (36,884)   (46,376)
-PRC  $-   $- 
    (240,168)   (239,941)
Less: valuation allowance  $240,168   $239,941 
Deferred tax assets  $-   $- 
XML 55 R35.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS OF RISKS (Tables)
 12 Months Ended
Dec. 31, 2022
Risks and Uncertainties [Abstract]  
SCHEDULE OF CONCENTRATIONS OF RISKS

(a) Major customers

 

For the year ended December 31, 2022 and 2021, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2022   2021   2022   2021   2022   2021 
   Revenues   Percentage of Revenues   Accounts Receivable, Trade 
Customer A  $501,470   $1,176,280    26%   60%  $-   $87 
Customer B  $386,232   $374,555    20%   19%  $-   $122 
Customer C  $221,638   $-    12%   -%  $-   $- 
   $1,109,340   $1,550,835    58%   79%  $-   $209 

 

(b) Major vendors

 

For the year ended December 31, 2022 and 2021, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2022   2021   2022   2021   2022   2021 
   Purchases   Percentage of Purchases   Account Payable, Trade 
Vendor A  $477,099   $746,964    23%   51%  $1,626   $- 
Vendor B  $331,538   $-    15%   -%  $-   $- 
Vendor C  $221,743   $-    33%   -%  $16,759   $- 
   $1,030,380   $746,964    71%   51%  $18,385   $- 
XML 56 R36.htm IDEA: XBRL DOCUMENT v3.23.1
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET

As of December 31, 2022, operating lease right of use asset as follow:

 

   Year ended December 31, 
   2022   2021 
As of January 1,  $92,606   $47,653 
Add: New Lease commenced on 1 January 2022   -    92,606 
Accumulated amortization   (42,310)   (46,571)
Effect of translation exchange   (5,748)   (1,082)
Balance as of December 31  $44,548   $92,606 
SCHEDULE OF OPERATING LEASE LIABILITY

As of December 31, 2022, operating lease liability as follow:

 

As of January 1,  $92,606 
Less: gross repayment   (45,763)
Add: imputed interest   3,453 
Effect of translation exchange   (5,748)
Balance as of December 31, 2022  $44,548 
Less: lease liability current portion   44,548 
Lease liability non-current portion  $- 
SCHEDULE OF OPERATING LEASE OTHER INFORMATION

 

   Year ended December 31, 
   2022   2021 
         
Cash paid for amounts included in the measurement of lease liabilities:        - 
Operating cash flow from operating lease  $42,212   $44,486 
Right-of-use assets obtained in exchange for operating lease liabilities   44,548    45,270 
Remaining lease term for operating lease (years)   1    - 
Weighted average discount rate for operating lease   5.40%   4.47%
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Tables)
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTY TRANSACTION

For the years ended December 31, 2022 and December 31, 2021, the Company has the following transactions with related party:

 

   For the year ended
December 31, 2022 (Audited)		   For the year ended
December 31, 2021 (Audited)		 
Professional Fees:          
- Related party A  $12,226   $13,279 
           
Sales          
- Related party B  $386,232   $374,555 
- Related party C   -    13,124 
- Related party D   24,261    11,607 
           
Total  $36,487   $412,565 
XML 58 R38.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENTED INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
SCHEDULE OF REPORTABLE SEGMENTS

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada *   Seychelles *   Hong Kong *   Malaysia *   Total * 
   For the year ended December 31, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,849,047   $1,849,047 
Cost of revenue   -    -    -    (1,404,054)   (1,404,054)
Depreciation and amortization   -    -    -    (72,441)   (72,441)
Net (loss) / profit before taxation   (43,174)   (11,643)   (3,951)   56,347    (2,421)
                          
Total assets  $27,294   $7,056   $14,264   $333,310   $381,924 

 

   Nevada *   Seychelles *   Hong Kong *   Malaysia *   Total * 
   For the year ended December 31, 2021 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,958,655   $1,958,655 
Cost of revenue   -    -    -    (1,459,531)   (1,459,531)
Depreciation and amortization   -    -    -    (65,382)   (65,382)
Net (loss) / profit before taxation   (43,429)   (1,427)   (4,937)   200,071    150,278 
                          
Total assets  $7,366   $6,475   $16,287   $468,183   $498,311 

 

*Revenues and costs are attributed to countries based on the location of customers.
XML 59 R39.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF VARIABLE INTEREST ENTITY (Details)
 12 Months Ended
Dec. 31, 2022
DSwiss Holding Limited [Member]  
Company name DSwiss Holding Limited
Place of incorporation Seychelles
Date of incorporation May 28, 2015
Particulars of issued capital 1 share of ordinary share of US$1 each
Principal activities Investment holding
Proportional of ownership interest and voting power held 100.00%
DSwiss HK Limited [Member]  
Company name DSwiss (HK) Limited
Place of incorporation Hong Kong
Date of incorporation May 28, 2015
Particulars of issued capital 1 share of ordinary share of HK$1 each
Principal activities Supply of beauty products
Proportional of ownership interest and voting power held 100.00%
DSwiss Sdn Bhd [Member]  
Company name DSwiss Sdn Bhd
Place of incorporation Malaysia
Date of incorporation Mar. 10, 2011
Particulars of issued capital 2 shares of ordinary share of RM 1 each
Principal activities Supply of beauty products
Proportional of ownership interest and voting power held 100.00%
DSwiss Biotech Sdn Bhd [Member]  
Company name DSwiss Biotech Sdn Bhd [1],[2]
Place of incorporation Malaysia [1],[2]
Date of incorporation Mar. 17, 2016 [1],[2]
Particulars of issued capital 250,000 shares of ordinary share of RM 1 each [1],[2]
Principal activities Supply of biotech products [1],[2]
Proportional of ownership interest and voting power held 40.00% [1],[2]
[1] Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of this entity unilaterally, and hence the Company has control over this entity.
[2] On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF VARIABLE INTEREST ENTITY (Details) (Parenthetical) - DSwiss HK Limited [Member] - Subsequent Event [Member]
Jan. 18, 2023
RM / shares
shares
Number of shares, acquired | shares 150,000
Equity ownership interest rate percentage 60.00%
Consideration price per share | RM / shares RM 1
XML 61 R41.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)
Dec. 31, 2022
DSwiss Holding Limited [Member] | HONG KONG  
Equity ownership interest rate percentage 100.00%
DSwiss Sdn Bhd [Member] | MALAYSIA  
Equity ownership interest rate percentage 100.00%
DSwiss Biotech Sdn Bhd [Member] | MALAYSIA  
Equity ownership interest rate percentage 40.00%
XML 62 R42.htm IDEA: XBRL DOCUMENT v3.23.1
GOING CONCERN UNCERTAINTIES (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Going Concern Uncertainties    
Accumulated deficit $ 1,324,002 $ 1,309,711
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)
 12 Months Ended
Dec. 31, 2022
Computer and Software [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
Furniture and Fixtures [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
Office Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 10 years
Motor Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
XML 64 R44.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)
Dec. 31, 2022
Dec. 31, 2021
Year-end MYR [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 4.42 4.17
Year-Average MYR [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 4.41 4.13
Year-end HK [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 7.81 7.80
Year-Average HK [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 7.83 7.78
Year-end RMB [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 6.92 6.46
Year-Avereage RMB [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 6.75 6.45
XML 65 R45.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
 12 Months Ended
Dec. 31, 2022
USD ($)
Accounting Policies [Abstract]  
Intangible asset, useful life 10 years
Impairment loss $ 0
Finance lease, description Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value.
Largest amount of tax benefit, description greater than 50%
XML 66 R46.htm IDEA: XBRL DOCUMENT v3.23.1
VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) - RM / shares
Jan. 18, 2023
Jun. 27, 2016
DSwiss HK Limited [Member] | Subsequent Event [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Number of shares, acquired 150,000  
Equity ownership interest rate percentage 60.00%  
Consideration price per share RM 1  
Management Services Agreement I [Member] | DSwiss HK Limited [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Percentage of annual net profit to be received as fee   100.00%
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - shares
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Common stock shares issued 206,904,585 206,904,585
Common stock shares outstanding 206,904,585 206,904,585
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
XML 68 R48.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF PLANT AND EQUIPMENT (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 268,699 $ 254,323
Accumulated depreciation (187,236) (157,105)
Effect of translation exchange (9,284) (4,249)
Property and equipment, net 72,179 92,970
Computer and Software [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 105,535 102,050
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 6,144 6,144
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 21,152 13,126
Motor Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 135,868 $ 133,003
XML 69 R49.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 30,131 $ 18,734
XML 70 R50.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Trademarks $ 12,077 $ 12,077
Amortization (8,164) (7,135)
Effect of translation exchange (454) (444)
Intangible assets, net $ 3,459 $ 4,498
XML 71 R51.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization of Intangible Assets $ 1,029 $ 1,034
XML 72 R52.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid expenses $ 2,080 $ 977
Deposits 19,669 52,716
Total other receivables, prepaid expenses and deposits $ 21,749 $ 53,693
XML 73 R53.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INVENTORIES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Finished goods, at cost $ 7,483 $ 17,131
Total inventories $ 7,483 $ 17,131
XML 74 R54.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Other payables $ 100,385 $ 164,529
Accrued audit fees 20,266 21,342
Accrued other expenses 16,683 14,136
Accrued professional fees 17,376 5,352
Total payables and accrued liabilities $ 154,710 $ 205,359
XML 75 R55.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Finance Lease Liabilities    
Finance leases $ 58,768 $ 81,676
Less: interest expense (3,792) (6,924)
Total 54,976 74,752
Current portion 16,515 16,697
Non-current portion $ 38,461 $ 58,055
XML 76 R56.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Finance Lease Liabilities    
2023 $ 16,515  
2024 17,222  
2025 13,153  
2026 8,086  
Total $ 54,976 $ 74,752
XML 77 R57.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCE LEASE LIABILITIES (Details Narrative)
 12 Months Ended
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Finance lease, description Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value.
First Finance Lease Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Finance lease, description The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly.
Second Finance Lease Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Finance lease, description The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly.
XML 78 R58.htm IDEA: XBRL DOCUMENT v3.23.1
AMOUNT DUE TO A DIRECTOR (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Amount Due To Director    
Amount due to a director $ 40,509
XML 79 R59.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
(Loss)/Profit before income tax [1] $ (2,421) $ 150,278
UNITED STATES    
(Loss)/Profit before income tax (43,174) (43,429)
SEYCHELLES    
(Loss)/Profit before income tax [1] (11,643) (1,427)
HONG KONG    
(Loss)/Profit before income tax [1] (3,951) (4,937)
MALAYSIA    
(Loss)/Profit before income tax [1] $ 56,347 $ 200,071
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 80 R60.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF PROVISION FOR INCOME TAXES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Current:    
- Local
- Foreign (516) (176)
Deferred:    
- Local
- Foreign
Income tax expense $ (516) $ (176)
XML 81 R61.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards $ (240,168) $ (239,941)
Less: valuation allowance 240,168 239,941
Deferred tax assets
United States of America [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards (99,152) (90,085)
Seychelles [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards
Hong Kong [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards (104,132) (103,480)
Malaysia [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards (36,884) (46,376)
People's Republic of China (PRC) [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards
XML 82 R62.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details Narrative)
 12 Months Ended
Dec. 31, 2022
USD ($)
United States of America [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 472,151
Income tax rate 21.00%
Net operating loss carryforwards expiration The net operating loss carry forwards begin to expire in 2038, if unutilized.
Valuation allowance $ 99,152
Hong Kong [Member] | DSwiss HK Limited [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 631,103
Income tax rate 16.50%
Valuation allowance $ 104,132
Statutory income tax, rate 16.50%
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 216,968
Income tax rate 17.00%
Valuation allowance $ 36,884
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] | Minimum [Member]  
Operating Loss Carryforwards [Line Items]  
Statutory income tax, rate 17.00%
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] | Maximum [Member]  
Operating Loss Carryforwards [Line Items]  
Statutory income tax, rate 24.00%
XML 83 R63.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF CONCENTRATIONS OF RISKS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Concentration Risk [Line Items]    
Revenues [1] $ 1,849,047 $ 1,958,655
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]    
Concentration Risk [Line Items]    
Revenues $ 501,470 $ 1,176,280
Concentration risk, percentage 26.00% 60.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer B [Member]    
Concentration Risk [Line Items]    
Revenues $ 386,232 $ 374,555
Concentration risk, percentage 20.00% 19.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer C [Member]    
Concentration Risk [Line Items]    
Revenues $ 221,638
Concentration risk, percentage 12.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customers [Member]    
Concentration Risk [Line Items]    
Revenues $ 1,109,340 $ 1,550,835
Concentration risk, percentage 58.00% 79.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade $ 87
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade 122
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer C [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customers [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade $ 209
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 23.00% 51.00%
Purchases $ 477,099 $ 746,964
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 15.00%
Purchases $ 331,538
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor C [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 33.00%
Purchases $ 221,743
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendors [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 71.00% 51.00%
Purchases $ 1,030,380 $ 746,964
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]    
Concentration Risk [Line Items]    
Account Payable, Trade 1,626
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]    
Concentration Risk [Line Items]    
Account Payable, Trade
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor C [Member]    
Concentration Risk [Line Items]    
Account Payable, Trade 16,759
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendors [Member]    
Concentration Risk [Line Items]    
Account Payable, Trade $ 18,385
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 84 R64.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Operating lease right of use asset $ 92,606 $ 47,653
New Lease commenced on 1 January 2022 92,606
Accumulated amortization (42,310) (46,571)
Effect of translation exchange (5,748) (1,082)
Operating lease right of use asset, ending $ 44,548 $ 92,606
XML 85 R65.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OPERATING LEASE LIABILITY (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Operating lease liability, beginning $ 92,606  
Less: gross repayment (45,763)  
Add: imputed interest 3,453  
Effect of translation exchange (5,748)  
Operating lease liability, ending 44,548  
Less: lease liability current portion 44,548 $ 45,270
Lease liability non-current portion $ 47,336
XML 86 R66.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Operating cash flow from operating lease $ 42,212 $ 44,486
Right-of-use assets obtained in exchange for operating lease liabilities $ 44,548 $ 45,270
Remaining lease term for operating lease (years) 1 year
Weighted average discount rate for operating lease 5.40% 4.47%
XML 87 R67.htm IDEA: XBRL DOCUMENT v3.23.1
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Jan. 01, 2022
Dec. 31, 2020
Lease liability $ 44,548 $ 92,606    
Lease asset- right of use $ 44,548 $ 92,606   $ 47,653
Discount rate of lease payment 5.40% 4.47%    
Amortization of operating lease right of use asset $ 42,310 $ 46,571    
Lease expenses 42,310 44,486    
Accounting Standards Update 2016-02 [Member]        
Lease liability     $ 386,451  
Lease asset- right of use     $ 386,451  
Discount rate of lease payment     5.40%  
Amortization of operating lease right of use asset $ 42,310 $ 44,486    
XML 88 R68.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF RELATED PARTY TRANSACTION (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]    
Total $ 36,487 $ 412,565
Related Party A [Member]    
Related Party Transaction [Line Items]    
Professional Fees 12,226 13,279
Related Party B [Member]    
Related Party Transaction [Line Items]    
Sales 386,232 374,555
Related Party C [Member]    
Related Party Transaction [Line Items]    
Sales 13,124
Related Party D [Member]    
Related Party Transaction [Line Items]    
Sales $ 24,261 $ 11,607
XML 89 R69.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative)
Dec. 31, 2022
Related Party A [Member]  
Ownership percentage 7.33%
XML 90 R70.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF REPORTABLE SEGMENTS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1] $ 1,849,047 $ 1,958,655
Cost of revenue [1] (1,404,054) (1,459,531)
Depreciation and amortization [1] (72,441) (65,382)
Net (loss) / profit before taxation [1] (2,421) 150,278
Assets [1] 381,924 498,311
NV [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1]
Cost of revenue [1]
Depreciation and amortization [1]
Net (loss) / profit before taxation [1] (43,174) (43,429)
Assets [1] 27,294 7,366
SEYCHELLES    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1]
Cost of revenue [1]
Depreciation and amortization [1]
Net (loss) / profit before taxation [1] (11,643) (1,427)
Assets [1] 7,056 6,475
HONG KONG    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1]
Cost of revenue [1]
Depreciation and amortization [1]
Net (loss) / profit before taxation [1] (3,951) (4,937)
Assets [1] 14,264 16,287
MALAYSIA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1] 1,849,047 1,958,655
Cost of revenue [1] (1,404,054) (1,459,531)
Depreciation and amortization [1] (72,441) (65,382)
Net (loss) / profit before taxation [1] 56,347 200,071
Assets [1] $ 333,310 $ 468,183
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 91 R71.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Details Narrative) - DSwiss HK Limited [Member] - Subsequent Event [Member]
Jan. 18, 2023
RM / shares
shares
Subsequent Event [Line Items]  
Number of shares, acquired | shares 150,000
Equity ownership interest rate percentage 60.00%
Consideration price per share | RM / shares RM 1
XML 92 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001652561 2022-01-01 2022-12-31 0001652561 2022-06-30 0001652561 2022-12-31 0001652561 2021-12-31 0001652561 2021-01-01 2021-12-31 0001652561 us-gaap:CommonStockMember 2020-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001652561 us-gaap:RetainedEarningsMember 2020-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2020-12-31 0001652561 2020-12-31 0001652561 us-gaap:CommonStockMember 2021-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001652561 us-gaap:RetainedEarningsMember 2021-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2021-12-31 0001652561 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001652561 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001652561 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001652561 us-gaap:CommonStockMember 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-12-31 0001652561 DQWS:DSwissHoldingLimitedMember country:HK 2022-12-31 0001652561 DQWS:DSwissSdnBhdMember country:MY 2022-12-31 0001652561 DQWS:DSwissBiotechMember country:MY 2022-12-31 0001652561 DQWS:DSwissHoldingLimitedMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissHKLimitedMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissSdnBhdMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissBiotechSdnBhdMember 2022-01-01 2022-12-31 0001652561 DQWS:DSwissHKLimitedMember us-gaap:SubsequentEventMember 2023-01-17 2023-01-18 0001652561 DQWS:DSwissHKLimitedMember us-gaap:SubsequentEventMember 2023-01-18 0001652561 DQWS:ComputerAndSoftwareMember 2022-01-01 2022-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001652561 us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001652561 DQWS:MotorVehiclesMember 2022-01-01 2022-12-31 0001652561 DQWS:MalaysianRinggitExchangeMember 2022-12-31 0001652561 DQWS:MalaysianRinggitExchangeMember 2021-12-31 0001652561 DQWS:PeriodAverageMalaysianRinggitMember 2022-12-31 0001652561 DQWS:PeriodAverageMalaysianRinggitMember 2021-12-31 0001652561 DQWS:HongKongExchangeMember 2022-12-31 0001652561 DQWS:HongKongExchangeMember 2021-12-31 0001652561 DQWS:PeriodAverageHongKongMember 2022-12-31 0001652561 DQWS:PeriodAverageHongKongMember 2021-12-31 0001652561 DQWS:ChineseRenminbiExchangeMember 2022-12-31 0001652561 DQWS:ChineseRenminbiExchangeMember 2021-12-31 0001652561 DQWS:PeriodAverageChineseRenminbiMember 2022-12-31 0001652561 DQWS:PeriodAverageChineseRenminbiMember 2021-12-31 0001652561 DQWS:ManagementServicesAgreementIMember DQWS:DSwissHKLimitedMember 2016-06-26 2016-06-27 0001652561 DQWS:ComputerAndSoftwareMember 2022-12-31 0001652561 DQWS:ComputerAndSoftwareMember 2021-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001652561 us-gaap:OfficeEquipmentMember 2022-12-31 0001652561 us-gaap:OfficeEquipmentMember 2021-12-31 0001652561 DQWS:MotorVehiclesMember 2022-12-31 0001652561 DQWS:MotorVehiclesMember 2021-12-31 0001652561 DQWS:FirstFinanceLeaseAgreementMember 2022-01-01 2022-12-31 0001652561 DQWS:SecondFinanceLeaseAgreementMember 2022-01-01 2022-12-31 0001652561 country:US 2022-01-01 2022-12-31 0001652561 country:US 2021-01-01 2021-12-31 0001652561 country:SC 2022-01-01 2022-12-31 0001652561 country:SC 2021-01-01 2021-12-31 0001652561 country:HK 2022-01-01 2022-12-31 0001652561 country:HK 2021-01-01 2021-12-31 0001652561 country:MY 2022-01-01 2022-12-31 0001652561 country:MY 2021-01-01 2021-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2022-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2021-12-31 0001652561 DQWS:SeychellesMember 2022-12-31 0001652561 DQWS:SeychellesMember 2021-12-31 0001652561 DQWS:HongKongMember 2022-12-31 0001652561 DQWS:HongKongMember 2021-12-31 0001652561 DQWS:MalaysiaMember 2022-12-31 0001652561 DQWS:MalaysiaMember 2021-12-31 0001652561 DQWS:PeoplesRepublicOfChinaPRCMember 2022-12-31 0001652561 DQWS:PeoplesRepublicOfChinaPRCMember 2021-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2022-01-01 2022-12-31 0001652561 DQWS:HongKongMember DQWS:DSwissHKLimitedMember 2022-01-01 2022-12-31 0001652561 DQWS:HongKongMember DQWS:DSwissHKLimitedMember 2022-12-31 0001652561 srt:MinimumMember DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2022-01-01 2022-12-31 0001652561 srt:MaximumMember DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2022-01-01 2022-12-31 0001652561 DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2022-12-31 0001652561 DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001652561 DQWS:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001652561 DQWS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001652561 DQWS:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001652561 DQWS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001652561 DQWS:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001652561 DQWS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001652561 DQWS:CustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001652561 DQWS:VendorAMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:VendorAMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001652561 DQWS:VendorAMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001652561 DQWS:VendorAMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2021-12-31 0001652561 DQWS:VendorBMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:VendorBMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001652561 DQWS:VendorBMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001652561 DQWS:VendorBMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2021-12-31 0001652561 DQWS:VendorCMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:VendorCMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001652561 DQWS:VendorCMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001652561 DQWS:VendorCMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2021-12-31 0001652561 DQWS:VendorsMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:VendorsMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001652561 DQWS:VendorsMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001652561 DQWS:VendorsMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2021-12-31 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 2022-12-31 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyAMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyAMember 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyBMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyBMember 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyCMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyCMember 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyDMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyDMember 2021-01-01 2021-12-31 0001652561 DQWS:RelatedPartyAMember 2022-12-31 0001652561 DQWS:NVMember 2022-01-01 2022-12-31 0001652561 DQWS:NVMember 2022-12-31 0001652561 country:SC 2022-12-31 0001652561 country:HK 2022-12-31 0001652561 country:MY 2022-12-31 0001652561 DQWS:NVMember 2021-01-01 2021-12-31 0001652561 DQWS:NVMember 2021-12-31 0001652561 country:SC 2021-12-31 0001652561 country:HK 2021-12-31 0001652561 country:MY 2021-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:MYR shares iso4217:MYR 0001652561 false FY No 10-K true 2022-12-31 --12-31 2022 false 333-208083 DSwiss, Inc. NV 47-4215595 Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite Avenue 3, Bangsar South No.8 Jalan Kerinchi 59200 Kuala Lumpur MY 603 2770-4032 No No Yes Non-accelerated Filer true true false false 0 0 206904585 JP CENTURION & PARTNERS PLT 6723 Kuala Lumpur, Malaysia 214269 234546 17492 2053 21749 53693 745 814 7483 17131 261738 308237 72179 92970 3459 4498 44548 92606 120186 190074 381924 498311 29539 10901 154710 205359 16515 16697 40509 44548 45270 175 245312 318911 38461 58055 47336 38461 105391 283773 424302 0.0001 0.0001 200000000 200000000 0 0 0 0 0.0001 0.0001 600000000 600000000 206904585 206904585 206904585 206904585 20690 20690 1395426 1395426 -5846 -32985 -1324002 -1309711 86268 73420 11883 589 98151 74009 381924 498311 1849047 1958655 1404054 1459531 444993 499124 4823 8390 402412 308686 -1303 -1464 6212 2600 42310 44486 -2421 150278 516 176 -2937 150102 11354 -23357 27139 -4808 12848 168651 -0.0001 0.0008 206904585 206904585 206904600 20690 1395426 -28177 -1483170 25727 -69504 -15 -4808 -1781 -6589 173459 -23357 150102 206904585 20690 1395426 -32985 -1309711 589 74009 27139 -60 27079 -14291 11354 -2937 -14291 11354 -2937 206904585 20690 1395426 -5846 -1324002 11883 98151 -2421 150278 72441 65382 1029 1034 15551 -6848 14702 9819 -8707 -19764 -42440 49249 -28995 460 -42212 -46923 23250 254991 822 3300 22428 251691 14376 62075 -14376 -62075 -38284 -112851 398 43535 15671 9237 -53955 -78951 25626 -34123 -20277 76542 234546 158004 214269 234546 -141 -3300 421 2600 <p id="xdx_803_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zZ5xolMWWT59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82B_zoGBTNnhxvEd">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss, Inc. operates through its wholly owned subsidiary, DSwiss Holding Limited, a Company organized under the laws of Seychelles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal activity of the Company and its subsidiaries is to supply high-quality health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to improve the overall health system in our body.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissHoldingLimitedMember__srt--StatementGeographicalAxis__country--HK_zq0KhNo1jlI9" title="Equity ownership interest rate percentage">100</span>% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissSdnBhdMember__srt--StatementGeographicalAxis__country--MY_zXkUG8iqNvZb" title="Equity ownership interest rate percentage">100</span>% equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__srt--StatementGeographicalAxis__country--MY__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissBiotechMember_zewkJ7p7eji4" title="Equity ownership interest rate percentage">40</span>% equity interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_89F_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zwMqqf3Kfq8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its subsidiaries and its variable interest entities (“VIEs”), mainly supplies high quality beauty products. Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zDAPWyHyp4fk" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: White; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Company name</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place and date of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proportional of ownership</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>interest and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>voting power</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>held</b></span></p></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="vertical-align: top; width: 22%; text-align: left"><span id="xdx_90D_eus-gaap--VariableInterestEntityTypeOfEntity_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zal7kSbjggDa" title="Company name">DSwiss Holding Limited</span></td><td style="width: 2%"> </td> <td style="text-align: center; width: 14%; vertical-align: top"><span id="xdx_90F_ecustom--PlaceOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_znZBrI18UL39" title="Place and date of incorporation">Seychelles</span>, <br/> <span id="xdx_90C_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zrBu6mc5MCP9" title="Place and date of incorporation">May 28, 2015</span></td><td style="width: 2%"> </td> <td style="vertical-align: top; width: 24%; text-align: center"><span id="xdx_906_ecustom--ParticularsOfIssuedCapital_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zJk5xN440M17" title="Particulars of issued capital">1 share of ordinary share of US$1 each</span></td><td style="width: 2%"> </td> <td style="vertical-align: top; width: 15%; text-align: center"><span id="xdx_905_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zRzRbObbvxBh" title="Principal activities">Investment holding</span></td><td style="width: 2%"> </td> <td id="xdx_987_eus-gaap--VariableInterestEntityOwnershipPercentage_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zl5CaRHvIs1b" style="width: 14%; text-align: center" title="Proportional of ownership interest and voting power held">100%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left; vertical-align: bottom"> </td><td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="vertical-align: top; text-align: left"><span id="xdx_90F_eus-gaap--VariableInterestEntityTypeOfEntity_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zGp17iopOZK7" title="Company name">DSwiss (HK) Limited</span></td><td> </td> <td style="text-align: center; vertical-align: top"><span id="xdx_909_ecustom--PlaceOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zh1bweKbGBIl">Hong Kong</span>,<br/> <span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_z9sRvy5clmWf">May 28, 2015</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_905_ecustom--ParticularsOfIssuedCapital_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zZfKyuujPY6g" title="Particulars of issued capital">1 share of ordinary share of HK$1 each</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_90B_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zOUzLO9T9bVc" title="Principal activities">Supply of beauty products</span></td><td> </td> <td id="xdx_98D_eus-gaap--VariableInterestEntityOwnershipPercentage_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zTbPxrqTI4y" style="text-align: center" title="Proportional of ownership interest and voting power held">100%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left; vertical-align: bottom"> </td><td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="vertical-align: top; text-align: left"><span id="xdx_90F_eus-gaap--VariableInterestEntityTypeOfEntity_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zPPBLtiiqtMi" title="Company name">DSwiss Sdn Bhd</span></td><td> </td> <td style="text-align: center; vertical-align: top"><span id="xdx_90B_ecustom--PlaceOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zhsSI116N6j1">Malaysia</span>, <br/> <span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zi7wdwCLxWg5">March 10, 2011</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_902_ecustom--ParticularsOfIssuedCapital_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zuj0QJgpQcih" title="Particulars of issued capital">2 shares of ordinary share of RM 1 each</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_90A_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zCqKCSk6s4da" title="Principal activities">Supply of beauty products</span></td><td> </td> <td id="xdx_989_eus-gaap--VariableInterestEntityOwnershipPercentage_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_z7wV4S9lQa9e" style="text-align: center" title="Proportional of ownership interest and voting power held">100%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left; vertical-align: bottom"> </td><td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="vertical-align: top; text-align: left"><span id="xdx_902_eus-gaap--VariableInterestEntityTypeOfEntity_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zWnvGj1jQppb">DSwiss Biotech Sdn Bhd</span> <span style="font-family: Times New Roman, Times, Serif">(1) (2)</span></td><td> </td> <td style="text-align: center; vertical-align: top"><span id="xdx_902_ecustom--PlaceOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zysUQjCLq048" title="Place of incorporation">Malaysia</span>, <br/> <span id="xdx_909_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_z4V4HImx878l" title="Date of incorporation">March 17, 2016</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_90C_ecustom--ParticularsOfIssuedCapital_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_znGAEyrGsMM1" title="Particulars of issued capital">250,000 shares of ordinary share of RM 1 each</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_90E_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zChINITBAq6f" title="Principal activities">Supply of biotech products</span></td><td> </td> <td id="xdx_98E_eus-gaap--VariableInterestEntityOwnershipPercentage_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zvNABiZTMpMc" style="text-align: center" title="Proportional of ownership interest and voting power held">40%</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_F02_zeQ15QCupnx" style="text-align: justify; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_F16_z3RNFz5CfzAc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of this entity unilaterally, and hence the Company has control over this entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"/></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td id="xdx_F0D_z9VGpZ4rS0Aj" style="text-align: justify">(2)</td> <td id="xdx_F1D_zBXQB0jMiTfc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On January 18, 2023, DSwiss (HK) Limited acquired <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFZBUklBQkxFIElOVEVSRVNUIEVOVElUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230117__20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJffKisf7ey2" title="Number of shares, acquired">150,000</span> shares, representing <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFZBUklBQkxFIElOVEVSRVNUIEVOVElUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIKFApQH4TI6" title="Equity ownership interest rate percentage">60</span>% equity interest in DSwiss Biotech Sdn. Bhd., from the other party <span style="background-color: white">with consideration of RM <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFZBUklBQkxFIElOVEVSRVNUIEVOVElUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_uMYRPShare_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUeBQLuftbaj" title="Consideration price per share">1</span>. After such acquisition, </span>DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.</td></tr> </table> <p id="xdx_8A7_zUW0repMFct4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business Overview</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One of the leading one-stop ODM/OEM manufacturing companies, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms. DSwiss addresses a distinct demand in the market for a manufacturer who could ensure the quality of the ingredient sources and offer efficient one-stop service from raw material, product development, manufacturing and packaging.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since our founding, we have experienced tremendous growth in Malaysia. We offer exceptional lifestyle solutions to consumers all over the world thanks to our over 10 years of continuous innovation and work in the health and beauty business. Our company’s Chief Executive Officer, Vincent Leong has led it with a strong hand, and as a result, our products are now consumed around the world, such as Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. With the help of our distributors, we have so far extended throughout Asia, and we are adamant about extending our geographic reach into untapped markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a team of professionals at the helm, DSwiss is assured of providing the best products and attending client’s needs from consultations to products. To fulfil customer needs, we carry out research and development based on our philosophy of “creating beauty, health, and the ecosystem”. Our cutting-edge research and development team has always been exploring new product lines and integrating the most recent science and technology, which will enable us to produce more evidence-based, high-value added formulations and products and maintain our competitive position in the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With our extensive years of expertise in the OEM and ODM services industry, we offer comprehensive solutions to our customers. In addition to business consultancy, DSwiss offers useful guidance on current market trends as we all as marketing solutions and support to assist our clients’ business endeavours. Versatility and reliability are evidently the driving principles behind DSwiss, who manufactures products using high-grade ingredients and materials at every stage of research, development, and production.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As advocates of natural and high-quality active ingredients, we actively seek for and select the best ingredients, as we are dedicated to adhering to policies under rigorous quality control and assurance criteria, thereby maximizing the safety and efficacy of our products. We dedicate ourselves to maintaining the highest standard in our products in order to provide assurance and a continual commitment to producing high-quality products in accordance with the strict specifications and guidelines specified out by Ministry of Health (“MOH”) Malaysia. Each step of production process has quality control built in and implemented. We guarantee the highest quality product using precise production techniques and specialised equipment, promising ongoing improvements and enhancements based on customer feedback. DSwiss takes pride in offering the best results in customisable solutions for health supplements and beauty product manufacturing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 0.40 <p id="xdx_89F_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zwMqqf3Kfq8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its subsidiaries and its variable interest entities (“VIEs”), mainly supplies high quality beauty products. Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zDAPWyHyp4fk" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: White; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Company name</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place and date of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proportional of ownership</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>interest and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>voting power</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>held</b></span></p></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="vertical-align: top; width: 22%; text-align: left"><span id="xdx_90D_eus-gaap--VariableInterestEntityTypeOfEntity_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zal7kSbjggDa" title="Company name">DSwiss Holding Limited</span></td><td style="width: 2%"> </td> <td style="text-align: center; width: 14%; vertical-align: top"><span id="xdx_90F_ecustom--PlaceOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_znZBrI18UL39" title="Place and date of incorporation">Seychelles</span>, <br/> <span id="xdx_90C_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zrBu6mc5MCP9" title="Place and date of incorporation">May 28, 2015</span></td><td style="width: 2%"> </td> <td style="vertical-align: top; width: 24%; text-align: center"><span id="xdx_906_ecustom--ParticularsOfIssuedCapital_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zJk5xN440M17" title="Particulars of issued capital">1 share of ordinary share of US$1 each</span></td><td style="width: 2%"> </td> <td style="vertical-align: top; width: 15%; text-align: center"><span id="xdx_905_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zRzRbObbvxBh" title="Principal activities">Investment holding</span></td><td style="width: 2%"> </td> <td id="xdx_987_eus-gaap--VariableInterestEntityOwnershipPercentage_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zl5CaRHvIs1b" style="width: 14%; text-align: center" title="Proportional of ownership interest and voting power held">100%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left; vertical-align: bottom"> </td><td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="vertical-align: top; text-align: left"><span id="xdx_90F_eus-gaap--VariableInterestEntityTypeOfEntity_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zGp17iopOZK7" title="Company name">DSwiss (HK) Limited</span></td><td> </td> <td style="text-align: center; vertical-align: top"><span id="xdx_909_ecustom--PlaceOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zh1bweKbGBIl">Hong Kong</span>,<br/> <span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_z9sRvy5clmWf">May 28, 2015</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_905_ecustom--ParticularsOfIssuedCapital_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zZfKyuujPY6g" title="Particulars of issued capital">1 share of ordinary share of HK$1 each</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_90B_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zOUzLO9T9bVc" title="Principal activities">Supply of beauty products</span></td><td> </td> <td id="xdx_98D_eus-gaap--VariableInterestEntityOwnershipPercentage_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zTbPxrqTI4y" style="text-align: center" title="Proportional of ownership interest and voting power held">100%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left; vertical-align: bottom"> </td><td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="vertical-align: top; text-align: left"><span id="xdx_90F_eus-gaap--VariableInterestEntityTypeOfEntity_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zPPBLtiiqtMi" title="Company name">DSwiss Sdn Bhd</span></td><td> </td> <td style="text-align: center; vertical-align: top"><span id="xdx_90B_ecustom--PlaceOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zhsSI116N6j1">Malaysia</span>, <br/> <span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zi7wdwCLxWg5">March 10, 2011</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_902_ecustom--ParticularsOfIssuedCapital_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zuj0QJgpQcih" title="Particulars of issued capital">2 shares of ordinary share of RM 1 each</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_90A_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zCqKCSk6s4da" title="Principal activities">Supply of beauty products</span></td><td> </td> <td id="xdx_989_eus-gaap--VariableInterestEntityOwnershipPercentage_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_z7wV4S9lQa9e" style="text-align: center" title="Proportional of ownership interest and voting power held">100%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left; vertical-align: bottom"> </td><td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="vertical-align: top; text-align: left"><span id="xdx_902_eus-gaap--VariableInterestEntityTypeOfEntity_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zWnvGj1jQppb">DSwiss Biotech Sdn Bhd</span> <span style="font-family: Times New Roman, Times, Serif">(1) (2)</span></td><td> </td> <td style="text-align: center; vertical-align: top"><span id="xdx_902_ecustom--PlaceOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zysUQjCLq048" title="Place of incorporation">Malaysia</span>, <br/> <span id="xdx_909_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_z4V4HImx878l" title="Date of incorporation">March 17, 2016</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_90C_ecustom--ParticularsOfIssuedCapital_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_znGAEyrGsMM1" title="Particulars of issued capital">250,000 shares of ordinary share of RM 1 each</span></td><td> </td> <td style="vertical-align: top; text-align: center"><span id="xdx_90E_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zChINITBAq6f" title="Principal activities">Supply of biotech products</span></td><td> </td> <td id="xdx_98E_eus-gaap--VariableInterestEntityOwnershipPercentage_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zvNABiZTMpMc" style="text-align: center" title="Proportional of ownership interest and voting power held">40%</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_F02_zeQ15QCupnx" style="text-align: justify; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_F16_z3RNFz5CfzAc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of this entity unilaterally, and hence the Company has control over this entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"/></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td id="xdx_F0D_z9VGpZ4rS0Aj" style="text-align: justify">(2)</td> <td id="xdx_F1D_zBXQB0jMiTfc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On January 18, 2023, DSwiss (HK) Limited acquired <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFZBUklBQkxFIElOVEVSRVNUIEVOVElUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230117__20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJffKisf7ey2" title="Number of shares, acquired">150,000</span> shares, representing <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFZBUklBQkxFIElOVEVSRVNUIEVOVElUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIKFApQH4TI6" title="Equity ownership interest rate percentage">60</span>% equity interest in DSwiss Biotech Sdn. Bhd., from the other party <span style="background-color: white">with consideration of RM <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFZBUklBQkxFIElOVEVSRVNUIEVOVElUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_uMYRPShare_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUeBQLuftbaj" title="Consideration price per share">1</span>. After such acquisition, </span>DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.</td></tr> </table> DSwiss Holding Limited Seychelles 2015-05-28 1 share of ordinary share of US$1 each Investment holding 1 DSwiss (HK) Limited Hong Kong 2015-05-28 1 share of ordinary share of HK$1 each Supply of beauty products 1 DSwiss Sdn Bhd Malaysia 2011-03-10 2 shares of ordinary share of RM 1 each Supply of beauty products 1 DSwiss Biotech Sdn Bhd Malaysia 2016-03-17 250,000 shares of ordinary share of RM 1 each Supply of biotech products 0.40 150000 0.60 1 <p id="xdx_803_ecustom--GoingConcernUncertaintiesTextBlock_zu5QbQD1Kzn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_825_z50TuQcX5Q06">GOING CONCERN UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company suffered an accumulated deficit of $<span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20221231_zfu4oszXqJN8" title="Accumulated deficit">1,324,002</span>. The continuation of the Company as a going concern through December 31, 2022 is dependent upon improving the profitability and the continuing financial support from its major stockholders. Management believes the existing major shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no assurance that the Company will able to maintain profitable in the future, which raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result in the Company not being able to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> -1324002 <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zFhdIkLUixJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_823_z2FQ0k7bmpfa">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zfbHpHI0H1si" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z7EGOCM9zDIe">Basis of presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zS8vfoRXuOFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zDijlMpIu5nd">Basis of consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zS1CiwXytHY9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zYIFaWt7QU0k">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbS9VwS0VLDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zJ2XrpuauQC2">Cash and cash equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zOI5iL78g1Uc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zxgO8bzB6xo3">Property and equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zd4LuWraxoQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_ztPP57iqTE0e" style="display: none">SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 58%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated useful lives</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer and software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zGT50kbRWKja" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and Fittings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQXhLwi1vd3d" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zvmSJ4LBA7p6" title="Property and equipment, estimated useful lives">10</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zdgk4I6Jkgu" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AC_zxOHzGWvq0F1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z0IC2yd3lNUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zxszOPWG3Sy9">Intangible assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dc_c20220101__20221231_zss46zrHVk22" title="Intangible asset, useful life">ten years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were <span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pp0p0_do_c20220101__20221231_znXBbImWN2H3" title="Impairment loss">no</span> impairment losses recorded on intangible assets for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p> <p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zU93ZPNUoAVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zrPrFyRxVVjj">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. <span id="xdx_909_eus-gaap--LesseeFinanceLeaseDescription_c20220101__20221231_zdqqq4Xxn6Mb" title="Finance lease, description">Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value.</span> At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zG2yc89nd4qb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zLmkybaaA5vd">Inventories</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z4iKALBv0db3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zuM0B6A96Qch">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance of Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts</i>. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--CostOfSalesPolicyTextBlock_z7Mbhiqg9cbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zKi0JW3aRRyj">Cost of revenue</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--ShippingAndHandlingPolicyTextBlock_zrJycqoyh8M1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zL3TqPfszqge">Shipping and handling fees</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zsHjFnVf4MW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_z6LqBryR9F1e">Selling and distribution expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zHMT5Exja1f9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zd52DMQdzmX2">Income taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a <span id="xdx_904_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20220101__20221231_zthYAHFKbxQ9" title="Largest amount of tax benefit, description">greater than 50%</span> likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zjoN0aWTS2Xh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_z0Ay5MWuPzph">Net profit per share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net profit per share in accordance with ASC Topic 260 “<i>Earnings per share</i>”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z2DoPKz3rff8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zEaIwfHfJdv1">Foreign currencies translation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zKbJs2amndW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from MYR into US$1, HK$ into US$1, RMB into US$1 and THB into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_z5aIbG1SSbOf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the year ended <br/>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Year-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--MalaysianRinggitExchangeMember_zd8i2HIHQHlb" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--MalaysianRinggitExchangeMember_zYSP2Wulqgi7" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.17</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average MYR : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageMalaysianRinggitMember_z45UY5hV2UKe" style="text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageMalaysianRinggitMember_z02EiO1uhWc" style="text-align: right" title="Foreign currency exchange rate, translation">4.13</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--HongKongExchangeMember_zw33G3yZTcm5" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--HongKongExchangeMember_z6cVxdFCIjN4" style="text-align: right" title="Foreign currency exchange rate, translation">7.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageHongKongMember_zrUgfJA5PAO1" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageHongKongMember_z6cNzDlvNa7b" style="text-align: right" title="Foreign currency exchange rate, translation">7.78</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--ChineseRenminbiExchangeMember_zGJoNvtQIWOe" style="text-align: right" title="Foreign currency exchange rate, translation">6.92</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--ChineseRenminbiExchangeMember_z1ud8SekY1P6" style="text-align: right" title="Foreign currency exchange rate, translation">6.46</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageChineseRenminbiMember_zQT000OKB8F1" style="text-align: right" title="Foreign currency exchange rate, translation">6.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageChineseRenminbiMember_zEUoEJVsXQah" style="text-align: right" title="Foreign currency exchange rate, translation">6.45</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_zxYZAK2dQOF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--RelatedPartiesPolicyTextBlock_z2ZtT2VdIEtc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zk6KiYmksIQc">Related parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zvyLYPhlEU65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_z2rEjogWrD4i">Fair value of financial instruments</span>:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also follows the guidance of the ASC Topic 820-10, “<i>Fair Value Measurements and Disclosures</i>” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Observable inputs such as quoted prices in active markets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zEtwpKp6fIEi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zsKgTP1tjEv8">Recent accounting pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB issues various Accounting Standards Updates relating to the treatment and recording of certain accounting transactions. On June 10, 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-10, <i>Development Stage Entities </i>(Topic 915) Elimination of Certain Financial Reporting Requirements, including an Amendment to Variable Interest Entities Guidance in Topic 810, <i>Consolidation</i>, which eliminates the concept of a development stage entity (DSE) entirely from current accounting guidance. The Company has elected adoption of this standard, which eliminates the designation of DSEs and the requirement to disclose results of operations and cash flows since inception.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.</p> <p id="xdx_859_zDaWUunnkMEc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zfbHpHI0H1si" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z7EGOCM9zDIe">Basis of presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zS8vfoRXuOFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zDijlMpIu5nd">Basis of consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zS1CiwXytHY9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zYIFaWt7QU0k">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbS9VwS0VLDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zJ2XrpuauQC2">Cash and cash equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zOI5iL78g1Uc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zxgO8bzB6xo3">Property and equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zd4LuWraxoQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_ztPP57iqTE0e" style="display: none">SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 58%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated useful lives</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer and software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zGT50kbRWKja" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and Fittings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQXhLwi1vd3d" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zvmSJ4LBA7p6" title="Property and equipment, estimated useful lives">10</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zdgk4I6Jkgu" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AC_zxOHzGWvq0F1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zd4LuWraxoQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_ztPP57iqTE0e" style="display: none">SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 58%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated useful lives</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer and software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zGT50kbRWKja" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and Fittings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQXhLwi1vd3d" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zvmSJ4LBA7p6" title="Property and equipment, estimated useful lives">10</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zdgk4I6Jkgu" title="Property and equipment, estimated useful lives">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> P5Y P5Y P10Y P5Y <p id="xdx_84C_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z0IC2yd3lNUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zxszOPWG3Sy9">Intangible assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dc_c20220101__20221231_zss46zrHVk22" title="Intangible asset, useful life">ten years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were <span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pp0p0_do_c20220101__20221231_znXBbImWN2H3" title="Impairment loss">no</span> impairment losses recorded on intangible assets for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p> P10Y 0 <p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zU93ZPNUoAVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zrPrFyRxVVjj">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. <span id="xdx_909_eus-gaap--LesseeFinanceLeaseDescription_c20220101__20221231_zdqqq4Xxn6Mb" title="Finance lease, description">Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value.</span> At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. <p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zG2yc89nd4qb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zLmkybaaA5vd">Inventories</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z4iKALBv0db3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zuM0B6A96Qch">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance of Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts</i>. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--CostOfSalesPolicyTextBlock_z7Mbhiqg9cbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zKi0JW3aRRyj">Cost of revenue</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--ShippingAndHandlingPolicyTextBlock_zrJycqoyh8M1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zL3TqPfszqge">Shipping and handling fees</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zsHjFnVf4MW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_z6LqBryR9F1e">Selling and distribution expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zHMT5Exja1f9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zd52DMQdzmX2">Income taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a <span id="xdx_904_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20220101__20221231_zthYAHFKbxQ9" title="Largest amount of tax benefit, description">greater than 50%</span> likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than 50% <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zjoN0aWTS2Xh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_z0Ay5MWuPzph">Net profit per share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net profit per share in accordance with ASC Topic 260 “<i>Earnings per share</i>”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z2DoPKz3rff8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zEaIwfHfJdv1">Foreign currencies translation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zKbJs2amndW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from MYR into US$1, HK$ into US$1, RMB into US$1 and THB into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_z5aIbG1SSbOf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the year ended <br/>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Year-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--MalaysianRinggitExchangeMember_zd8i2HIHQHlb" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--MalaysianRinggitExchangeMember_zYSP2Wulqgi7" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.17</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average MYR : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageMalaysianRinggitMember_z45UY5hV2UKe" style="text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageMalaysianRinggitMember_z02EiO1uhWc" style="text-align: right" title="Foreign currency exchange rate, translation">4.13</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--HongKongExchangeMember_zw33G3yZTcm5" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--HongKongExchangeMember_z6cVxdFCIjN4" style="text-align: right" title="Foreign currency exchange rate, translation">7.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageHongKongMember_zrUgfJA5PAO1" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageHongKongMember_z6cNzDlvNa7b" style="text-align: right" title="Foreign currency exchange rate, translation">7.78</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--ChineseRenminbiExchangeMember_zGJoNvtQIWOe" style="text-align: right" title="Foreign currency exchange rate, translation">6.92</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--ChineseRenminbiExchangeMember_z1ud8SekY1P6" style="text-align: right" title="Foreign currency exchange rate, translation">6.46</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageChineseRenminbiMember_zQT000OKB8F1" style="text-align: right" title="Foreign currency exchange rate, translation">6.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageChineseRenminbiMember_zEUoEJVsXQah" style="text-align: right" title="Foreign currency exchange rate, translation">6.45</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_zxYZAK2dQOF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zKbJs2amndW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from MYR into US$1, HK$ into US$1, RMB into US$1 and THB into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_z5aIbG1SSbOf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the year ended <br/>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Year-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--MalaysianRinggitExchangeMember_zd8i2HIHQHlb" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--MalaysianRinggitExchangeMember_zYSP2Wulqgi7" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.17</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average MYR : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageMalaysianRinggitMember_z45UY5hV2UKe" style="text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageMalaysianRinggitMember_z02EiO1uhWc" style="text-align: right" title="Foreign currency exchange rate, translation">4.13</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--HongKongExchangeMember_zw33G3yZTcm5" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--HongKongExchangeMember_z6cVxdFCIjN4" style="text-align: right" title="Foreign currency exchange rate, translation">7.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageHongKongMember_zrUgfJA5PAO1" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageHongKongMember_z6cNzDlvNa7b" style="text-align: right" title="Foreign currency exchange rate, translation">7.78</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--ChineseRenminbiExchangeMember_zGJoNvtQIWOe" style="text-align: right" title="Foreign currency exchange rate, translation">6.92</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--ChineseRenminbiExchangeMember_z1ud8SekY1P6" style="text-align: right" title="Foreign currency exchange rate, translation">6.46</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--PeriodAverageChineseRenminbiMember_zQT000OKB8F1" style="text-align: right" title="Foreign currency exchange rate, translation">6.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--AwardTypeAxis__custom--PeriodAverageChineseRenminbiMember_zEUoEJVsXQah" style="text-align: right" title="Foreign currency exchange rate, translation">6.45</td><td style="text-align: left"> </td></tr> </table> 4.42 4.17 4.41 4.13 7.81 7.80 7.83 7.78 6.92 6.46 6.75 6.45 <p id="xdx_84C_ecustom--RelatedPartiesPolicyTextBlock_z2ZtT2VdIEtc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zk6KiYmksIQc">Related parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zvyLYPhlEU65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_z2rEjogWrD4i">Fair value of financial instruments</span>:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also follows the guidance of the ASC Topic 820-10, “<i>Fair Value Measurements and Disclosures</i>” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Observable inputs such as quoted prices in active markets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zEtwpKp6fIEi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zsKgTP1tjEv8">Recent accounting pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB issues various Accounting Standards Updates relating to the treatment and recording of certain accounting transactions. On June 10, 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-10, <i>Development Stage Entities </i>(Topic 915) Elimination of Certain Financial Reporting Requirements, including an Amendment to Variable Interest Entities Guidance in Topic 810, <i>Consolidation</i>, which eliminates the concept of a development stage entity (DSE) entirely from current accounting guidance. The Company has elected adoption of this standard, which eliminates the designation of DSEs and the requirement to disclose results of operations and cash flows since inception.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.</p> <p id="xdx_800_eus-gaap--VariableInterestEntityDisclosureTextBlock_zdQFii4p7cF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_82B_zXJHlYlV136d">VIE STRUCTURE AND ARRANGEMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to <span id="xdx_90F_ecustom--PercentageOfAnnualNetProfitToBeReceivedAsFee_pid_dp_uPure_c20160626__20160627__us-gaap--TypeOfArrangementAxis__custom--ManagementServicesAgreementIMember__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zM6wfViekCh1" title="Percentage of annual net profit to be received as fee">100</span>% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an Equity Pledge Agreement that pledges the shares in DSBT.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2023, DSwiss (HK) Limited acquired <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230117__20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMiczwNf7DC9" title="Number of shares, acquired">150,000</span> shares, representing <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4bbgC34ZUH" title="Equity ownership interest rate percentage">60</span>% equity interest in DSwiss Biotech Sdn. Bhd., from the other party <span style="background-color: white">with consideration of RM <span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pid_uMYRPShare_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvGo2BRT5nO1" title="Consideration price per share">1</span>. After such acquisition, </span>DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 150000 0.60 1 <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zWsxTjCKQfoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_828_zKYrdFzFG3y7">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, the Company had a total of <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_z0kcQH89kBS1" title="Common stock shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_z8jxAq9DK51f" title="Common stock shares outstanding">206,904,585</span></span> and <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_z2nwzp16s5j3" title="Common stock shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_znC3djWg9EL1" title="Common stock shares outstanding">206,904,585</span></span> of its common stock issued and outstanding. There are <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20221231_zcYzIv9PWn8k" title="Preferred stock shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20221231_zZwfrIwLBqEf" title="Preferred stock shares outstanding"><span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20211231_zKDjlHBaKRVb" title="Preferred stock shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20211231_z3MnhMDPlAJ4" title="Preferred stock shares outstanding">no</span></span></span></span> shares of preferred stock issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 206904585 206904585 206904585 206904585 0 0 0 0 <p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zgWfqQ64vYwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_82E_zV8JuO9prkCa">PROPERTY AND EQUIPMENT</span></b></span></p> <p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zsGL1UB1pZEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zcc9zO0Yi5ea" style="display: none">SCHEDULE OF PLANT AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20221231_zdyx9dLLngc1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20211231_zeYrYBGBfEtk" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_z0IjYi6C67fd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Computer and software</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">105,535</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">102,050</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0S2QXibg5U1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fittings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,144</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,144</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zsmRwL5Nl6O8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,152</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,126</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zGd4y2mHzI8l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Motor vehicle</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,868</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">133,003</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzRDA_zXeuf6jGJvFl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">268,699</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">254,323</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzRDA_zRKJ5tsO66l8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(187,236</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(157,105</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectOfTranslationExchange_iNI_pp0p0_di_msPPAENzRDA_zrQyaUym0Fm5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,249</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzRDA_z74WQt3YeDY8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">72,179</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">92,970</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zoTo49cG4dJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Depreciation expense for the year ended December 31, 2022 and December 31, 2021 were $<span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20220101__20221231_zARsHuiOGWl5" title="Depreciation expense">30,131</span> and $<span id="xdx_90E_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zI6id5797F9g" title="Depreciation expense">18,734</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zsGL1UB1pZEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zcc9zO0Yi5ea" style="display: none">SCHEDULE OF PLANT AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20221231_zdyx9dLLngc1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20211231_zeYrYBGBfEtk" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_z0IjYi6C67fd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Computer and software</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">105,535</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">102,050</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0S2QXibg5U1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fittings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,144</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,144</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zsmRwL5Nl6O8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,152</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,126</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zGd4y2mHzI8l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Motor vehicle</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,868</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">133,003</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzRDA_zXeuf6jGJvFl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">268,699</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">254,323</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzRDA_zRKJ5tsO66l8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(187,236</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(157,105</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectOfTranslationExchange_iNI_pp0p0_di_msPPAENzRDA_zrQyaUym0Fm5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,249</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzRDA_z74WQt3YeDY8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">72,179</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">92,970</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 105535 102050 6144 6144 21152 13126 135868 133003 268699 254323 187236 157105 9284 4249 72179 92970 30131 18734 <p id="xdx_805_eus-gaap--IntangibleAssetsDisclosureTextBlock_zZi66E61Bjh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_82C_zsHrWazLCmI7">INTANGIBLE ASSETS</span></b></span></p> <p id="xdx_89A_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zeh85i3gdZR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zxIOY7uwXkab" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20221231_zGNkMk8Kng03" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20211231_zbRTk0Tm0Gqg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedTrademarksGross_iI_pp0p0_maIANEGzWXd_zADzm3Rao92c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Trademarks</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msIANEGzWXd_zEdkY4LvxxX1" style="vertical-align: bottom; background-color: White"> <td>Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,164</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,135</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_ecustom--IntangibleAssetsEffectOfTranslationExchange_iNI_pp0p0_di_msIANEGzWXd_z1FrcMLlfJ3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(454</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(444</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_pp0p0_mtIANEGzWXd_zk2GJg67Ovdc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,459</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,498</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zcDYgRhQo1U1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Amortization for the year ended December 31, 2022 and December 31, 2021 were $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231_z0Gqgh9PZgg9" title="Amortization of Intangible Assets">1,029</span> and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_zyVzH0O6Fst3" title="Amortization of Intangible Assets">1,034</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zeh85i3gdZR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zxIOY7uwXkab" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20221231_zGNkMk8Kng03" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20211231_zbRTk0Tm0Gqg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedTrademarksGross_iI_pp0p0_maIANEGzWXd_zADzm3Rao92c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Trademarks</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msIANEGzWXd_zEdkY4LvxxX1" style="vertical-align: bottom; background-color: White"> <td>Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,164</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,135</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_ecustom--IntangibleAssetsEffectOfTranslationExchange_iNI_pp0p0_di_msIANEGzWXd_z1FrcMLlfJ3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(454</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(444</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_pp0p0_mtIANEGzWXd_zk2GJg67Ovdc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,459</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,498</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12077 12077 8164 7135 454 444 3459 4498 1029 1034 <p id="xdx_802_eus-gaap--OtherCurrentAssetsTextBlock_ziAehPvxzKB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_822_zZk3yYbdau25">OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></b></span></p> <p id="xdx_890_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zBhfkXmhvma5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z4fja4p38xWc" style="display: none">SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_494_20221231_zffI0nhXDTh7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20211231_zoMgdPvGOVAi" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzAo0_z2PwwlGj409h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,080</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">977</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--DepositsAssets_iI_pp0p0_maPEAOAzAo0_zyoLQDcwDwxj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,669</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,716</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzAo0_z88wX5CQNml7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total other receivables, prepaid expenses and deposits</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-top: Black 1.5pt solid; border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-top: Black 1.5pt solid; border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,749</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-top: Black 1.5pt solid; border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-top: Black 1.5pt solid; border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,693</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_z91q6oBOqnj3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zBhfkXmhvma5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z4fja4p38xWc" style="display: none">SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_494_20221231_zffI0nhXDTh7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20211231_zoMgdPvGOVAi" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzAo0_z2PwwlGj409h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,080</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">977</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--DepositsAssets_iI_pp0p0_maPEAOAzAo0_zyoLQDcwDwxj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,669</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,716</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzAo0_z88wX5CQNml7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total other receivables, prepaid expenses and deposits</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-top: Black 1.5pt solid; border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-top: Black 1.5pt solid; border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,749</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-top: Black 1.5pt solid; border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-top: Black 1.5pt solid; border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,693</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2080 977 19669 52716 21749 53693 <p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zDFuYjwMiPrb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_828_zYoWWRPu22u5">INVENTORIES</span></b></span></p> <p id="xdx_898_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zgCGtjRAUQXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zMDGQLAbfBe" style="display: none">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zK6j7kXsBk19" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20211231_zyEOT4n6ksm6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzv95_z4w0YPGZPohk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Finished goods, at cost</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">7,483</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">17,131</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pp0p0_mtINzv95_zDuUbJVZChyl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,131</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zBjl6k8v11Hl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_898_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zgCGtjRAUQXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zMDGQLAbfBe" style="display: none">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zK6j7kXsBk19" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20211231_zyEOT4n6ksm6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzv95_z4w0YPGZPohk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Finished goods, at cost</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">7,483</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">17,131</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pp0p0_mtINzv95_zDuUbJVZChyl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,131</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 7483 17131 7483 17131 <p id="xdx_808_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zJerW9Dc8kuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_82A_zpEmMypEN34i">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <p id="xdx_898_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z7UEjJ3kwsz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B3_zGOT9uxzrspe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zqQIHwmMbMUd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20211231_z9S8JJgoxHe7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0_maOAPAAzLk2_zeZPYDrJKlsd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Other payables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">100,385</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">164,529</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedAuditFeesCurrent_iI_pp0p0_maOAPAAzLk2_zAhnswo1nJj3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued audit fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,266</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,342</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzLk2_zr2E3RJlpKMb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued other expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,683</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,136</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzLk2_z2chJ8bgGrOl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued professional fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,376</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,352</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzLk2_zTG7GJXD9TBd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total payables and accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">154,710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">205,359</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zfBTRmxlccog" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z7UEjJ3kwsz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B3_zGOT9uxzrspe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zqQIHwmMbMUd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20211231_z9S8JJgoxHe7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0_maOAPAAzLk2_zeZPYDrJKlsd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Other payables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">100,385</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">164,529</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedAuditFeesCurrent_iI_pp0p0_maOAPAAzLk2_zAhnswo1nJj3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued audit fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,266</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,342</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzLk2_zr2E3RJlpKMb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued other expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,683</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,136</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzLk2_z2chJ8bgGrOl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued professional fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,376</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,352</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzLk2_zTG7GJXD9TBd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total payables and accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">154,710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">205,359</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 100385 164529 20266 21342 16683 14136 17376 5352 154710 205359 <p id="xdx_80A_eus-gaap--LesseeFinanceLeasesTextBlock_zJ7h7BuIHjGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_82C_zSkoQsI36YS2">FINANCE LEASE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company purchased motor vehicles with finance lease. <span id="xdx_907_eus-gaap--LesseeFinanceLeaseDescription_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--FirstFinanceLeaseAgreementMember_zCFKBnqQoRXf" title="Finance lease, description">The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly.</span> <span id="xdx_901_eus-gaap--LesseeFinanceLeaseDescription_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SecondFinanceLeaseAgreementMember_z7ErBtDqzJXk" title="Finance lease, description">The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly.</span> The obligation under the finance lease is as follows:</span></p> <p id="xdx_897_ecustom--ScheduleOfObligationUnderFinanceLeaseTableTextBlock_z7vnTqL6Rc3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b><span id="xdx_8B5_zaOLyplRloMj" style="display: none">SCHEDULE OF OBLIGATION UNDER FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zF2mWeoJFy0i" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As</p> <p style="margin-top: 0; margin-bottom: 0">of December 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20211231_zLe5LYeLPpt4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_z6kd8b6X4hFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Finance leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">58,768</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">81,676</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_z8pFXvJ1hmS3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: interest expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,792</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,924</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiability_iI_pp0p0_zBVrXuAgC6tb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net present value of finance leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">74,752</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseLiabilityCurrent_iI_pp0p0_zoOnStcW7QW1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,515</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,697</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_zqQV7QWKjXGc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Non-current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseLiability_iI_pp0p0_zyzGcQfKJCE3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">74,752</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zT0e9zZlMP25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--FinanceLeaseLiabilityMaturityTableTextBlock_zcyuJ1O4i6Nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the maturities of the finance leases for each of the years are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_zpKXW0X4D8Pb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF MATURITIES OF FINANCE LEASE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20221231_z2J3XkCM6eP5" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maFLLPDzFyD_zCnNhIbkZ089" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">16,515</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maFLLPDzFyD_zxaQJpEy3gU4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,222</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maFLLPDzFyD_zv3aUEtBCCtk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,153</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maFLLPDzFyD_zTk93R4AMmP8" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,086</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_mtFLLPDzFyD_z06uWZdtA5u5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_z76BKtMCLnw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly. The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly. <p id="xdx_897_ecustom--ScheduleOfObligationUnderFinanceLeaseTableTextBlock_z7vnTqL6Rc3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b><span id="xdx_8B5_zaOLyplRloMj" style="display: none">SCHEDULE OF OBLIGATION UNDER FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zF2mWeoJFy0i" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As</p> <p style="margin-top: 0; margin-bottom: 0">of December 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20211231_zLe5LYeLPpt4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_z6kd8b6X4hFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Finance leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">58,768</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">81,676</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_z8pFXvJ1hmS3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: interest expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,792</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,924</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiability_iI_pp0p0_zBVrXuAgC6tb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net present value of finance leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">74,752</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseLiabilityCurrent_iI_pp0p0_zoOnStcW7QW1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,515</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,697</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_zqQV7QWKjXGc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Non-current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseLiability_iI_pp0p0_zyzGcQfKJCE3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">74,752</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 58768 81676 3792 6924 54976 74752 16515 16697 38461 58055 54976 74752 <p id="xdx_89A_eus-gaap--FinanceLeaseLiabilityMaturityTableTextBlock_zcyuJ1O4i6Nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the maturities of the finance leases for each of the years are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_zpKXW0X4D8Pb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF MATURITIES OF FINANCE LEASE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20221231_z2J3XkCM6eP5" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maFLLPDzFyD_zCnNhIbkZ089" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">16,515</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maFLLPDzFyD_zxaQJpEy3gU4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,222</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maFLLPDzFyD_zv3aUEtBCCtk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,153</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maFLLPDzFyD_zTk93R4AMmP8" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,086</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_mtFLLPDzFyD_z06uWZdtA5u5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 16515 17222 13153 8086 54976 <p id="xdx_803_ecustom--DueToOfficersOrStockholdersTextBlock_zGmYLInq4jya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_82A_zb17UFv4DbL1">AMOUNT DUE TO A DIRECTOR</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and December 31, 2021, the amount due to director of the Company are $<span id="xdx_90A_eus-gaap--DueToOfficersOrStockholdersCurrent_iI_pp0p0_dxL_c20221231_z4ezxvul2sh9" title="Amount due to a director::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0718">0</span></span> and $<span id="xdx_903_eus-gaap--DueToOfficersOrStockholdersCurrent_iI_pp0p0_c20211231_zyuKr6dQnSbj" title="Amount due to a director">40,509</span>, respectively. The advance from a director of Company is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 40509 <p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zRFfK2biMcv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_821_zbv6RtzQqO7g">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zTTk4OsNQVz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and year ended December 31, 2021, the local (United States) and foreign components of (loss) / profit before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zcTkedenX5ji" style="display: none">SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_495_20220101__20221231_zP6dnOZXEVEh" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_491_20210101__20211231_znXGTVvu62ak" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax jurisdictions from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--US_zpWbDOp1s5r8" style="vertical-align: bottom; background-color: White"> <td style="width: 60%">- Local</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(43,174</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(43,429</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">- Foreign, representing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--SC_zRF17nyWpFBk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Seychelles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,643</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,427</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--HK_z1fpUsENa6oa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,951</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,937</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--MY_zx3u82ljtLBi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Malaysia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">56,347</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,071</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zCw6lvbnmCO9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">(Loss)/Profit before income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,421</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">150,278</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zabCOYRDMYId" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z350lJ9sQ9Yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zWjEcsTPdZf9" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49A_20220101__20221231_zuxI4ip3EG14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_490_20210101__20211231_zrtLrhCKkaAb" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_z60QYEwbyTYi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Current:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_maITEBzLRa_zyN6qtpIaN5h" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0747">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CurrentForeignTaxExpenseBenefit_i01N_di_maITEBzLRa_zXNZ3EN0UUud" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 60%">- Foreign</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(516</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(176</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zAH5wj4nw9Ea" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_maITEBzLRa_z3udbnqPqVI1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0755">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0756">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_i01_maITEBzLRa_zHDQDXboUhI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">- Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0759">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzLRa_ztF7odyrEAsl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(516</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(176</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A6_zOlRpB7ZjgU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z9rVtVdns6q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zzxwxfGc2vMa" style="display: none">SCHEDULE OF DEFERRED INCOME TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Net operating loss carry forwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">-United States of America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zl0295uu0DZ5" style="width: 16%; text-align: right" title="Net operating loss carry forwards">(99,152</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zs3PSZlGchj5" style="width: 16%; text-align: right" title="Net operating loss carry forwards">(90,085</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">-Seychelles</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pdp0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--SeychellesMember_ziI8alw2FA25" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pdp0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--SeychellesMember_zr3J6LrnfkU2" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">-Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_z7WoYqZEagJc" style="text-align: right" title="Net operating loss carry forwards">(104,132</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zRCHb5l2M0X" style="text-align: right" title="Net operating loss carry forwards">(103,480</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">-Malaysia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zTWKhQY64OF6" style="text-align: right" title="Net operating loss carry forwards">(36,884</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_z63drIG7PLUk" style="text-align: right" title="Net operating loss carry forwards">(46,376</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">-PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--PeoplesRepublicOfChinaPRCMember_zmdAZSs67It1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--PeoplesRepublicOfChinaPRCMember_zZseCCHFOB0l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231_zUldW7DjPOX7" style="text-align: right" title="Net operating loss carry forwards">(240,168</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231_zhDy7HJA9Aa8" style="text-align: right" title="Net operating loss carry forwards">(239,941</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: valuation allowance</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20221231_zHPegYlnXRLb" style="text-align: right" title="Less: valuation allowance">240,168</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231_zKurR9pzgCg9" style="text-align: right" title="Less: valuation allowance">239,941</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredTaxAssetsNet_iI_pdp0_c20221231_zF5aHuXOt6uh" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets"><span style="-sec-ix-hidden: xdx2ixbrl0794">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iI_pdp0_c20211231_z6PdAbm6Fgqh" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zFxpUrevA9Cg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Seychelles, Hong Kong, Malaysia, PRC that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United States of America</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of 31 December, 2022, the operations in the United States of America incurred $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zSnk0xmowWff" title="Cumulative net operating losses">472,151</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20220101__20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_z9mWpY4imTJc" title="Income tax rate">21</span>%. <span id="xdx_901_eus-gaap--OperatingLossCarryforwardsLimitationsOnUse_c20220101__20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zzdJOd1AYWD6" title="Net operating loss carryforwards expiration">The net operating loss carry forwards begin to expire in 2038, if unutilized.</span> The Company has provided for a full valuation allowance of $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_za7kjbHGfhTj" title="Valuation allowance">99,152</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Seychelles</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong Kong</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zAjNOTPaDov5" title="Income tax rate">16.5</span>% on its assessable income. As of December 31, 2022, the operations in the Hong Kong incurred $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zsOevwiJC6Se" title="Cumulative net operating losses">631,103</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zQ1gvw0iBfF2" title="Statutory income tax, rate">16.5</span>%. The Company has provided for a full valuation allowance of $<span id="xdx_907_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zRtt6pa7WKt3" title="Valuation allowance">104,132</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Malaysia</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from <span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember__srt--RangeAxis__srt--MinimumMember_z7zc8guHgvrf" title="Percentage of statutory income rate">17</span>% to <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember__srt--RangeAxis__srt--MaximumMember_zsctYzYjcwN1" title="Statutory income tax, rate">24</span>% on its assessable income. As of December 31, 2022, the operations in the Malaysia incurred $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zVra3vhlyi39" title="Cumulative net operating losses">216,968</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20220101__20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zMm1LiYtzVCb" title="Income tax rate">17</span>%. The Company has provided for a full valuation allowance of $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zCIKGPupKRP5" title="Valuation allowance">36,884</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zTTk4OsNQVz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and year ended December 31, 2021, the local (United States) and foreign components of (loss) / profit before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zcTkedenX5ji" style="display: none">SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_495_20220101__20221231_zP6dnOZXEVEh" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_491_20210101__20211231_znXGTVvu62ak" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax jurisdictions from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--US_zpWbDOp1s5r8" style="vertical-align: bottom; background-color: White"> <td style="width: 60%">- Local</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(43,174</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(43,429</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">- Foreign, representing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--SC_zRF17nyWpFBk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Seychelles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,643</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,427</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--HK_z1fpUsENa6oa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,951</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,937</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--MY_zx3u82ljtLBi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Malaysia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">56,347</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,071</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zCw6lvbnmCO9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">(Loss)/Profit before income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,421</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">150,278</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -43174 -43429 -11643 -1427 -3951 -4937 56347 200071 -2421 150278 <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z350lJ9sQ9Yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zWjEcsTPdZf9" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49A_20220101__20221231_zuxI4ip3EG14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_490_20210101__20211231_zrtLrhCKkaAb" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_z60QYEwbyTYi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Current:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_maITEBzLRa_zyN6qtpIaN5h" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0747">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CurrentForeignTaxExpenseBenefit_i01N_di_maITEBzLRa_zXNZ3EN0UUud" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 60%">- Foreign</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(516</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(176</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zAH5wj4nw9Ea" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_maITEBzLRa_z3udbnqPqVI1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0755">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0756">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_i01_maITEBzLRa_zHDQDXboUhI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">- Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0759">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzLRa_ztF7odyrEAsl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(516</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(176</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 516 176 516 176 <p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z9rVtVdns6q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zzxwxfGc2vMa" style="display: none">SCHEDULE OF DEFERRED INCOME TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the year ended<br/> December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Net operating loss carry forwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">-United States of America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zl0295uu0DZ5" style="width: 16%; text-align: right" title="Net operating loss carry forwards">(99,152</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zs3PSZlGchj5" style="width: 16%; text-align: right" title="Net operating loss carry forwards">(90,085</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">-Seychelles</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pdp0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--SeychellesMember_ziI8alw2FA25" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pdp0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--SeychellesMember_zr3J6LrnfkU2" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">-Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_z7WoYqZEagJc" style="text-align: right" title="Net operating loss carry forwards">(104,132</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zRCHb5l2M0X" style="text-align: right" title="Net operating loss carry forwards">(103,480</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">-Malaysia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zTWKhQY64OF6" style="text-align: right" title="Net operating loss carry forwards">(36,884</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_z63drIG7PLUk" style="text-align: right" title="Net operating loss carry forwards">(46,376</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">-PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--PeoplesRepublicOfChinaPRCMember_zmdAZSs67It1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__custom--PeoplesRepublicOfChinaPRCMember_zZseCCHFOB0l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231_zUldW7DjPOX7" style="text-align: right" title="Net operating loss carry forwards">(240,168</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20211231_zhDy7HJA9Aa8" style="text-align: right" title="Net operating loss carry forwards">(239,941</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: valuation allowance</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20221231_zHPegYlnXRLb" style="text-align: right" title="Less: valuation allowance">240,168</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231_zKurR9pzgCg9" style="text-align: right" title="Less: valuation allowance">239,941</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredTaxAssetsNet_iI_pdp0_c20221231_zF5aHuXOt6uh" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets"><span style="-sec-ix-hidden: xdx2ixbrl0794">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iI_pdp0_c20211231_z6PdAbm6Fgqh" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 99152 90085 104132 103480 36884 46376 240168 239941 240168 239941 472151 0.21 The net operating loss carry forwards begin to expire in 2038, if unutilized. 99152 0.165 631103 0.165 104132 0.17 0.24 216968 0.17 36884 <p id="xdx_80C_eus-gaap--ConcentrationRiskDisclosureTextBlock_ziSmcmO8j7U" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. <span id="xdx_821_zSv2ogv4Wgac">CONCENTRATIONS OF RISKS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zJH1twoieU5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zKRHEyBrtka4" style="display: none">SCHEDULE OF CONCENTRATIONS OF RISKS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and 2021, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Revenues</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Percentage of Revenues</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Accounts Receivable, Trade</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zD9E0hFNsTBb" style="width: 9%; text-align: right" title="Revenues">501,470</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zJAQcPdo4Lhj" style="width: 9%; text-align: right" title="Revenues">1,176,280</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zOgGpPv2p114" style="width: 9%; text-align: right" title="Percentage of revenues">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zUoaab8kwUdl" style="width: 9%; text-align: right" title="Percentage of revenues">60</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zYbCwi8TaU6f" style="width: 9%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0836">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_pp0p0" style="width: 9%; text-align: right" title="Accounts receivable, trade">87</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z0z5socwR3Vc" style="text-align: right" title="Revenues">386,232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zIkU39C0UOp3" style="text-align: right" title="Revenues">374,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z1mlrouOyHeg" style="text-align: right" title="Percentage of revenues">20</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zz0KOaPGXmKa" style="text-align: right" title="Percentage of revenues">19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zO7Ltc1R6bW2" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsReceivableNet_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_pp0p0" style="text-align: right" title="Accounts receivable, trade">122</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Customer C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zHrKveVSDIZj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">221,638</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zEdjoW7vWnMb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z69nvhazwUTk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">12</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pp0p0_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zcdIkDC4YKp4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zvu7SpHcTAai" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsReceivableNet_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zIDyNeHi14c7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,109,340</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zPz4JJVSBXs6" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,550,835</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zJ0BZlkzcYx" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">58</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zgApCpanYp05" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">79</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zM1qrLZe6rNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z5SVrfL48fLg" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">209</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and 2021, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">For the year ended December 31</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2022</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2021</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2022</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2021</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2022</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2021</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Purchases</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Percentage of Purchases</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Account Payable, Trade</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: left">Vendor A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z7TFvlOhjD1g" style="width: 9%; text-align: right" title="Purchase">477,099</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z7Jhc5hI1Uy" style="width: 9%; text-align: right" title="Purchase">746,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zRNSLGuubMi2" style="width: 9%; text-align: right" title="Percentage of revenues">23</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zFIsK1YS41oi" style="width: 9%; text-align: right" title="Percentage of revenues">51</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zBANwEwWTcvk" style="width: 9%; text-align: right" title="Account Payable, trade">1,626</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zddWf02ZXavl" style="width: 9%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0886">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zt3jvO4hZUZ8" style="text-align: right" title="Purchase">331,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_pp0p0" style="text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl0890">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zDFmlFmILYGh" style="text-align: right" title="Percentage of revenues">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_z5zqc2GA5CRf" style="text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0894">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zMrOI2n0QA33" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0895">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zM5PkzydJ4I5" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0896">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zRW4HAT2Xuvh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">221,743</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl0900">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zVP9lpEsQbtc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">33</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zdUUVB1iML8d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0904">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_z5nA1I8o9ibb" style="border-bottom: Black 1.5pt solid; text-align: right">16,759</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zv04KDVYZBh6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_znOIvJ7doLAl" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">1,030,380</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zrwTZHnWDSmg" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchases">746,964</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zqYSNVQ7NNl3" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">71</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z37L8DTAE2ge" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">51</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zGTOddKoskH2" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, trade">18,385</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z7FsFIz7ycq1" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, Trade"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zctQUOxXbTo" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Exchange rate risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of MYR, HK$ and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zJH1twoieU5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zKRHEyBrtka4" style="display: none">SCHEDULE OF CONCENTRATIONS OF RISKS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and 2021, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Revenues</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Percentage of Revenues</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Accounts Receivable, Trade</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zD9E0hFNsTBb" style="width: 9%; text-align: right" title="Revenues">501,470</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zJAQcPdo4Lhj" style="width: 9%; text-align: right" title="Revenues">1,176,280</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zOgGpPv2p114" style="width: 9%; text-align: right" title="Percentage of revenues">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zUoaab8kwUdl" style="width: 9%; text-align: right" title="Percentage of revenues">60</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zYbCwi8TaU6f" style="width: 9%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0836">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_pp0p0" style="width: 9%; text-align: right" title="Accounts receivable, trade">87</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z0z5socwR3Vc" style="text-align: right" title="Revenues">386,232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zIkU39C0UOp3" style="text-align: right" title="Revenues">374,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z1mlrouOyHeg" style="text-align: right" title="Percentage of revenues">20</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zz0KOaPGXmKa" style="text-align: right" title="Percentage of revenues">19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zO7Ltc1R6bW2" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsReceivableNet_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_pp0p0" style="text-align: right" title="Accounts receivable, trade">122</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Customer C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zHrKveVSDIZj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">221,638</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zEdjoW7vWnMb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z69nvhazwUTk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">12</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pp0p0_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zcdIkDC4YKp4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zvu7SpHcTAai" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsReceivableNet_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zIDyNeHi14c7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,109,340</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zPz4JJVSBXs6" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,550,835</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zJ0BZlkzcYx" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">58</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zgApCpanYp05" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">79</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zM1qrLZe6rNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z5SVrfL48fLg" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">209</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and 2021, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">For the year ended December 31</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2022</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2021</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2022</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2021</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2022</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">2021</td><td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Purchases</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Percentage of Purchases</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Account Payable, Trade</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: left">Vendor A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z7TFvlOhjD1g" style="width: 9%; text-align: right" title="Purchase">477,099</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z7Jhc5hI1Uy" style="width: 9%; text-align: right" title="Purchase">746,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zRNSLGuubMi2" style="width: 9%; text-align: right" title="Percentage of revenues">23</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zFIsK1YS41oi" style="width: 9%; text-align: right" title="Percentage of revenues">51</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zBANwEwWTcvk" style="width: 9%; text-align: right" title="Account Payable, trade">1,626</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zddWf02ZXavl" style="width: 9%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0886">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zt3jvO4hZUZ8" style="text-align: right" title="Purchase">331,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_pp0p0" style="text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl0890">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zDFmlFmILYGh" style="text-align: right" title="Percentage of revenues">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_z5zqc2GA5CRf" style="text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0894">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zMrOI2n0QA33" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0895">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zM5PkzydJ4I5" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0896">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zRW4HAT2Xuvh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">221,743</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl0900">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zVP9lpEsQbtc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">33</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zdUUVB1iML8d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0904">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_z5nA1I8o9ibb" style="border-bottom: Black 1.5pt solid; text-align: right">16,759</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zv04KDVYZBh6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_znOIvJ7doLAl" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">1,030,380</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zrwTZHnWDSmg" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchases">746,964</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zqYSNVQ7NNl3" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">71</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z37L8DTAE2ge" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">51</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zGTOddKoskH2" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, trade">18,385</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z7FsFIz7ycq1" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, Trade"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 501470 1176280 0.26 0.60 87 386232 374555 0.20 0.19 122 221638 0.12 1109340 1550835 0.58 0.79 209 477099 746964 0.23 0.51 1626 331538 0.15 221743 0.33 16759 1030380 746964 0.71 0.51 18385 <p id="xdx_809_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zKpm6ZATqGx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15. <span id="xdx_820_zNs1YYUVb6k3">LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022, the Company recognized approximately US$<span id="xdx_901_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20220101__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zH7H4l0u88Kc" title="Lease liability"><span id="xdx_902_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20220101__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zBi1DpeCgka6" title="Lease asset- right of use">386,451</span></span>, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20220101__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_z3POi765Dujk" title="Discount rate of lease payment">5.40</span>% adopted from Malayan Banking Berhad’s base lending rate as a reference for discount rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The initial recognition of operating lease right and lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zUx38ValGKXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, operating lease right of use asset as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_znN3EhzfDRk5" style="display: none">SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Year ended December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">As of January 1,</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iS_c20220101__20221231_zojR9UCrD8ah" style="width: 14%; text-align: right" title="Operating lease right of use asset">92,606</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pp0p0_c20210101__20211231_zYFQ0LuuXvve" style="width: 14%; text-align: right" title="Operating lease right of use asset">47,653</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Add: New Lease commenced on 1 January 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--AddtionInOperatingLeaseRightOfUseAsset_c20220101__20221231_zr91mBUbvImd" style="text-align: right" title="New Lease commenced on 1 January 2022"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AddtionInOperatingLeaseRightOfUseAsset_c20210101__20211231_zaJAEi2Lxgn6" style="text-align: right" title="New Lease commenced on 1 January 2022">92,606</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20220101__20221231_zBG1SEwIVEs8" style="text-align: right" title="Accumulated amortization">(42,310</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20210101__20211231_zN8uypThcJl5" style="text-align: right" title="Accumulated amortization">(46,571</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20220101__20221231_zwo3sZlMhR56" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(5,748</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20210101__20211231_zFzSdNpmSyz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,082</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance as of December 31</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20220101__20221231_zZb2e8sbt5Ok" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">44,548</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20210101__20211231_zZWKs5HWwjI8" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">92,606</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zzYRrAoZIxAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock_zhW3TfYpuDD1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, operating lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zCQE75Fvf75b" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify">As of January 1,</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeaseLiability_iS_c20220101__20221231_zGqYDHD3kaxl" style="width: 14%; text-align: right" title="Operating lease liability, beginning">92,606</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: gross repayment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLeasePayments_iN_pp0p0_di_c20220101__20221231_zQq3fc2GtFhe" style="text-align: right" title="Less: gross repayment">(45,763</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Add: imputed interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pp0p0_c20221231_z1mHf9bWZZ26" style="text-align: right" title="Add: imputed interest">3,453</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--EffectOfTranslationExchangeOfOperatingLeaseLiability_pp0p0_c20220101__20221231_z16qDVg5dPhf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(5,748</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance as of December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_iE_pp0p0_c20220101__20221231_z04bxXc6crVh" style="text-align: right" title="Operating lease liability, ending">44,548</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: lease liability current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_c20221231_zsAbtnu1YC8h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: lease liability current portion">44,548</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Lease liability non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20221231_zRo73G9Bjz8a" style="border-bottom: Black 2.5pt double; text-align: right" title="Lease liability non-current portion"><span style="-sec-ix-hidden: xdx2ixbrl0964">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_z4ozJQMf4kA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and 2021, the amortization of the operating lease right of use asset are $<span id="xdx_902_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pp0p0_c20220101__20221231__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zz0Gfw7wtIda" title="Amortization of operating lease right of use asset">42,310</span> and $<span id="xdx_902_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pp0p0_c20210101__20211231__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zwvxfNhaO6H3" title="Amortization of operating lease right of use asset">44,486</span> respectively.</span></p> <p id="xdx_890_ecustom--ScheduleOfOperatingLeaseOtherInformationTableTextBlock_zxPV4Amvieyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zYJKV8GklV8e" style="display: none">SCHEDULE OF OPERATING LEASE OTHER INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cash paid for amounts included in the measurement of lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: justify">Operating cash flow from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20220101__20221231_z5FJLpAr39Tf" style="width: 14%; text-align: right" title="Operating cash flow from operating lease">42,212</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20210101__20211231_z5XVauHSOkh7" style="width: 14%; text-align: right" title="Operating cash flow from operating lease">44,486</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Right-of-use assets obtained in exchange for operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20220101__20221231_zpKsf4JMqLCe" style="text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities">44,548</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20210101__20211231_zqkDJU4gaKZ" style="text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities">45,270</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Remaining lease term for operating lease (years)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zHhLfOP3oGJh" style="text-align: right" title="Remaining lease term for operating lease (years)">1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_c20211231_zxXajYJG801d" style="text-align: right" title="Remaining lease term for operating lease (years)"><span style="-sec-ix-hidden: xdx2ixbrl0982">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Weighted average discount rate for operating lease</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20221231_zGn00RU6ydc8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average discount rate for operating lease">5.40</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20211231_zmz7nssrB0f7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average discount rate for operating lease">4.47</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A0_zkO5SqSsY9f1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and 2021, lease expenses were $<span id="xdx_90C_eus-gaap--PaymentsForRent_pp0p0_c20220101__20221231_zO7bFI2Ou6Ni" title="Lease expenses">42,310</span> and $<span id="xdx_907_eus-gaap--PaymentsForRent_pp0p0_c20210101__20211231_z6LWpuLMjg6j" title="Lease expenses">44,486</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 386451 386451 0.0540 <p id="xdx_89F_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zUx38ValGKXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, operating lease right of use asset as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_znN3EhzfDRk5" style="display: none">SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Year ended December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">As of January 1,</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iS_c20220101__20221231_zojR9UCrD8ah" style="width: 14%; text-align: right" title="Operating lease right of use asset">92,606</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pp0p0_c20210101__20211231_zYFQ0LuuXvve" style="width: 14%; text-align: right" title="Operating lease right of use asset">47,653</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Add: New Lease commenced on 1 January 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--AddtionInOperatingLeaseRightOfUseAsset_c20220101__20221231_zr91mBUbvImd" style="text-align: right" title="New Lease commenced on 1 January 2022"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AddtionInOperatingLeaseRightOfUseAsset_c20210101__20211231_zaJAEi2Lxgn6" style="text-align: right" title="New Lease commenced on 1 January 2022">92,606</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20220101__20221231_zBG1SEwIVEs8" style="text-align: right" title="Accumulated amortization">(42,310</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20210101__20211231_zN8uypThcJl5" style="text-align: right" title="Accumulated amortization">(46,571</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20220101__20221231_zwo3sZlMhR56" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(5,748</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20210101__20211231_zFzSdNpmSyz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,082</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance as of December 31</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20220101__20221231_zZb2e8sbt5Ok" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">44,548</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20210101__20211231_zZWKs5HWwjI8" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">92,606</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 92606 47653 92606 42310 46571 -5748 -1082 44548 92606 <p id="xdx_89B_ecustom--ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock_zhW3TfYpuDD1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, operating lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zCQE75Fvf75b" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify">As of January 1,</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeaseLiability_iS_c20220101__20221231_zGqYDHD3kaxl" style="width: 14%; text-align: right" title="Operating lease liability, beginning">92,606</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: gross repayment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLeasePayments_iN_pp0p0_di_c20220101__20221231_zQq3fc2GtFhe" style="text-align: right" title="Less: gross repayment">(45,763</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Add: imputed interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pp0p0_c20221231_z1mHf9bWZZ26" style="text-align: right" title="Add: imputed interest">3,453</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--EffectOfTranslationExchangeOfOperatingLeaseLiability_pp0p0_c20220101__20221231_z16qDVg5dPhf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(5,748</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance as of December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_iE_pp0p0_c20220101__20221231_z04bxXc6crVh" style="text-align: right" title="Operating lease liability, ending">44,548</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: lease liability current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_c20221231_zsAbtnu1YC8h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: lease liability current portion">44,548</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Lease liability non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20221231_zRo73G9Bjz8a" style="border-bottom: Black 2.5pt double; text-align: right" title="Lease liability non-current portion"><span style="-sec-ix-hidden: xdx2ixbrl0964">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 92606 45763 3453 -5748 44548 44548 42310 44486 <p id="xdx_890_ecustom--ScheduleOfOperatingLeaseOtherInformationTableTextBlock_zxPV4Amvieyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zYJKV8GklV8e" style="display: none">SCHEDULE OF OPERATING LEASE OTHER INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cash paid for amounts included in the measurement of lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: justify">Operating cash flow from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20220101__20221231_z5FJLpAr39Tf" style="width: 14%; text-align: right" title="Operating cash flow from operating lease">42,212</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20210101__20211231_z5XVauHSOkh7" style="width: 14%; text-align: right" title="Operating cash flow from operating lease">44,486</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Right-of-use assets obtained in exchange for operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20220101__20221231_zpKsf4JMqLCe" style="text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities">44,548</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20210101__20211231_zqkDJU4gaKZ" style="text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities">45,270</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Remaining lease term for operating lease (years)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zHhLfOP3oGJh" style="text-align: right" title="Remaining lease term for operating lease (years)">1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_c20211231_zxXajYJG801d" style="text-align: right" title="Remaining lease term for operating lease (years)"><span style="-sec-ix-hidden: xdx2ixbrl0982">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Weighted average discount rate for operating lease</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20221231_zGn00RU6ydc8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average discount rate for operating lease">5.40</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20211231_zmz7nssrB0f7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average discount rate for operating lease">4.47</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 42212 44486 44548 45270 P1Y 0.0540 0.0447 42310 44486 <p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zyMVo2TCfBp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. <span id="xdx_821_zM0ZiQri9Gp6">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zTfAg8DIRqq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and December 31, 2021, the Company has the following transactions with related party:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zKyUaz1Gmlg3" style="display: none">SCHEDULE OF RELATED PARTY TRANSACTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended <br/> December 31, 2022 (Audited)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended <br/> December 31, 2021 (Audited)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional Fees:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">- Related party A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ProfessionalFees_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_z6kr8YRioP5a" style="width: 16%; text-align: right" title="Professional Fees">12,226</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ProfessionalFees_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_z2xmxtHkS4s4" style="width: 16%; text-align: right" title="Professional Fees">13,279</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">- Related party B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_zA32O53twYqh" style="text-align: right" title="Sales">386,232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromRelatedParties_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_zNskK96If2Y7" style="text-align: right" title="Sales">374,555</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">- Related party C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromRelatedParties_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zNJsowh0uBfg" style="text-align: right" title="Sales"><span style="-sec-ix-hidden: xdx2ixbrl1004">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zsstoD3nwrT3" style="text-align: right" title="Sales">13,124</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">- Related party D</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromRelatedParties_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyDMember_zrsPVGicuPt4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales">24,261</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromRelatedParties_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyDMember_z30QUHXii4h9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales">11,607</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pp0p0_c20220101__20221231_zV2GiFTBQj6h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">36,487</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pp0p0_c20210101__20211231_z3dsQPu5Cgtj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">412,565</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zq3t0s9gWfke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party A is a wholly owned subsidiary of a <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_c20221231__srt--OwnershipAxis__custom--RelatedPartyAMember_zF6begeOtx51" title="Ownership percentage">7.33</span>% shareholder of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party B’s director and shareholder is the founder of the Company. Founder <span style="background-color: white">of the Company</span> resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The r<span style="background-color: white">elated party C’s director and shareholder is the founder of the Company.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party D’s director is the founder of the Company. The shareholder of related party D is related party C.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zTfAg8DIRqq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and December 31, 2021, the Company has the following transactions with related party:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zKyUaz1Gmlg3" style="display: none">SCHEDULE OF RELATED PARTY TRANSACTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended <br/> December 31, 2022 (Audited)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended <br/> December 31, 2021 (Audited)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional Fees:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">- Related party A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ProfessionalFees_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_z6kr8YRioP5a" style="width: 16%; text-align: right" title="Professional Fees">12,226</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ProfessionalFees_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_z2xmxtHkS4s4" style="width: 16%; text-align: right" title="Professional Fees">13,279</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">- Related party B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_zA32O53twYqh" style="text-align: right" title="Sales">386,232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromRelatedParties_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_zNskK96If2Y7" style="text-align: right" title="Sales">374,555</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">- Related party C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromRelatedParties_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zNJsowh0uBfg" style="text-align: right" title="Sales"><span style="-sec-ix-hidden: xdx2ixbrl1004">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zsstoD3nwrT3" style="text-align: right" title="Sales">13,124</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">- Related party D</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromRelatedParties_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyDMember_zrsPVGicuPt4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales">24,261</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromRelatedParties_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyDMember_z30QUHXii4h9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales">11,607</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pp0p0_c20220101__20221231_zV2GiFTBQj6h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">36,487</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pp0p0_c20210101__20211231_z3dsQPu5Cgtj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">412,565</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 12226 13279 386232 374555 13124 24261 11607 36487 412565 0.0733 <p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_zRbK9VomBpmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. <span id="xdx_82A_zQe79FHNcrN8">SEGMENTED INFORMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zFFHfGmyXWd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BA_zLyfUAuK47dj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF REPORTABLE SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Geography*:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_499_20220101__20221231__srt--StatementGeographicalAxis__custom--NVMember_zOB6zI99woO8" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada <sup id="xdx_F55_zOwDGm19Gtfc">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20220101__20221231__srt--StatementGeographicalAxis__country--SC_zyEhn49x3jr9" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles <sup id="xdx_F51_zdZLYUJgjkrj">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_494_20220101__20221231__srt--StatementGeographicalAxis__country--HK_zDd8n8QKniz" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong <sup id="xdx_F52_z8cwkSCirBW5">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_496_20220101__20221231__srt--StatementGeographicalAxis__country--MY_z6rwGcbGbpJj" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia <sup id="xdx_F58_z09VHzQIfnPi">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_49C_20220101__20221231_zMPFqtGlbfUl" style="border-bottom: Black 1.5pt solid; text-align: center">Total <sup id="xdx_F5C_z4JxurgmPpu6">*</sup></td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the year ended December 31, 2022</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zGh6VNG4TN67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1023">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,849,047</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,849,047</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_zk0cqVBsu7O9" style="vertical-align: bottom; background-color: White"> <td>Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1029">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,404,054</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,404,054</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_zexssegjL9f1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1035">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1036">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,441</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,441</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zEVx4aUbf8tb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss) / profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(43,174</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,643</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,951</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,421</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F40_zpClTXBITlR9" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zwbqPRN1Dam" style="text-align: right">27,294</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--SC_fKg_____zhxWasGkdNpb" style="text-align: right">7,056</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--HK_fKg_____z6EdCbmiJpRd" style="text-align: right">14,264</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--MY_fKg_____zwke7vtTHIvb" style="text-align: right">333,310</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_iI_c20221231_fKg_____zLCJSz5V3MVa" style="text-align: right">381,924</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_498_20210101__20211231__srt--StatementGeographicalAxis__custom--NVMember_zwgEdBPMPVOl" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada <sup id="xdx_F54_zC2uih35Suoh">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_491_20210101__20211231__srt--StatementGeographicalAxis__country--SC_z5z42et3lR9h" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles <sup id="xdx_F54_zCwqBlw0imUj">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_490_20210101__20211231__srt--StatementGeographicalAxis__country--HK_zcHq9TUJvZU1" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong <sup id="xdx_F54_zlVfUqzDmvCa">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_49B_20210101__20211231__srt--StatementGeographicalAxis__country--MY_zjP50joyrrf3" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia <sup id="xdx_F56_zh499DCLNl1j">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_499_20210101__20211231_zuymrfhtqFzi" style="border-bottom: Black 1.5pt solid; text-align: center">Total <sup id="xdx_F52_zCfN00istbBf">*</sup></td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the year ended December 31, 2021</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_ztgiQQS4T7s1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1053">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,958,655</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,958,655</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_zazwNDptW0j1" style="vertical-align: bottom; background-color: White"> <td>Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1057">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1058">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1059">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,459,531</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,459,531</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_zGeONeTksG95" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(65,382</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(65,382</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zlhn7ig60Btb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss) / profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(43,429</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,427</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,937</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,071</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,278</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F44_z6ztAsMtaq2j" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__custom--NVMember_fKg_____ziVwf0Bx7SR1" style="text-align: right">7,366</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--SC_fKg_____zbYc7jh4gle2" style="text-align: right">6,475</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--HK_fKg_____zpEE52t84nBc" style="text-align: right">16,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--MY_fKg_____znlScwpYIp4l" style="text-align: right">468,183</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_c20211231_fKg_____zI3KzfUBY4G" style="text-align: right">498,311</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F09_zBzerOCzNmH9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">*</span></td><td style="text-align: justify"><span id="xdx_F1A_zOoZkOXSmPnk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues and costs are attributed to countries based on the location of customers.</span></td> </tr></table> <p id="xdx_8A8_zm70fN0p4BIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zFFHfGmyXWd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BA_zLyfUAuK47dj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF REPORTABLE SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Geography*:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_499_20220101__20221231__srt--StatementGeographicalAxis__custom--NVMember_zOB6zI99woO8" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada <sup id="xdx_F55_zOwDGm19Gtfc">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20220101__20221231__srt--StatementGeographicalAxis__country--SC_zyEhn49x3jr9" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles <sup id="xdx_F51_zdZLYUJgjkrj">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_494_20220101__20221231__srt--StatementGeographicalAxis__country--HK_zDd8n8QKniz" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong <sup id="xdx_F52_z8cwkSCirBW5">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_496_20220101__20221231__srt--StatementGeographicalAxis__country--MY_z6rwGcbGbpJj" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia <sup id="xdx_F58_z09VHzQIfnPi">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_49C_20220101__20221231_zMPFqtGlbfUl" style="border-bottom: Black 1.5pt solid; text-align: center">Total <sup id="xdx_F5C_z4JxurgmPpu6">*</sup></td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the year ended December 31, 2022</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zGh6VNG4TN67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1023">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,849,047</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,849,047</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_zk0cqVBsu7O9" style="vertical-align: bottom; background-color: White"> <td>Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1029">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,404,054</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,404,054</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_zexssegjL9f1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1035">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1036">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,441</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,441</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zEVx4aUbf8tb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss) / profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(43,174</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,643</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,951</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,421</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F40_zpClTXBITlR9" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zwbqPRN1Dam" style="text-align: right">27,294</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--SC_fKg_____zhxWasGkdNpb" style="text-align: right">7,056</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--HK_fKg_____z6EdCbmiJpRd" style="text-align: right">14,264</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--MY_fKg_____zwke7vtTHIvb" style="text-align: right">333,310</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_iI_c20221231_fKg_____zLCJSz5V3MVa" style="text-align: right">381,924</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_498_20210101__20211231__srt--StatementGeographicalAxis__custom--NVMember_zwgEdBPMPVOl" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada <sup id="xdx_F54_zC2uih35Suoh">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_491_20210101__20211231__srt--StatementGeographicalAxis__country--SC_z5z42et3lR9h" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles <sup id="xdx_F54_zCwqBlw0imUj">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_490_20210101__20211231__srt--StatementGeographicalAxis__country--HK_zcHq9TUJvZU1" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong <sup id="xdx_F54_zlVfUqzDmvCa">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_49B_20210101__20211231__srt--StatementGeographicalAxis__country--MY_zjP50joyrrf3" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia <sup id="xdx_F56_zh499DCLNl1j">*</sup></td><td> </td><td> </td> <td colspan="2" id="xdx_499_20210101__20211231_zuymrfhtqFzi" style="border-bottom: Black 1.5pt solid; text-align: center">Total <sup id="xdx_F52_zCfN00istbBf">*</sup></td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the year ended December 31, 2021</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_ztgiQQS4T7s1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1053">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,958,655</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,958,655</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_zazwNDptW0j1" style="vertical-align: bottom; background-color: White"> <td>Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1057">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1058">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1059">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,459,531</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,459,531</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_zGeONeTksG95" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(65,382</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(65,382</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zlhn7ig60Btb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss) / profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(43,429</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,427</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,937</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,071</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,278</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F44_z6ztAsMtaq2j" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__custom--NVMember_fKg_____ziVwf0Bx7SR1" style="text-align: right">7,366</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--SC_fKg_____zbYc7jh4gle2" style="text-align: right">6,475</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--HK_fKg_____zpEE52t84nBc" style="text-align: right">16,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--MY_fKg_____znlScwpYIp4l" style="text-align: right">468,183</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_c20211231_fKg_____zI3KzfUBY4G" style="text-align: right">498,311</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F09_zBzerOCzNmH9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">*</span></td><td style="text-align: justify"><span id="xdx_F1A_zOoZkOXSmPnk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues and costs are attributed to countries based on the location of customers.</span></td> </tr></table> 1849047 1849047 1404054 1404054 72441 72441 -43174 -11643 -3951 56347 -2421 27294 7056 14264 333310 381924 1958655 1958655 1459531 1459531 65382 65382 -43429 -1427 -4937 200071 150278 7366 6475 16287 468183 498311 <p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_z5FFktuIMBLc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18. <span id="xdx_82D_zyolyMUcS8fi">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC Topic 855, “<i>Subsequent Events</i>”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2022 up through the date the Company issued the audited consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2023, DSwiss (HK) Limited acquired <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230117__20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zu80r2ixEkpc" title="Number of shares, acquired">150,000</span> shares, representing <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqfkGPIBGej8" title="Equity ownership interest rate percentage">60</span>% equity interest in DSwiss Biotech Sdn. Bhd., from the other party <span style="background-color: white">with consideration of RM <span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_uMYRPShare_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zC1hcU772Ky2" title="Consideration price per share">1</span>. After such acquisition, </span>DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.</span></p> 150000 0.60 1 Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of this entity unilaterally, and hence the Company has control over this entity. On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited. Revenues and costs are attributed to countries based on the location of customers. EXCEL 93 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ,XT?U8'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #.-']6@R-@7NT K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)OIVE )'1[6?&D(+B@> O)[&ZP24,RTN[;F\;=+J(/X#$S?[[Y M!J;30>HQXG,< T:RF&YF-_@D==BP(U&0 $D?T:E4YX3/S?T8G:+\C <(2G^H M T+;-+?@D)11I& !5F$ELKXS6NJ(BL9XQAN]XL-G' K,:, !'7I*P&L.K%\F MAM,\=' %+##"Z-)W &PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?= MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%, M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @ MSC1_5AOH_:VQ!@ 8R0 !@ !X;"]W;W)K.Q6)XVW,;ZP$TTFVMSH#TX6; 9GW)]MYA(V&MO7,(HX:F*1$HD?SQM M#-WWOMA'@R.Z/PM.&8$O&8!]I8,/AXYCZ/8^,$Y?AW M9=K8_*81OMU>NU_F\ #SP!3W1?PE"O7\M-%OD) _LBS6-V+Y)U\!=8U?(&*5 M_R?+XMRNTR!!IK1(5F(H01*EQ2=[65V(-X)>E8"N!/0[@=NI$'@K@9>#%B7+ ML3 MM@93\U4[6!F<%0:TPL"EY%JD>J[(11KR\%N#-I1F4R2Z+M(911W/>7!(/+=) MJ$.II4 ^+O^8I2!W;/)OBN-MKI"7^WGH%?I[^*"TA$;WC^T2%0X=NX.Y$]^K M!0OX:0-N-<7E,V\,WOWB]IP/-KR?9/8-;&<#V\'3V=<%MI+C< M=5J?;$BHJB92=X/41ANHWF[U-$S3 MC,7DAB^$U#8XW$?+S,J&JFJR'6W8CG9L@Y+!<)'W]M5\N%=EY:&RFH#]#6!_ M-\ )EY$(3<=)H/.VWF];G-9=965?B>IK5C15W MN_QJXT,U-?ERP)KSAL\B$&:C4,4OLE8@;G4^7D5+-@U$:'%HY]Y%AW#+$N'@,67'Z MT&PE--D1!-,7\HF_6DEQ*\=QW%Z7=GOV%KN/8..6R<;%H\F*\Y:]D%$(L-%C M%+!\O$3:+V[9.6IUJ-OM'G>MO/O(/&X9>EP\K:QXH=4)"7D@1VV2J8:>B A) M?)%!A4.]B]#>J''W\;T5>1]1R"VSD(L'F!7R, S!7377&^0*SB.?4SLG;GF7 M1OK [;=I%PR^$S3S-^X#7)&4MG"L:\J61%WT?\HF7\HGAB^A[=-WO0$4 3 M3FW06^P^P4R*D:LL662VKM/'Y75IRR!&\>3T/]JBN[."XD[7UBB-B^KBE?&+ M[A2_-G@3H31T/G]%B\H.?8MC]Y@ZCI5T'S&,EC&,XNDI;Z9#R5DU&&[08L)/3IR6AW'LR_\[2-NT3)NT9WBUA<>QZVG M%/H8,N5, 6Y(1DIE%;RXY]@V./FXJ"YHF;/H3CGK7L30PS!9S(FD=4Z[Q:D" M;Q^9BI:9BNZ4J=83VV)M*4IG>9*T3]VW.'[E-I6/J^IREK&([A2+1JGFLGA< M8B;M; UNY<0=*ZIS'P&(E@&([A2 \C9*?)@+S$3%J+@M\Z0M%@0<;, D+ RM MO/M(/5Z9>KR=4L\T87&9S:U/)7"?JK5?7%87KXPYWDXQYR+AEKQCGF1",QL+#8&5W"E.])R3BQ?-S8.TMZO? MQ<*I%1W_C3NM/TVRAS@* MR&4LF+6SQ5U^^+%AX=;-W+R=$@_44 +-<*I%\-2$6F-0 M'/(YTQ#0TQ#N42MGE&&61AIF#56 MK85ND7^<'/@7X]N[F]'G\6HE93*\N1U?W$S)Y.K66E7[R#]>F7\\/*VL@2\C MF9#1N949=^@=4>L,!)?5!2L#C[=ET68%9F8BIN.TDN$6^1K 8&_8AV@2:[A MP*N*F)7WIR:?]IO7.,SHE[_=HDA@YOG%&QV;HYLW:(;Y>R/M\O3B]9MK9@9/ M16+^"%+G\ AN,5F\T5+L:+'(7PIY$%J+)-^<%?HP)K%VJ"Q^S]B+V/L,="I/G'_27R;I90]J1"QG MB=0AJ/JS82.6YSJ2PO'/+FBO?J9VW/_\&OW'*GF5S!,5;,3S/[)4+BY[40^D M;$[7N7SD+S^S74*^CI?P7%2_P?=0.PY(-+A M@'<.N.W@=3B0G0-YJX.W<_"JD=FF4HW#F$HZO"CY"RBUM8JF/U2#67FK]+-" MO_>I+-7=3/G)X8@7@N=92B5+P37-:9$P,-7A!#@#'Z=C\-TWWU\,I'J4=A@D MN["C;5C<$7;,DG- 4!]@B+'%??QV=W3H/E )UEGB.DM$^E5DO"U J;:1\(4RJ>A%^,61-,*0Y_8 ?HU0-\) M\%XN6+F'3O2!>F$KFJ6 ?5:-5^@K>JA3MN(BDS;TOHE+PV^A-ZU\$L0=\(,: M?N"$/Z.?-7B^8677V ;&T.+W;&CO%.P@700;BH+.M_)0*IE3RB]5K>F.ME+"0_9! MP:PEMXMV,']4T;5KSF(6XSB$]I>#]@@5'9G'Y!D[3 MRO/BJ -FPXC(R4+#>S6D5&;%,\B9TDV@U +IC,_/UN(X<&R!Y'OMZ6\QBW$ M.V@#-0R'W!2WK=*"%V?'*W47ZJ!/8(BBH(W58A=#&'9T.M20''*SW.Q^=G7; M7:?71]S_0G];TS+YCD0HQEX[+=-.S1V".OHD:J@1^6]25+>3J^O)[60VN;%V M(>1DV%/;T'M%.\RYX5/D)M1:L*SHERY&129=XM@G1E&;9@C&L.NU-,2*W,RZ ME2P[?*)JF#1)RK42]WE&G[(\DQVDBRR$ZGLA@FWDIIU66GMMZQ!Z0[W(S;T_ M9D6U^-BVHU>T7ZQ836)%@8_:RL5J%L0=](L:_D5.OAM>+?4T .F: 11[/D$M== %CN" MHKBKV>.&<#%YL^(\TO"QD[I/7DB_4[3#O!ONQF[R/:$E81LA>P%JOR+3S(^@ MWS6?&CK&1Y:J)U7Q_Z!1>VV8ZU8O)*1#X.&&:/&1E:LA\(Y5B$FGUM&WL:XB MYZX":6@7NVEW*_*.E8:%.2,2ANV5K<7.PQZ!N -EP[ X/TVZ\CM2;Z =S\]G$R^],*UTG7)U?R.T4[3+VA;.RF[(>2S9F:2BD0DB>? M^N ;> XA1$HJE6!#\S73>XVP#[<_0"QHJ?736BYXF?W+TCZXXP4#F1!:2VE= MQ==2J)5>JHK..GSO1?SO$.AP([&1!L0M#49\N>2%8\0"]XAA&/1CZ/7]R*]O MJX&S7+8/JUK6 3X'8Y:PY9.2M:_[R;LH& 'ENV+5R4%N[73$%"+JZ7%;TQXU M.QS 1J\0MUZY2M-,GVZH9J9W#<^R B1TE:GF9@5K41HD]CW<7JN^P? 0<"-+ MB%N6J!7.>KG.J\, 7BTE$KY4TVJA#WHVBE:X6FC;=Y)-[7'F1YX!W6)&3NY]4 M!K.;QYOIS K5E @(1<9NKL7,CSK6-J31$>2(CJ@&^L2Q-35"'"&_+24L9J&: M15V0&R5!3E02X.IN?&H*H7%>8]T(%AJ'5QK^)6[^_0O]_<@VK%@S M\55U.,6%5&Q0,D"E++.GM:Y;M9BN-ECTN4!UF*N:4 %4&U)])Z'5,;&B@^VA M*"O%N8WD!GM'HZVKY/HPTBE;+L3JSO52?>@ M><3VG/Q76CYGA5 J?*X>!\]#-;CE]NAY^T7R5748^\2ERJ+ZN& T9:4V4/?G MG,O7+_H!]3\ #/\#4$L#!!0 ( ,XT?U:GVS.$VP( .L) 8 >&PO M=V]R:W-H965T&ULK99=;]HP%(;_BI5-TR9UY ,(T$&DEFK: M+B:AHFT7TR[?U\SK'L:<[J>YU"F#( M0\:%GCFI,?FEZ^HXA8SJGLQ!X).55!DUV%5K5^<*:%(D9=P-/"]T,\J$$TV+ M>PL53>7&<"9@H8C>9!E5OZ^!R]W,\9W'&[=LG1I[PXVF.5W#$LS7?*&PY]8J M"B:T*\2^H71 MDJRP=4,-C:9*[HBRT:AF&\7<%-GHA@G[&I=&X5.&>2::2Z$E9PDUD)!KRJF( M@2RMG"9O%U2!,"D8%E/^CKPGKXE+=(IW]=0U.+K5<.-JI.MRI.# 2#<0]TC? MOR"!%P0MZ?/NZ7XSW47/M?&@-AX4>OT#>DN#EK$>#9$K\I$)-,XH)PNI65%? M/Z[NM%%893_;K);:@W9MN_0N=4YCF#FXMC2H+3C1FU=^Z'UH,_Z?Q!K3T*^G MH7],/5K@J@&E\.5CJ<7W%R2GBFPIWT";[5)K5&C9#\0V\GJ>Y^'[V.X;.AG6 M0!W4J(/S4,M*)'1C4JG8'TC:D$O-<(\%OW#E[PEUE\@&^+ &'[X(G&F]:8<> M/D-Y"GLLH@$9UI#ABR#QTZ\-%0D3ZS;2\"3IL8@&Z:@F'1TEGKU9%B#I)33TYG_IPI4Y:%DTX\0;#\? ) M<9?(!K'O_=O#O/.93Q1N)=F%O%-HB>[N[<3V&/2%JC43FG!88:[7&^&Z5>7) MHNP8F1>;\YTTN-47S11/8Z!L #Y?26D>.W:_K\]WT5]02P,$% @ SC1_ M5AU&UTI=!0 E!( !@ !X;"]W;W)K8%$OO>ZW.N8Q]?]U]9^HUO*17H>QPE_+:S%6)WHVE\M:6QSZ_9CB;0 MLV9I[ MX33<:WZ74#S*G.-*(KMM:[(=)9]#/VF;IH,_V(@H3.DL1W\>QG_ZX MHQ%[O>W@SEO#/-QLA6S0!OV=OZ$+*C[M9BF\:664((QIPD.6H)2N;SM#?#,F M1#ID%L\A?>4GSTA2>6'LFWR9!+<=72*B$5T)&<*'OP,=T2B2D0#'OT703CFF M=#Q]?HM^GY$',B\^IR,6?0X#L;WM.!T4T+6_C\2_Z+6P MU3MHM>>"Q84S((C#)/_WOQ>).'' 1H,#*1Q(U<%N<# *!Z/J8#8XF(6#F64F MIY+E8>P+?]!/V2M*I35$DP]9,C-OH!\F$/S$8,02SJ(P\ 4-T$+ M'TRJX(BMT71'4U].#D=^$J 1B^'+VLHI/U T258LIN@*?5J,T<4?EWU- !H9 M4UL5(X_RD4G#R)B@)Y:(+4=N$M#@/( &-$HNY(W+B+1&'-/5-3+P!T1T0A2 MQN]WQRUPC#*U1A;/:(A7I*A,*OHZ?.$BA2_];U6V\F"F.IA<_C=\YZ_H;0=F M@=/T0#N#/W_'MOZ7BNDO"G;&VRQYFVW1!W/WV?4^N0I8=^V.7[$R,;F3E3G) M;>PPP([9T\UN7SN<YM/% LWFT_O)4@70KHUKFF:O9U3@ M*7,^=#Q_1T!NCX?AIXDT6R_EP.7EVD?MEYGH+=Z$"[M1GT]2) MB4D%N\+.T!W;L=7P>R7\7GM>9ZX$Z3VT@NPI/CE#KZ97967:#1./]:,BZ:T0 M[R?>T!NY2"X\I:SH]7%M4DN@RHS8>L/TXQ/!Q*WP'MWAHGV*BP#G8Y- M@JM$ZV;8TDG7:2!Z5%C<*F2#(R)XO)U%,B->I(+6Q7@2JL<+=I/HZ" MB-N%S7.7Z&Q.E A-12Y[1E7E%&:02ZR3!I!'F"58D2-FK:I; CAF%U&\ >I0O;K6>KJ=C2%*W.CJ1A=M[2+B+&^>6- M$G6K(/[?,]:OBG:>@J- XG:%O$)0^$!9DT"9D*8T6?U <+A,>.3G!57P#U0/ M\MRIS$1=&DD7&[WJ]-7-KDQ';UJW1PW%[2(*JW8V=S_"#BKELEGEBS!G9SKB MF$X5IL(,E-)J."#AHUCB=K7TH/#.OR=ME[)U*!#41(AO_91>H3N?AZNL- K" M:"^J)4S!(!^@>YI!_5K7]=H>63?,[!IR38YR2MKE]'-6^D)UYQ^@GMM0E.SC M%V !%1ZLEQ@^E8P/E'Q[P070D8O_G>Q(76.);L/9W'*L"K]WF9Y3E))\WG)4 M0/)3O9K3 TWVE/\F.:P8;&0(:")?B#1\D8208-"^AQTO!/;R\B! D W865#$ M5ODJDDG*BG":\FO5LM5.2F\PVF17&#R/FY=,96MY37*770Y4VD?X9HP5[4." M;T9$W4.@)XNE'8?.[VN>_'030N$>T37 T*^[L#;2_ HD?Q%LEUT*O# ![++' M+?4#FDH#Z%\S)MY>Y #E1=3@/U!+ P04 " #.-']6_<=MX_P$ #.&@ M& 'AL+W=O=7D D)+$F"06 K/CM"QY,2R#(6 UZ8_&P^P'<_;E8 M@Y,#H8]LBS$'7_.L8%?&EO/=Y7C,XBW.$;L@.UR(.VM"<\3%*=V,V8YBE%1. M>3:V3-,;YR@MC.FDNG9'IQ.RYUE:X#L*V#[/$7V^P1DY7!G0>+EPGVZVO+PP MGDYV:(,?,/^\NZ/B;-Q2DC3'!4M) 2A>7QG7\'()[=*ALO@CQ0=V= S*1UD1 M\EB>W"97AEG."&0 :&DM:.5!E=_*6V0D+4HI/G J[J;"CT]G MI& D2Q/$<0(>N/@1.N,,D#68;5&QP0RDA;A!XLU-<:[8GQ]7Q3#FV@[,H%\5+MD,QOC+$JL

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end XML 94 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 95 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 96 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 146 243 1 true 60 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://dswissbeauty.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://dswissbeauty.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://dswissbeauty.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income Sheet http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome Consolidated Statements of Operations and Comprehensive Income Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://dswissbeauty.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND Sheet http://dswissbeauty.com/role/OrganizationAndBusinessBackground ORGANIZATION AND BUSINESS BACKGROUND Notes 7 false false R8.htm 00000008 - Disclosure - GOING CONCERN UNCERTAINTIES Sheet http://dswissbeauty.com/role/GoingConcernUncertainties GOING CONCERN UNCERTAINTIES Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS Sheet http://dswissbeauty.com/role/VieStructureAndArrangements VIE STRUCTURE AND ARRANGEMENTS Notes 10 false false R11.htm 00000011 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://dswissbeauty.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 11 false false R12.htm 00000012 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://dswissbeauty.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 12 false false R13.htm 00000013 - Disclosure - INTANGIBLE ASSETS Sheet http://dswissbeauty.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 13 false false R14.htm 00000014 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Sheet http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Notes 14 false false R15.htm 00000015 - Disclosure - INVENTORIES Sheet http://dswissbeauty.com/role/Inventories INVENTORIES Notes 15 false false R16.htm 00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES Sheet http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities OTHER PAYABLES AND ACCRUED LIABILITIES Notes 16 false false R17.htm 00000017 - Disclosure - FINANCE LEASE LIABILITIES Sheet http://dswissbeauty.com/role/FinanceLeaseLiabilities FINANCE LEASE LIABILITIES Notes 17 false false R18.htm 00000018 - Disclosure - AMOUNT DUE TO A DIRECTOR Sheet http://dswissbeauty.com/role/AmountDueToDirector AMOUNT DUE TO A DIRECTOR Notes 18 false false R19.htm 00000019 - Disclosure - INCOME TAXES Sheet http://dswissbeauty.com/role/IncomeTaxes INCOME TAXES Notes 19 false false R20.htm 00000020 - Disclosure - CONCENTRATIONS OF RISKS Sheet http://dswissbeauty.com/role/ConcentrationsOfRisks CONCENTRATIONS OF RISKS Notes 20 false false R21.htm 00000021 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Notes 21 false false R22.htm 00000022 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://dswissbeauty.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 22 false false R23.htm 00000023 - Disclosure - SEGMENTED INFORMATION Sheet http://dswissbeauty.com/role/SegmentedInformation SEGMENTED INFORMATION Notes 23 false false R24.htm 00000024 - Disclosure - SUBSEQUENT EVENTS Sheet http://dswissbeauty.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 24 false false R25.htm 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) Sheet http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundTables ORGANIZATION AND BUSINESS BACKGROUND (Tables) Tables http://dswissbeauty.com/role/OrganizationAndBusinessBackground 26 false false R27.htm 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 00000028 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://dswissbeauty.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://dswissbeauty.com/role/PropertyAndEquipment 28 false false R29.htm 00000029 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://dswissbeauty.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://dswissbeauty.com/role/IntangibleAssets 29 false false R30.htm 00000030 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) Sheet http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) Tables http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits 30 false false R31.htm 00000031 - Disclosure - INVENTORIES (Tables) Sheet http://dswissbeauty.com/role/InventoriesTables INVENTORIES (Tables) Tables http://dswissbeauty.com/role/Inventories 31 false false R32.htm 00000032 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Sheet http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Tables http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities 32 false false R33.htm 00000033 - Disclosure - FINANCE LEASE LIABILITIES (Tables) Sheet http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables FINANCE LEASE LIABILITIES (Tables) Tables http://dswissbeauty.com/role/FinanceLeaseLiabilities 33 false false R34.htm 00000034 - Disclosure - INCOME TAXES (Tables) Sheet http://dswissbeauty.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://dswissbeauty.com/role/IncomeTaxes 34 false false R35.htm 00000035 - Disclosure - CONCENTRATIONS OF RISKS (Tables) Sheet http://dswissbeauty.com/role/ConcentrationsOfRisksTables CONCENTRATIONS OF RISKS (Tables) Tables http://dswissbeauty.com/role/ConcentrationsOfRisks 35 false false R36.htm 00000036 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) Tables http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities 36 false false R37.htm 00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://dswissbeauty.com/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) Tables http://dswissbeauty.com/role/RelatedPartyTransactions 37 false false R38.htm 00000038 - Disclosure - SEGMENTED INFORMATION (Tables) Sheet http://dswissbeauty.com/role/SegmentedInformationTables SEGMENTED INFORMATION (Tables) Tables http://dswissbeauty.com/role/SegmentedInformation 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Sheet http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Details 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) (Parenthetical) Sheet http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical SCHEDULE OF VARIABLE INTEREST ENTITY (Details) (Parenthetical) Details 40 false false R41.htm 00000041 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) Sheet http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) Details http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundTables 41 false false R42.htm 00000042 - Disclosure - GOING CONCERN UNCERTAINTIES (Details Narrative) Sheet http://dswissbeauty.com/role/GoingConcernUncertaintiesDetailsNarrative GOING CONCERN UNCERTAINTIES (Details Narrative) Details http://dswissbeauty.com/role/GoingConcernUncertainties 42 false false R43.htm 00000043 - Disclosure - SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) Sheet http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) Details 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) Details 44 false false R45.htm 00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables 45 false false R46.htm 00000046 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) Sheet http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) Details http://dswissbeauty.com/role/VieStructureAndArrangements 46 false false R47.htm 00000047 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://dswissbeauty.com/role/StockholdersEquity 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details) Sheet http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails SCHEDULE OF PLANT AND EQUIPMENT (Details) Details 48 false false R49.htm 00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://dswissbeauty.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://dswissbeauty.com/role/PropertyAndEquipmentTables 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails SCHEDULE OF INTANGIBLE ASSETS (Details) Details 50 false false R51.htm 00000051 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://dswissbeauty.com/role/IntangibleAssetsTables 51 false false R52.htm 00000052 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) Details 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) Details 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) Sheet http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) Details 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) Sheet http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) Details 56 false false R57.htm 00000057 - Disclosure - FINANCE LEASE LIABILITIES (Details Narrative) Sheet http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative FINANCE LEASE LIABILITIES (Details Narrative) Details http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables 57 false false R58.htm 00000058 - Disclosure - AMOUNT DUE TO A DIRECTOR (Details Narrative) Sheet http://dswissbeauty.com/role/AmountDueToDirectorDetailsNarrative AMOUNT DUE TO A DIRECTOR (Details Narrative) Details http://dswissbeauty.com/role/AmountDueToDirector 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) Details 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails SCHEDULE OF PROVISION FOR INCOME TAXES (Details) Details 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details) Details 61 false false R62.htm 00000062 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://dswissbeauty.com/role/IncomeTaxesTables 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISKS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails SCHEDULE OF CONCENTRATIONS OF RISKS (Details) Details 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperatingLeaseRightOfUseAssetDetails SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET (Details) Details 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails SCHEDULE OF OPERATING LEASE LIABILITY (Details) Details 65 false false R66.htm 00000066 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) Details 66 false false R67.htm 00000067 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) Details http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails SCHEDULE OF RELATED PARTY TRANSACTION (Details) Details 68 false false R69.htm 00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://dswissbeauty.com/role/RelatedPartyTransactionsTables 69 false false R70.htm 00000070 - Disclosure - SCHEDULE OF REPORTABLE SEGMENTS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails SCHEDULE OF REPORTABLE SEGMENTS (Details) Details 70 false false R71.htm 00000071 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://dswissbeauty.com/role/SubsequentEvents 71 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueToOfficersOrStockholdersCurrent in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 28, 56, 6059, 7975 [dq-0542-Deprecated-Concept] Concept RevenueFromRelatedParties in us-gaap/2022 used in 6 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 88, 8643, 8644, 8648, 8651, 8652 form10-k.htm dqws-20221231.xsd dqws-20221231_cal.xml dqws-20221231_def.xml dqws-20221231_lab.xml dqws-20221231_pre.xml ex31-1.htm ex32-1.htm form10-k_024.jpg form10-k_025.jpg form10-k_026.jpg form10-k_027.jpg form10-k_028.jpg form10-k_029.jpg form10-k_030.jpg form10-k_031.jpg form10-k_032.jpg form10-k_033.jpg form10-k_034.jpg form10-k_035.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 99 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 16, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 553, "http://xbrl.sec.gov/dei/2022": 40 }, "contextCount": 146, "dts": { "calculationLink": { "local": [ "dqws-20221231_cal.xml" ] }, "definitionLink": { "local": [ "dqws-20221231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "dqws-20221231_lab.xml" ] }, "presentationLink": { "local": [ "dqws-20221231_pre.xml" ] }, "schema": { "local": [ "dqws-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 413, "entityCount": 1, "hidden": { "http://dswissbeauty.com/20221231": 3, "http://fasb.org/us-gaap/2022": 76, "http://xbrl.sec.gov/dei/2022": 4, "total": 83 }, "keyCustom": 24, "keyStandard": 219, "memberCustom": 35, "memberStandard": 21, "nsprefix": "DQWS", "nsuri": "http://dswissbeauty.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://dswissbeauty.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS", "menuCat": "Notes", "order": "10", "role": "http://dswissbeauty.com/role/VieStructureAndArrangements", "shortName": "VIE STRUCTURE AND ARRANGEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "11", "role": "http://dswissbeauty.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - PROPERTY AND EQUIPMENT", "menuCat": "Notes", "order": "12", "role": "http://dswissbeauty.com/role/PropertyAndEquipment", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INTANGIBLE ASSETS", "menuCat": "Notes", "order": "13", "role": "http://dswissbeauty.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS", "menuCat": "Notes", "order": "14", "role": "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits", "shortName": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - INVENTORIES", "menuCat": "Notes", "order": "15", "role": "http://dswissbeauty.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES", "menuCat": "Notes", "order": "16", "role": "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - FINANCE LEASE LIABILITIES", "menuCat": "Notes", "order": "17", "role": "http://dswissbeauty.com/role/FinanceLeaseLiabilities", "shortName": "FINANCE LEASE LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:DueToOfficersOrStockholdersTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - AMOUNT DUE TO A DIRECTOR", "menuCat": "Notes", "order": "18", "role": "http://dswissbeauty.com/role/AmountDueToDirector", "shortName": "AMOUNT DUE TO A DIRECTOR", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:DueToOfficersOrStockholdersTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "19", "role": "http://dswissbeauty.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://dswissbeauty.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - CONCENTRATIONS OF RISKS", "menuCat": "Notes", "order": "20", "role": "http://dswissbeauty.com/role/ConcentrationsOfRisks", "shortName": "CONCENTRATIONS OF RISKS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES", "menuCat": "Notes", "order": "21", "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "22", "role": "http://dswissbeauty.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - SEGMENTED INFORMATION", "menuCat": "Notes", "order": "23", "role": "http://dswissbeauty.com/role/SegmentedInformation", "shortName": "SEGMENTED INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "24", "role": "http://dswissbeauty.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "25", "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "menuCat": "Tables", "order": "26", "role": "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundTables", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "27", "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "28", "role": "http://dswissbeauty.com/role/PropertyAndEquipmentTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "29", "role": "http://dswissbeauty.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)", "menuCat": "Tables", "order": "30", "role": "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables", "shortName": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - INVENTORIES (Tables)", "menuCat": "Tables", "order": "31", "role": "http://dswissbeauty.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "menuCat": "Tables", "order": "32", "role": "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - FINANCE LEASE LIABILITIES (Tables)", "menuCat": "Tables", "order": "33", "role": "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables", "shortName": "FINANCE LEASE LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://dswissbeauty.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - CONCENTRATIONS OF RISKS (Tables)", "menuCat": "Tables", "order": "35", "role": "http://dswissbeauty.com/role/ConcentrationsOfRisksTables", "shortName": "CONCENTRATIONS OF RISKS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)", "menuCat": "Tables", "order": "36", "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "menuCat": "Tables", "order": "37", "role": "http://dswissbeauty.com/role/RelatedPartyTransactionsTables", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SEGMENTED INFORMATION (Tables)", "menuCat": "Tables", "order": "38", "role": "http://dswissbeauty.com/role/SegmentedInformationTables", "shortName": "SEGMENTED INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_DSwissHoldingLimitedMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityTypeOfEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "menuCat": "Details", "order": "39", "role": "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "shortName": "SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_DSwissHoldingLimitedMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityTypeOfEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income", "menuCat": "Statements", "order": "4", "role": "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome", "shortName": "Consolidated Statements of Operations and Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-01-172023-01-18_custom_DSwissHKLimitedMember_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) (Parenthetical)", "menuCat": "Details", "order": "40", "role": "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "shortName": "SCHEDULE OF VARIABLE INTEREST ENTITY (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_DSwissHoldingLimitedMember_country_HK", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_DSwissHoldingLimitedMember_country_HK", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - GOING CONCERN UNCERTAINTIES (Details Narrative)", "menuCat": "Details", "order": "42", "role": "http://dswissbeauty.com/role/GoingConcernUncertaintiesDetailsNarrative", "shortName": "GOING CONCERN UNCERTAINTIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_ComputerAndSoftwareMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)", "menuCat": "Details", "order": "43", "role": "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails", "shortName": "SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_ComputerAndSoftwareMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_MalaysianRinggitExchangeMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)", "menuCat": "Details", "order": "44", "role": "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails", "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_MalaysianRinggitExchangeMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-01-172023-01-18_custom_DSwissHKLimitedMember_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative", "shortName": "VIE STRUCTURE AND ARRANGEMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2016-06-262016-06-27_custom_ManagementServicesAgreementIMember_custom_DSwissHKLimitedMember", "decimals": "INF", "lang": null, "name": "DQWS:PercentageOfAnnualNetProfitToBeReceivedAsFee", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details)", "menuCat": "Details", "order": "48", "role": "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "shortName": "SCHEDULE OF PLANT AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://dswissbeauty.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedTrademarksGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "50", "role": "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedTrademarksGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "menuCat": "Details", "order": "51", "role": "http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details)", "menuCat": "Details", "order": "52", "role": "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails", "shortName": "SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "menuCat": "Details", "order": "53", "role": "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails", "shortName": "SCHEDULE OF INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableOtherCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)", "menuCat": "Details", "order": "54", "role": "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails", "shortName": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableOtherCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details)", "menuCat": "Details", "order": "55", "role": "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails", "shortName": "SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details)", "menuCat": "Details", "order": "56", "role": "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails", "shortName": "SCHEDULE OF MATURITIES OF FINANCE LEASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeLeasesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeaseDescription", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - FINANCE LEASE LIABILITIES (Details Narrative)", "menuCat": "Details", "order": "57", "role": "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "shortName": "FINANCE LEASE LIABILITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_FirstFinanceLeaseAgreementMember", "decimals": null, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToOfficersOrStockholdersCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - AMOUNT DUE TO A DIRECTOR (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://dswissbeauty.com/role/AmountDueToDirectorDetailsNarrative", "shortName": "AMOUNT DUE TO A DIRECTOR (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details)", "menuCat": "Details", "order": "59", "role": "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "shortName": "SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_country_US", "decimals": "0", "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://dswissbeauty.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)", "menuCat": "Details", "order": "60", "role": "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails", "shortName": "SCHEDULE OF PROVISION FOR INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details)", "menuCat": "Details", "order": "61", "role": "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails", "shortName": "SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_UnitedStatesOfAmericaMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_UnitedStatesOfAmericaMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISKS (Details)", "menuCat": "Details", "order": "63", "role": "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails", "shortName": "SCHEDULE OF CONCENTRATIONS OF RISKS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET (Details)", "menuCat": "Details", "order": "64", "role": "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseRightOfUseAssetDetails", "shortName": "SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "lang": null, "name": "DQWS:AddtionInOperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)", "menuCat": "Details", "order": "65", "role": "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails", "shortName": "SCHEDULE OF OPERATING LEASE LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details)", "menuCat": "Details", "order": "66", "role": "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails", "shortName": "SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative)", "menuCat": "Details", "order": "67", "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details)", "menuCat": "Details", "order": "68", "role": "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails", "shortName": "SCHEDULE OF RELATED PARTY TRANSACTION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_RelatedPartyAMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "69", "role": "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_RelatedPartyAMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND", "menuCat": "Notes", "order": "7", "role": "http://dswissbeauty.com/role/OrganizationAndBusinessBackground", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - SCHEDULE OF REPORTABLE SEGMENTS (Details)", "menuCat": "Details", "order": "70", "role": "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails", "shortName": "SCHEDULE OF REPORTABLE SEGMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-01-172023-01-18_custom_DSwissHKLimitedMember_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "71", "role": "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:GoingConcernUncertaintiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - GOING CONCERN UNCERTAINTIES", "menuCat": "Notes", "order": "8", "role": "http://dswissbeauty.com/role/GoingConcernUncertainties", "shortName": "GOING CONCERN UNCERTAINTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:GoingConcernUncertaintiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "9", "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 60, "tag": { "DQWS_AccruedAuditFeesCurrent": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued audit fees current.", "label": "Accrued audit fees" } } }, "localname": "AccruedAuditFeesCurrent", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_AdditionalProceedsFromFinanceLease": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional proceeds from finance lease.", "label": "Additional of finance lease" } } }, "localname": "AdditionalProceedsFromFinanceLease", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DQWS_AddtionInOperatingLeaseRightOfUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Addtion in operating lease right of use asset.", "label": "New Lease commenced on 1 January 2022" } } }, "localname": "AddtionInOperatingLeaseRightOfUseAsset", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseRightOfUseAssetDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_ChineseRenminbiExchangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year-end RMB [Member]", "label": "Year-end RMB [Member]" } } }, "localname": "ChineseRenminbiExchangeMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_ComputerAndSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer and Software [Member]", "label": "Computer and Software [Member]" } } }, "localname": "ComputerAndSoftwareMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomerAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer A [Member]", "label": "Customer A [Member]" } } }, "localname": "CustomerAMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer B [Member]", "label": "Customer B [Member]" } } }, "localname": "CustomerBMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomerCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer C [Member]", "label": "Customer C [Member]" } } }, "localname": "CustomerCMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customers [Member]", "label": "Customers [Member]" } } }, "localname": "CustomersMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "DQWS_DSwissBiotechMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Biotech Sdn, Bhd [Member]", "label": "DSwiss Biotech Sdn Bhd [Member]" } } }, "localname": "DSwissBiotechMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_DSwissBiotechSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Biotech Sdn Bhd [Member]", "label": "DSwiss Biotech Sdn Bhd [Member] [Default Label]", "verboseLabel": "DSwiss Biotech Sdn Bhd [Member]" } } }, "localname": "DSwissBiotechSdnBhdMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "DQWS_DSwissHKLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss HK Limited [Member]", "label": "DSwiss HK Limited [Member]" } } }, "localname": "DSwissHKLimitedMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_DSwissHoldingLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Holding Limited [Member]", "label": "DSwiss Holding Limited [Member]" } } }, "localname": "DSwissHoldingLimitedMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "DQWS_DSwissSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Sdn Bhd [Member]", "label": "DSwiss Sdn Bhd [Member]" } } }, "localname": "DSwissSdnBhdMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "DQWS_DSwissSdnBhdandDSwissBiotechSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]", "label": "DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]" } } }, "localname": "DSwissSdnBhdandDSwissBiotechSdnBhdMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_DisclosureAmountDueToDirectorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amount Due To Director" } } }, "localname": "DisclosureAmountDueToDirectorAbstract", "nsuri": "http://dswissbeauty.com/20221231", "xbrltype": "stringItemType" }, "DQWS_DisclosureFinanceLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease Liabilities", "terseLabel": "Schedule Of Maturities Of Finance Lease", "verboseLabel": "Schedule Of Obligation Under Finance Lease" } } }, "localname": "DisclosureFinanceLeaseLiabilitiesAbstract", "nsuri": "http://dswissbeauty.com/20221231", "xbrltype": "stringItemType" }, "DQWS_DisclosureGoingConcernUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Going Concern Uncertainties" } } }, "localname": "DisclosureGoingConcernUncertaintiesAbstract", "nsuri": "http://dswissbeauty.com/20221231", "xbrltype": "stringItemType" }, "DQWS_DueToOfficersOrStockholdersTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due to Officers or Stockholders [Text Block]", "label": "AMOUNT DUE TO A DIRECTOR" } } }, "localname": "DueToOfficersOrStockholdersTextBlock", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/AmountDueToDirector" ], "xbrltype": "textBlockItemType" }, "DQWS_EffectOfTranslationExchange": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effect of translation exchange.", "label": "EffectOfTranslationExchange", "negatedLabel": "Effect of translation exchange" } } }, "localname": "EffectOfTranslationExchange", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_EffectOfTranslationExchangeOfOperatingLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effect of translation exchange of operating lease liability.", "label": "EffectOfTranslationExchangeOfOperatingLeaseLiability", "verboseLabel": "Effect of translation exchange" } } }, "localname": "EffectOfTranslationExchangeOfOperatingLeaseLiability", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effect of translation exchange of operating lease right of use asset.", "label": "Effect of translation exchange" } } }, "localname": "EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseRightOfUseAssetDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_FinanceExpenses": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance expenses.", "label": "FinanceExpenses", "negatedLabel": "FINANCE COST" } } }, "localname": "FinanceExpenses", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "DQWS_FirstFinanceLeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Finance Lease Agreement [Member]", "label": "First Finance Lease Agreement [Member]" } } }, "localname": "FirstFinanceLeaseAgreementMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_GoingConcernUncertaintiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Going Concern Uncertainties [Text Block]", "label": "GOING CONCERN UNCERTAINTIES" } } }, "localname": "GoingConcernUncertaintiesTextBlock", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/GoingConcernUncertainties" ], "xbrltype": "textBlockItemType" }, "DQWS_HongKongExchangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year-end HK [Member]", "label": "Year-end HK [Member]" } } }, "localname": "HongKongExchangeMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_HongKongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hong Kong [Member]", "label": "Hong Kong [Member]" } } }, "localname": "HongKongMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "DQWS_IncreaseDecreaseInReductionInLeaseLiability": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in reduction in lease liability.", "label": "Reduction in lease liability" } } }, "localname": "IncreaseDecreaseInReductionInLeaseLiability", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DQWS_IntangibleAssetsEffectOfTranslationExchange": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intangible assets, Effect of translation exchange.", "label": "IntangibleAssetsEffectOfTranslationExchange", "negatedLabel": "Effect of translation exchange" } } }, "localname": "IntangibleAssetsEffectOfTranslationExchange", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_MalaysiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Malaysia [Member]", "label": "Malaysia [Member]" } } }, "localname": "MalaysiaMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "DQWS_MalaysianRinggitExchangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year-end MYR [Member]", "label": "Year-end MYR [Member]" } } }, "localname": "MalaysianRinggitExchangeMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_ManagementServicesAgreementIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Management Services Agreement I [Member]", "label": "Management Services Agreement I [Member]" } } }, "localname": "ManagementServicesAgreementIMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_MotorVehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Motor Vehicles [Member]", "label": "Motor Vehicles [Member]" } } }, "localname": "MotorVehiclesMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "DQWS_NVMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NV [Member]", "label": "NV [Member]" } } }, "localname": "NVMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "DQWS_NetIncomeLossAttributableToMinorityInterest": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net income (loss) attributable to minority interest.", "label": "NetIncomeLossAttributableToMinorityInterest", "negatedLabel": "Non-Controlling Interests" } } }, "localname": "NetIncomeLossAttributableToMinorityInterest", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "DQWS_ParticularsOfIssuedCapital": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Particulars of Issued Capital.", "label": "Particulars of issued capital" } } }, "localname": "ParticularsOfIssuedCapital", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "DQWS_PaymentsForAdvanceToRelatedCompanies": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for advance to related companies.", "label": "PaymentsForAdvanceToRelatedCompanies", "negatedLabel": "Advance to related companies" } } }, "localname": "PaymentsForAdvanceToRelatedCompanies", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DQWS_PeoplesRepublicOfChinaPRCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "People's Republic of China (PRC) [Member]", "label": "People's Republic of China (PRC) [Member]" } } }, "localname": "PeoplesRepublicOfChinaPRCMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "DQWS_PercentageOfAnnualNetProfitToBeReceivedAsFee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of annual net profit to be received as fee.", "label": "Percentage of annual net profit to be received as fee" } } }, "localname": "PercentageOfAnnualNetProfitToBeReceivedAsFee", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "DQWS_PeriodAverageChineseRenminbiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year-Avereage RMB [Member]", "label": "Year-Avereage RMB [Member]" } } }, "localname": "PeriodAverageChineseRenminbiMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_PeriodAverageHongKongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year-Average HK [Member]", "label": "Year-Average HK [Member]" } } }, "localname": "PeriodAverageHongKongMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_PeriodAverageMalaysianRinggitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year-Average MYR [Member]", "label": "Year-Average MYR [Member]" } } }, "localname": "PeriodAverageMalaysianRinggitMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_PlaceOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Place of incorporation.", "label": "Place of incorporation" } } }, "localname": "PlaceOfIncorporation", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "DQWS_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Parties [Policy Text Block]", "label": "Related parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "DQWS_RelatedPartyAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party A [Member]", "label": "Related Party A [Member]" } } }, "localname": "RelatedPartyAMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "DQWS_RelatedPartyBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party B [Member]", "label": "Related Party B [Member]" } } }, "localname": "RelatedPartyBMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "DQWS_RelatedPartyCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party C [Member]", "label": "Related Party C [Member]" } } }, "localname": "RelatedPartyCMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "DQWS_RelatedPartyDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party D [Member]", "label": "Related Party D [Member]" } } }, "localname": "RelatedPartyDMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "DQWS_ScheduleOfObligationUnderFinanceLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Obligation under Finance Lease [Table Text Block]", "label": "SCHEDULE OF OBLIGATION UNDER FINANCE LEASE" } } }, "localname": "ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "DQWS_ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Operating Lease Liability Disclosure [Text Block]", "label": "SCHEDULE OF OPERATING LEASE LIABILITY" } } }, "localname": "ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "DQWS_ScheduleOfOperatingLeaseOtherInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Operating Lease Other Information [Table Text Block]", "label": "SCHEDULE OF OPERATING LEASE OTHER INFORMATION" } } }, "localname": "ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "DQWS_SecondFinanceLeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Finance Lease Agreement [Member]", "label": "Second Finance Lease Agreement [Member]" } } }, "localname": "SecondFinanceLeaseAgreementMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_SeychellesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seychelles [Member]", "label": "Seychelles [Member]" } } }, "localname": "SeychellesMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "DQWS_ShippingAndHandlingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shipping and Handling [Policy Text Block]", "label": "Shipping and handling fees" } } }, "localname": "ShippingAndHandlingPolicyTextBlock", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "DQWS_StockholdersEquityNoteSpinoffTransactionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholders equity note spinoff transaction shares.", "label": "Beginning balance, shares" } } }, "localname": "StockholdersEquityNoteSpinoffTransactionShares", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "DQWS_SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of Property and Equipment Useful Life [Table Text Block]", "label": "SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE" } } }, "localname": "SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "DQWS_TaxationPaid": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Taxation paid.", "label": "TaxationPaid", "negatedLabel": "Taxation paid" } } }, "localname": "TaxationPaid", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DQWS_UnitedStatesOfAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United States of America [Member]", "label": "United States of America [Member]" } } }, "localname": "UnitedStatesOfAmericaMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "DQWS_VendorAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor A [Member]", "label": "Vendor A [Member]" } } }, "localname": "VendorAMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "DQWS_VendorBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor B [Member]", "label": "Vendor B [Member]" } } }, "localname": "VendorBMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "DQWS_VendorCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor C [Member]", "label": "Vendor C [Member]" } } }, "localname": "VendorCMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "DQWS_VendorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendors [Member]", "label": "Vendors [Member]" } } }, "localname": "VendorsMember", "nsuri": "http://dswissbeauty.com/20221231", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "country_HK": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "HONG KONG" } } }, "localname": "HK", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "country_MY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MALAYSIA" } } }, "localname": "MY", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "country_SC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEYCHELLES" } } }, "localname": "SC", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r516", "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r516", "r518", "r519" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r516", "r518", "r519" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r516", "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Date of incorporation" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r245", "r499", "r545", "r567" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r266", "r267", "r268", "r269", "r307", "r437", "r456", "r485", "r486", "r497", "r500", "r504", "r544", "r561", "r562", "r563", "r564", "r565", "r566" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r266", "r267", "r268", "r269", "r307", "r437", "r456", "r485", "r486", "r497", "r500", "r504", "r544", "r561", "r562", "r563", "r564", "r565", "r566" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r245", "r499", "r545", "r567" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r266", "r267", "r268", "r269", "r306", "r307", "r332", "r333", "r334", "r436", "r437", "r456", "r485", "r486", "r497", "r500", "r504", "r541", "r544", "r562", "r563", "r564", "r565", "r566" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r266", "r267", "r268", "r269", "r306", "r307", "r332", "r333", "r334", "r436", "r437", "r456", "r485", "r486", "r497", "r500", "r504", "r541", "r544", "r562", "r563", "r564", "r565", "r566" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r242", "r243", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r498", "r503", "r545" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r242", "r243", "r470", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r498", "r503", "r545" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "OTHER PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r19", "r502" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableOtherCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other payables" } } }, "localname": "AccountsPayableOtherCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": { "auth_ref": [ "r129", "r138" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Account Payable, Trade" } } }, "localname": "AccountsPayableTradeCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r451", "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts receivable, trade" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r247", "r248" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r78", "r164" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r28", "r29", "r30", "r167", "r452", "r464", "r468" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive losses" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r27", "r30", "r103", "r426", "r459", "r460", "r529", "r530", "r531", "r535", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r11", "r502" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r336", "r337", "r338", "r535", "r536", "r537", "r553" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r153", "r154", "r155", "r156", "r157", "r195", "r196", "r197", "r198", "r207", "r249", "r250", "r253", "r254", "r255", "r256", "r257", "r258", "r336", "r337", "r338", "r350", "r351", "r352", "r353", "r362", "r363", "r364", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r400", "r401", "r403", "r404", "r405", "r406", "r421", "r422", "r423", "r424", "r425", "r426", "r444", "r445", "r446", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net (loss)/profit to net cash generated from operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r45", "r71", "r75" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization for intangible assets", "verboseLabel": "Amortization of Intangible Assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative", "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r125", "r133", "r166", "r189", "r228", "r232", "r237", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r365", "r367", "r382", "r502", "r542", "r543", "r559" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r159", "r171", "r189", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r365", "r367", "r382", "r502", "r542", "r543", "r559" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r189", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r365", "r367", "r382", "r542", "r543", "r559" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CURRENT ASSETS" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r0", "r51", "r62" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "ORGANIZATION AND BUSINESS BACKGROUND" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackground" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r47", "r162", "r487" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r41", "r47", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "CASH AND CASH EQUIVALENTS, END OF YEAR", "periodStartLabel": "Cash and cash equivalents, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r41", "r119" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r535", "r536", "r553" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r81" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding", "verboseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r10", "r502" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares and 206,904,585 shares issued and outstanding as of December 31, 2022 and 2021 respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r31", "r173", "r175", "r180", "r447", "r453" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "COMPREHENSIVE INCOME" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r56", "r57", "r116", "r117", "r245", "r472" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r56", "r57", "r116", "r117", "r245", "r469", "r472" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r56", "r57", "r116", "r117", "r245", "r472", "r568" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS OF RISKS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ConcentrationsOfRisks" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r56", "r57", "r116", "r117", "r245" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r54", "r56", "r57", "r58", "r116", "r118", "r472" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r56", "r57", "r116", "r117", "r245", "r472" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r100", "r490" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Basis of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r37", "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Purchases" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsTotalMember": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service Benchmark [Member]" } } }, "localname": "CostOfGoodsTotalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r38", "r189", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r382", "r542" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "negatedLabel": "COST OF REVENUE", "negatedTerseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of revenue" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r534", "r549" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "negatedLabel": "- Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r534", "r549", "r551" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "- Local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r55", "r245" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r95", "r534", "r550" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "- Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r534", "r550", "r551" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "- Local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r547" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r93", "r548" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "negatedLabel": "Net operating loss carry forwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r346" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssets": { "auth_ref": [ "r525" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.", "label": "Deposits" } } }, "localname": "DepositsAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r45", "r76" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r45", "r76" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r45", "r226" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "negatedLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToOfficersOrStockholdersCurrent": { "auth_ref": [ "r6", "r121", "r132", "r142" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Amount due to a director" } } }, "localname": "DueToOfficersOrStockholdersCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/AmountDueToDirectorDetailsNarrative", "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r181", "r199", "r200", "r201", "r202", "r203", "r208", "r209", "r211", "r212", "r213", "r214", "r379", "r380", "r448", "r454", "r494" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net (loss)/profit per share- Basic and diluted" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r52", "r53" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net profit per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r555" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r190", "r342", "r356" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory income tax, rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r81", "r155", "r177", "r178", "r179", "r192", "r193", "r194", "r196", "r204", "r206", "r216", "r256", "r294", "r336", "r337", "r338", "r352", "r353", "r378", "r391", "r392", "r393", "r394", "r395", "r396", "r426", "r459", "r460", "r461" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "verboseLabel": "Equity ownership interest rate percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r114", "r115" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r408", "r417" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Total", "totalLabel": "Total" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r408" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance lease liability", "verboseLabel": "Current portion" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "SCHEDULE OF MATURITIES OF FINANCE LEASE" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r408" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Non-current portion", "verboseLabel": "Finance lease liability" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r417" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance leases" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r417" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r417" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r417" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r417" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r417" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: interest expense" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r409", "r413" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedLabel": "Repayment of finance lease" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Intangible asset, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r165", "r264" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedTrademarksGross": { "auth_ref": [ "r74" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.", "label": "Trademarks" } } }, "localname": "FiniteLivedTrademarksGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r397", "r398" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign currency exchange rate, translation" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign currencies translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r36", "r189", "r228", "r231", "r236", "r239", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r382", "r496", "r542" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r532", "r540" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment loss" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r33", "r124", "r130", "r141", "r228", "r231", "r236", "r239", "r449", "r496" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 }, "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "(Loss)/Profit before tax", "terseLabel": "Net (loss) / profit before taxation", "totalLabel": "(LOSS)/PROFIT BEFORE INCOME TAX", "verboseLabel": "(Loss)/Profit before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfCashFlows", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r190", "r343", "r344", "r348", "r354", "r357", "r359", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r86", "r87" ], "lang": { "en-us": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Largest amount of tax benefit, description" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r191", "r205", "r206", "r227", "r341", "r355", "r358", "r455" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "INCOME TAXES PROVISION", "negatedTotalLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r176", "r339", "r340", "r344", "r345", "r347", "r349" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r49" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "negatedLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r128", "r139", "r526" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Tax recoverable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r44" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r44" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r44" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r44" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "verboseLabel": "Other payables and accrued liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r44" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and deposits" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r73", "r439", "r440", "r441", "r443", "r491" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r70", "r72" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net", "totalLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r183", "r185", "r186" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r527" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods, at cost" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r169", "r488", "r502" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r161", "r168", "r215", "r259", "r260", "r261", "r438", "r492" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeFinanceLeaseDescription": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Description of lessee's finance lease.", "label": "Finance lease, description" } } }, "localname": "LesseeFinanceLeaseDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "FINANCE LEASE LIABILITIES" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r417" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Add: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r21", "r189", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r366", "r367", "r368", "r382", "r495", "r542", "r559", "r560" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r15", "r127", "r136", "r502", "r533", "r539", "r554" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r23", "r160", "r189", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r366", "r367", "r368", "r382", "r502", "r542", "r559", "r560" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r3", "r4", "r5", "r7", "r8", "r189", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r366", "r367", "r368", "r382", "r542", "r559", "r560" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CURRENT LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r25", "r126", "r135", "r189", "r252", "r270", "r273", "r274", "r275", "r279", "r280", "r382" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "NON-CONTROLLING INTEREST" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Ownership percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Equity ownership interest rate percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r184" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r184" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activity" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITY:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r41", "r43", "r46" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash generated from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "auth_ref": [ "r41", "r43", "r46" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Cash generated from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r34", "r46", "r131", "r140", "r158", "r172", "r174", "r179", "r189", "r195", "r199", "r200", "r201", "r202", "r205", "r206", "r210", "r228", "r231", "r236", "r239", "r252", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r279", "r280", "r380", "r382", "r496", "r542" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net gain (loss)", "totalLabel": "NET (LOSS)/PROFIT" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r96", "r294", "r535", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r228", "r231", "r236", "r239", "r496" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "OPERATING EXPENSES" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r556" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "negatedLabel": "LEASE EXPENSES" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Lease liability", "periodEndLabel": "Operating lease liability, ending", "periodStartLabel": "Operating lease liability, beginning" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r408" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liability", "verboseLabel": "Less: lease liability current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r408" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liability non-current portion", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r410", "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "negatedLabel": "Less: gross repayment" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r407" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use assets, net", "periodEndLabel": "Operating lease right of use asset, ending", "periodStartLabel": "Operating lease right of use asset", "verboseLabel": "Lease asset- right of use" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseRightOfUseAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r532" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of operating lease right of use asset", "negatedLabel": "Accumulated amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseRightOfUseAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r416", "r501" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate for operating lease", "verboseLabel": "Discount rate of lease payment" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r415", "r501" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaining lease term for operating lease (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r146", "r148", "r149", "r150", "r151" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.", "label": "SCHEDULE OF OPERATING LEASE RIGHT OF USE ASSET" } } }, "localname": "OperatingLeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Cumulative net operating losses" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Net operating loss carryforwards expiration" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.", "label": "Other payables and accrued liabilities", "totalLabel": "Total payables and accrued liabilities" } } }, "localname": "OtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Accrued other expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r98", "r99", "r102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r26" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "- Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income/(loss):" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r182" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "OTHER INCOME" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Lease expenses" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r40" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r9", "r281" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r9", "r281" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued", "verboseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding", "verboseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r9", "r502" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r528" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Other receivables, prepaid expenses, and deposit", "totalLabel": "Total other receivables, prepaid expenses and deposits" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r170", "r262", "r263", "r489" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLeasePayments": { "auth_ref": [ "r419", "r420" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from lease payment, classified as operating activity.", "label": "Operating cash flow from operating lease" } } }, "localname": "ProceedsFromLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Repayment to directors" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r143", "r145" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r80", "r473", "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r77", "r163" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r79", "r137", "r450", "r502" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r79", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PLANT AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property and equipment, estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r123", "r429" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "verboseLabel": "Total" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r147", "r429", "r430", "r558" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r427", "r428", "r430", "r431", "r432" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r12", "r82", "r134", "r463", "r468", "r502" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/GoingConcernUncertaintiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r155", "r192", "r193", "r194", "r196", "r204", "r206", "r256", "r336", "r337", "r338", "r352", "r353", "r378", "r459", "r461" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r224", "r225", "r230", "r234", "r235", "r241", "r242", "r245", "r303", "r304", "r442" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "REVENUE", "terseLabel": "Revenue", "verboseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails", "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r305", "r493" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r35", "r144", "r272", "r273", "r274", "r278", "r279", "r280" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Sales" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r414", "r501" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-use assets obtained in exchange for operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r245", "r538" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r552" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF PROVISION FOR INCOME TAXES" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED INCOME TAX ASSETS" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "SCHEDULE OF INTANGIBLE ASSETS" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-term intercompany foreign balances, including related intercompany entity, underlying foreign currencies and amounts of intercompany foreign currency transactions that are of a long-term investment nature (that is settlement is not planned or anticipated in the foreseeable future), as of the balance sheet date.", "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION" } } }, "localname": "ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r1", "r16", "r17", "r18" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORIES" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r122", "r123" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "SCHEDULE OF RELATED PARTY TRANSACTION" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r32", "r66" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r63", "r64", "r65", "r69" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "SCHEDULE OF REPORTABLE SEGMENTS" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SegmentedInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "auth_ref": [ "r104", "r106", "r108", "r110", "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "SCHEDULE OF VARIABLE INTEREST ENTITY" } } }, "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r54", "r56", "r57", "r58", "r116", "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "SCHEDULE OF CONCENTRATIONS OF RISKS" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ConcentrationsOfRisksTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r221", "r222", "r223", "r228", "r229", "r233", "r237", "r238", "r239", "r240", "r241", "r244", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "SEGMENTED INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SegmentedInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r39" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "SELLING, GENERAL AND ADMINISTRATIVE EXPENSES" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling and distribution expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Consideration price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Beginning balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r51", "r187" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r24", "r81", "r155", "r177", "r178", "r179", "r192", "r193", "r194", "r196", "r204", "r206", "r216", "r256", "r294", "r336", "r337", "r338", "r352", "r353", "r378", "r391", "r392", "r393", "r394", "r395", "r396", "r426", "r459", "r460", "r461" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r192", "r193", "r194", "r216", "r442" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r9", "r10", "r82" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Number of shares, acquired" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r10", "r13", "r14", "r67", "r502", "r533", "r539", "r554" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "TOTAL DSWISS, INC. STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r96", "r97", "r112", "r155", "r156", "r178", "r192", "r193", "r194", "r196", "r204", "r256", "r294", "r336", "r337", "r338", "r352", "r353", "r378", "r391", "r392", "r396", "r426", "r460", "r461", "r533", "r539", "r554" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r84", "r188", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r369" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteSpinoffTransaction": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.", "label": "Shares spinoff adjustment resulted from a stock distribution by a corporate shareholder" } } }, "localname": "StockholdersEquityNoteSpinoffTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r397", "r434" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r397", "r434" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r397", "r434" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r397", "r434" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetailsParenthetical", "http://dswissbeauty.com/role/SubsequentEventsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r433", "r435" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOWS INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationsOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Current tax liabilities" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r153", "r154", "r155", "r156", "r157", "r195", "r196", "r197", "r198", "r207", "r249", "r250", "r253", "r254", "r255", "r256", "r257", "r258", "r336", "r337", "r338", "r350", "r351", "r352", "r353", "r362", "r363", "r364", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r400", "r401", "r403", "r404", "r405", "r406", "r421", "r422", "r423", "r424", "r425", "r426", "r444", "r445", "r446", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards." } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r552" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r59", "r60", "r61", "r217", "r218", "r219", "r220" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.", "label": "VIE STRUCTURE AND ARRANGEMENTS" } } }, "localname": "VariableInterestEntityDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Proportional of ownership interest and voting power held" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_VariableInterestEntityTypeOfEntity": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Structure or legal form of Variable Interest Entity (VIE). In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities.", "label": "Company name" } } }, "localname": "VariableInterestEntityTypeOfEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityVIEActivitiesOfVIE": { "auth_ref": [ "r101", "r105", "r107", "r109" ], "lang": { "en-us": { "role": { "documentation": "Description of the transactions or business conducted by the Variable Interest Entity (VIE), including how the VIE is financed.", "label": "Principal activities" } } }, "localname": "VariableInterestEntityVIEActivitiesOfVIE", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r208", "r213" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding - Basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c,d)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228967-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(17))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "https://asc.fasb.org/topic&trid=2208923", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919320-209978", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919327-209978", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r506": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r507": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r508": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r509": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r51": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r511": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r512": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r513": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r514": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r515": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r516": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r517": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r518": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r519": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r521": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r522": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r523": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r524": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org/topic&trid=2122478", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "60", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6406278&loc=d3e26268-112671", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 100 0001493152-23-009895-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-009895-xbrl.zip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